"Name","Gene.s.","Protein.change","Condition.s.","Clinical.significance..Last.reviewed.","Review.status","Accession","GRCh37Chromosome","GRCh37Location","GRCh38Chromosome","GRCh38Location","VariationID","AlleleID.s.","dbSNP.ID","Canonical.SPDI"
"0","0","0","0","0","0","0","0",0,"0",0,0,0,"0","0"
"NM_001111.5(ADAR):c.2768T>C (p.Leu923Pro)","ADAR","L923P, L628P, L932P, L602P, L878P, L897P","Symmetrical dyschromatosis of extremities","Pathogenic(Last reviewed: Sep 1, 2003)","no assertion criteria provided","VCV000014818","1",154561144,"1",154588668,14818,29857,"rs28936680","NC_000001.11:154588667:A:G"
"NM_170707.4(LMNA):c.178C>G (p.Arg60Gly)","LMNA","R60G","not provided|Familial partial lipodystrophy 2|Dilated cardiomyopathy 1A","Pathogenic(Last reviewed: Aug 27, 2002)","no assertion criteria provided","VCV000014479","1",156084887,"1",156115096,14479,29518,"rs28928900","NC_000001.11:156115095:C:G"
"NM_170707.4(LMNA):c.1411C>T (p.Arg471Cys)","LMNA","R471C, R390C, R359C","not provided|Mandibuloacral dysplasia with type A lipodystrophy, atypical|Charcot-Marie-Tooth disease, type 2","Uncertain significance(Last reviewed: Oct 14, 2019)","criteria provided, multiple submitters, no conflicts","VCV000014503","1",156106742,"1",156136951,14503,29542,"rs28928902","NC_000001.11:156136950:C:T"
"NM_000198.4(HSD3B2):c.29C>A (p.Ala10Glu)","HSD3B2","A10E","3 beta-Hydroxysteroid dehydrogenase deficiency","Pathogenic(Last reviewed: May 1, 2000)","no assertion criteria provided","VCV000012188","1",119958071,"1",119415448,12188,27227,"rs28934880","NC_000001.11:119415447:C:A"
"NM_000702.4(ATP1A2):c.1133C>A (p.Thr378Asn)","ATP1A2","T378N","Alternating hemiplegia of childhood 1|Familial hemiplegic migraine","Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2019)","criteria provided, conflicting interpretations","VCV000012921","1",160098557,"1",160128767,12921,27960,"rs28934002","NC_000001.11:160128766:C:A"
"NM_000702.4(ATP1A2):c.2192T>C (p.Met731Thr)","ATP1A2","M731T","Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Jan 13, 2012)","no assertion criteria provided","VCV000012919","1",160105300,"1",160135510,12919,27958,"rs28933400","NC_000001.11:160135509:T:C"
"NM_000488.3(SERPINC1):c.89T>A (p.Val30Glu)","SERPINC1","","not provided|Deep venous thrombosis|Thromboembolism|Antithrombin III deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2020)","criteria provided, conflicting interpretations","VCV000018012","1",173884010,"1",173914872,18012,33051,"rs2227624","NC_000001.11:173914871:A:T"
"NM_000186.3(CFH):c.3590T>C (p.Val1197Ala)","CFH","V1197A","Atypical hemolytic-uremic syndrome 1","Pathogenic(Last reviewed: Aug 23, 2019)","criteria provided, single submitter","VCV000021090","1",196716337,"1",196747207,21090,33942,"rs460184","NC_000001.11:196747206:T:C"
"NM_001007792.1(NTRK1):c.1702C>T (p.His568Tyr)","NTRK1","H598Y, H568Y, H604Y","not specified|not provided|Hereditary insensitivity to pain with anhidrosis|Familial medullary thyroid carcinoma","Benign/Likely benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000037077","1",156848918,"1",156879126,37077,38397,"rs6336","NC_000001.11:156879125:C:T"
"NM_006894.5(FMO3):c.472G>A (p.Glu158Lys)","FMO3","","Trimethylaminuria|not specified","Benign(Last reviewed: Mar 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000038394","1",171076966,"1",171107825,38394,38476,"rs2266782","NC_000001.11:171107824:G:A"
"NM_001002294.3(FMO3):c.923A>G (p.Glu308Gly)","FMO3","E308G, E245G, E288G","Trimethylaminuria|not specified","Benign/Likely benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000038395","1",171083242,"1",171114102,38395,31357,"rs2266780","NC_000001.11:171114101:A:G"
"NM_000186.3(CFH):c.1204= (p.His402=)","CFH","","Basal laminar drusen|Age-related macular degeneration 4","Pathogenic, risk factor(Last reviewed: Jun 11, 2019)","no assertion criteria provided","VCV000016549","1",196659237,"1",196690107,16549,31588,"rs1061170","NC_000001.11:196690106:C:C"
"NM_000069.3(CACNA1S):c.3716G>A (p.Arg1239His)","CACNA1S","R1239H","Malignant hyperthermia, susceptibility to, 5|Hypokalemic periodic paralysis 1|not provided|Hypokalemic periodic paralysis 1","Pathogenic(Last reviewed: Sep 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017623","1",201022666,"1",201053538,17623,32662,"rs28930068","NC_000001.11:201053537:C:T"
"NM_000069.3(CACNA1S):c.3715C>G (p.Arg1239Gly)","CACNA1S","R1239G","Malignant hyperthermia, susceptibility to, 5|Hypokalemic periodic paralysis 1|not provided|Hypokalemic periodic paralysis 1","Pathogenic(Last reviewed: May 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017624","1",201022667,"1",201053539,17624,32663,"rs28930069","NC_000001.11:201053538:G:C"
"NM_000157.4(GBA):c.680A>G (p.Asn227Ser)","GBA|LOC106627981","N227S, N140S, N178S","Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|not provided|Gaucher disease|Gaucher disease type I|Gaucher disease type III","Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004314","1",155208006,"1",155238215,4314,19353,"rs364897","NC_000001.11:155238214:T:C"
"NM_000157.4(GBA):c.754T>A (p.Phe252Ile)","GBA|LOC106627981","F252I, F165I, F203I","not provided|Gaucher disease|Gaucher disease type I|Gaucher disease type III|Gaucher disease type II","Pathogenic(Last reviewed: Oct 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004301","1",155207932,"1",155238141,4301,19340,"rs381737","NC_000001.11:155238140:A:T"
"NM_000157.4(GBA):c.259C>T (p.Arg87Trp)","GBA|LOC106627981","R87W","Gaucher disease|Gaucher disease type I|not provided","Pathogenic(Last reviewed: Feb 13, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004321","1",155209725,"1",155239934,4321,19360,"rs1141814","NC_000001.11:155239933:G:A"
"NM_006996.3(SLC19A2):c.515G>A (p.Gly172Asp)","SLC19A2","G172D","Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided","Pathogenic(Last reviewed: Oct 10, 2018)","criteria provided, multiple submitters, no conflicts","VCV000005957","1",169446685,"1",169477447,5957,20996,"rs28937595","NC_000001.11:169477446:C:T"
"NM_004700.4(KCNQ4):c.853G>A (p.Gly285Ser)","KCNQ4","G285S","Autosomal dominant nonsyndromic deafness 2A|Rare genetic deafness|Nonsyndromic hearing loss and deafness","Pathogenic(Last reviewed: Sep 11, 2018)","reviewed by expert panel","VCV000006241","1",41285565,"1",40819893,6241,21280,"rs28937588","NC_000001.11:40819892:G:A"
"NM_004700.4(KCNQ4):c.853G>T (p.Gly285Cys)","KCNQ4","G285C","Autosomal dominant nonsyndromic deafness 2A","Pathogenic(Last reviewed: Feb 17, 2011)","no assertion criteria provided","VCV000006244","1",41285565,"1",40819893,6244,21283,"rs28937588","NC_000001.11:40819892:G:T"
"NM_000110.4(DPYD):c.1905+1G>A","DPYD","","not provided|Dihydropyrimidine dehydrogenase deficiency|Fluorouracil response|capecitabine response - Toxicity/ADR, Metabolism/PK|fluorouracil response - Toxicity/ADR, Metabolism/PK|Pyrimidine analogues response - Toxicity/ADR, Metabolism/PK|tegafur response - Toxicity/ADR, Metabolism/PK|Hirschsprung disease 1|Shortening of all phalanges of fingers|Hallux valgus|Aggressive behavior|Mandibular prognathia|2-3 toe syndactyly|Seizures|Macroglossia|Abnormal aggressive, impulsive or violent behavior|Cognitive impairment|Global developmental delay|Coarse facial features|Intellectual disability|Widely spaced teeth|Slit-like opening of the exterior auditory meatus|Intellectual disability, profound|Frontal bossing|Autistic disorder of childhood onset|Short toe|Clinodactyly of the 5th toe|Thick lower lip vermilion|Bulbous nose|Profound global developmental delay","drug response(Last reviewed: May 14, 2018)","reviewed by expert panel","VCV000000432","1",97915614,"1",97450058,432,15471,"rs3918290","NC_000001.11:97450057:C:T"
"NM_005957.4(MTHFR):c.1286A>C (p.Glu429Ala)","MTHFR","E470A","not specified|Gastrointestinal stromal tumor|Neural tube defects, folate-sensitive|Homocystinuria due to methylene tetrahydrofolate reductase deficiency|not provided|none provided|Schizophrenia, susceptibility to|Homocystinuria due to MTHFR deficiency|MTHFR deficiency, thermolabile type","Conflicting interpretations of pathogenicity, other(Last reviewed: Jul 1, 2021)","criteria provided, conflicting interpretations","VCV000003521","1",11854476,"1",11794419,3521,18560,"rs1801131","NC_000001.11:11794418:T:G"
"NM_001008216.2(GALE):c.937C>A (p.Leu313Met)","GALE","L313M","UDPglucose-4-epimerase deficiency","Pathogenic(Last reviewed: Jan 1, 1998)","no assertion criteria provided","VCV000003680","1",24122692,"1",23796202,3680,18719,"rs3180383","NC_000001.11:23796201:G:T"
"NM_001122764.3(PPOX):c.35T>C (p.Ile12Thr)","PPOX","I12T","Variegate porphyria, homozygous","Pathogenic(Last reviewed: Apr 1, 2001)","no assertion criteria provided","VCV000008703","1",161136672,"1",161166882,8703,23742,"rs28936677","NC_000001.11:161166881:T:C"
"NM_001122764.3(PPOX):c.767C>G (p.Pro256Arg)","PPOX","P256R, P120R, P223R, P94R","not provided|Variegate porphyria|Variegate porphyria, homozygous","Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)","criteria provided, conflicting interpretations","VCV000008704","1",161138933,"1",161169143,8704,23743,"rs12735723","NC_000001.11:161169142:C:G"
"NM_000350.3(ABCA4):c.2828G>A (p.Arg943Gln)","ABCA4","R943Q","not provided|not specified|MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|none provided|Stargardt disease|Macular degeneration|Stargardt disease 1|ABCA4-Related Disorders|Stargardt Disease, Recessive|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive","Benign/Likely benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000007913","1",94512565,"1",94047009,7913,22952,"rs1801581","NC_000001.11:94047008:C:T"
"NM_000261.2(MYOC):c.1196G>T (p.Gly399Val)","MYOC","G399V","Glaucoma 1, open angle, a, digenic","Pathogenic(Last reviewed: Feb 1, 2002)","no assertion criteria provided","VCV000007957","1",171605384,"1",171636244,7957,22996,"rs28936694","NC_000001.11:171636243:C:A"
"NM_000447.3(PSEN2):c.365C>G (p.Thr122Arg)","PSEN2","T122R","not provided|Alzheimer disease, type 4","Pathogenic(Last reviewed: Dec 1, 2003)","no assertion criteria provided","VCV000008851","1",227073247,"1",226885546,8851,23890,"rs28936380","NC_000001.11:226885545:C:G"
"NM_000098.3(CPT2):c.149C>A (p.Pro50His)","CPT2","P50H","Carnitine palmitoyltransferase II deficiency|not provided|Carnitine palmitoyltransferase II deficiency, infantile|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Gastrointestinal dysmotility|Inappropriate sinus tachycardia|Chronic pain|Dysautonomia|Sinus tachycardia|Arthritis|Pancytopenia|Polyarticular arthritis|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Carnitine palmitoyltransferase II deficiency, infantile|Carnitine palmitoyltransferase II deficiency, lethal neonatal|Encephalopathy, acute, infection-induced, 4, susceptibility to","Pathogenic(Last reviewed: Sep 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008954","1",53662764,"1",53197092,8954,23993,"rs28936375","NC_000001.11:53197091:C:A"
"NM_000098.3(CPT2):c.520G>A (p.Glu174Lys)","CPT2","E174K","Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyltransferase II deficiency, infantile","Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008957","1",53675866,"1",53210194,8957,23996,"rs28936674","NC_000001.11:53210193:G:A"
"NM_001397.3(ECE1):c.2260C>T (p.Arg754Cys)","ECE1","R742C, R738C, R751C, R754C","Hirschsprung disease, cardiac defects, and autonomic dysfunction","Pathogenic(Last reviewed: Jan 1, 1999)","no assertion criteria provided","VCV000009133","1",21546501,"1",21220008,9133,24172,"rs3026906","NC_000001.11:21220007:G:A"
"NM_000350.3(ABCA4):c.6319C>A (p.Arg2107Ser)","ABCA4","R2107S","not provided","Uncertain significance(Last reviewed: Nov 21, 2016)","criteria provided, single submitter","VCV000497254","1",94466625,"1",94001069,497254,488678,"rs2297669","NC_000001.11:94001068:G:T"
"NM_000702.4(ATP1A2):c.1133C>T (p.Thr378Ile)","ATP1A2","T378I","Familial hemiplegic migraine|not specified","Uncertain significance(Last reviewed: Nov 27, 2017)","criteria provided, multiple submitters, no conflicts","VCV000392148","1",160098557,"1",160128767,392148,364492,"rs28934002","NC_000001.11:160128766:C:T"
"NM_001244753.2(FCGR3B):c.316A>G (p.Ile106Val)","FCGR3B","I106V, I105V, I89V","not specified","Benign(Last reviewed: Mar 28, 2016)","criteria provided, single submitter","VCV000402858","1",161599571,"1",161629781,402858,389362,"rs2290834","NC_000001.11:161629780:T:C"
"NM_018116.3(MSTO1):c.971C>T (p.Thr324Ile)","MSTO1","T324I, T146I, T147I, T143I, T269I","Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2021)","criteria provided, conflicting interpretations","VCV000438833","1",155582639,"1",155612848,438833,432466,"rs622288","NC_000001.11:155612847:C:T"
"NR_040073.1(MIR181A1HG):n.364-18748G>A","MIR181A1HG","","Acute myeloid leukemia with maturation","Pathogenic","no assertion criteria provided","VCV000427753","1",198796120,"1",198826991,427753,417642,"rs12406470","NC_000001.11:198826990:C:T"
"NR_040073.1(MIR181A1HG):n.363+1456C>T","MIR181A1HG","","Acute myeloid leukemia with maturation","Pathogenic","no assertion criteria provided","VCV000427755","1",198868084,"1",198898955,427755,417644,"rs10800597","NC_000001.11:198898954:G:A"
"NR_040073.1(MIR181A1HG):n.363+26A>G","MIR181A1HG","","Acute myeloid leukemia with maturation","Pathogenic","no assertion criteria provided","VCV000427756","1",198869514,"1",198900385,427756,417645,"rs10800598","NC_000001.11:198900384:T:C"
"NM_000350.3(ABCA4):c.6319C>T (p.Arg2107Cys)","ABCA4","R2107C","Retinal dystrophy|Stargardt disease|not provided","Pathogenic(Last reviewed: Oct 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000635988","1",94466625,"1",94001069,635988,623815,"rs2297669","NC_000001.11:94001068:G:A"
"NM_015602.3(TOR1AIP1):c.961C>T (p.Arg321Ter)","TOR1AIP1","R321*, R322*","Muscular dystrophy, limb-girdle, type 2y","Likely pathogenic(Last reviewed: Jun 20, 2019)","criteria provided, single submitter","VCV000804380","1",179883186,"1",179914051,804380,792713,"rs11581962","NC_000001.11:179914050:C:T"
"NM_000098.3(CPT2):c.520G>T (p.Glu174Ter)","CPT2","E174*","Carnitine palmitoyltransferase II deficiency, infantile","Likely pathogenic(Last reviewed: Jan 26, 2017)","criteria provided, single submitter","VCV000550520","1",53675866,"1",53210194,550520,541317,"rs28936674","NC_000001.11:53210193:G:T"
"NM_000143.3(FH):c.1302C>T (p.Cys434=)","FH","","none provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Multiple Cutaneous and Uterine Leiomyomas|not provided|Hereditary cancer-predisposing syndrome|not specified","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000137372","1",241663825,"1",241500525,137372,141075,"rs2070080","NC_000001.11:241500524:G:A"
"NM_170707.4(LMNA):c.178C>T (p.Arg60Cys)","LMNA","R60C","Charcot-Marie-Tooth disease, type 2|not specified|Cardiomyopathy","Uncertain significance(Last reviewed: Jun 5, 2019)","criteria provided, multiple submitters, no conflicts","VCV000179969","1",156084887,"1",156115096,179969,172341,"rs28928900","NC_000001.11:156115095:C:T"
"NM_000069.3(CACNA1S):c.2748C>G (p.His916Gln)","CACNA1S","H916Q","Hypokalemic periodic paralysis 1","Pathogenic(Last reviewed: Jul 31, 2014)","no assertion criteria provided","VCV000143198","1",201035071,"1",201065943,143198,152916,"rs2297902","NC_000001.11:201065942:G:C"
"NM_170707.4(LMNA):c.1411C>G (p.Arg471Gly)","LMNA","R471G, R390G, R359G","not provided","not provided","no assertion provided","VCV000066824","1",156106742,"1",156136951,66824,77721,"rs28928902","NC_000001.11:156136950:C:G"
"NM_000350.3(ABCA4):c.3386G>T (p.Arg1129Leu)","ABCA4","R1129L","Retinal dystrophy|not provided|Stargardt disease 1|Stargardt disease 1|Cone-rod dystrophy 3|Age-related macular degeneration 2|Retinitis pigmentosa 19|Age-related macular degeneration 2","Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000099224","1",94506901,"1",94041345,99224,105113,"rs1801269","NC_000001.11:94041344:C:A"
"NM_000350.3(ABCA4):c.4685T>C (p.Ile1562Thr)","ABCA4","I1562T","Stargardt disease|Cone-rod dystrophy 3|Retinal dystrophy|not provided|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|Cone-rod dystrophy|ABCA4-Related Disorders|Stargardt disease 1","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000099311","1",94487490,"1",94021934,99311,105200,"rs1762111","NC_000001.11:94021933:A:G"
"NM_000350.3(ABCA4):c.5461-10T>C","ABCA4","","Macular dystrophy|Retinal dystrophy|Stargardt disease 1|Age-related macular degeneration 2|Cone-rod dystrophy 3|Retinitis pigmentosa 19|Cone-rod dystrophy 3|Retinitis pigmentosa 19|Stargardt disease|not specified|Benign concentric annular macular dystrophy|Retinitis pigmentosa|Age-related macular degeneration 2|not provided|Stargardt disease 1","Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)","criteria provided, multiple submitters, no conflicts","VCV000092870","1",94476951,"1",94011395,92870,98777,"rs1800728","NC_000001.11:94011394:A:G"
"NM_000157.4(GBA):c.1483G>C (p.Ala495Pro)","GBA|LOC106627981","A495P, A408P, A446P","not specified","Benign(Last reviewed: Jul 24, 2012)","criteria provided, single submitter","VCV000093450","1",155205008,"1",155235217,93450,38384,"rs368060","NC_000001.11:155235216:C:G"
"NM_000069.3(CACNA1S):c.2748C>T (p.His916=)","CACNA1S","","Hypokalemic periodic paralysis 1|Malignant hyperthermia, susceptibility to, 5|not specified|Hypokalemic periodic paralysis 1|not provided","Benign(Last reviewed: Dec 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000254822","1",201035071,"1",201065943,254822,249618,"rs2297902","NC_000001.11:201065942:G:A"
"NM_003126.4(SPTA1):c.5572C>G (p.Leu1858Val)","SPTA1","L1858V","not specified|Elliptocytosis 2|Hereditary pyropoikilocytosis|Hemolytic anemia|Spherocytosis type 3","Benign/Likely benign(Last reviewed: May 15, 2018)","criteria provided, multiple submitters, no conflicts","VCV000258948","1",158597507,"1",158627717,258948,249434,"rs3737515","NC_000001.11:158627716:G:C"
"NM_003126.4(SPTA1):c.6531-12C>T","SPTA1","","Hemolytic anemia|Elliptocytosis 2|Hereditary pyropoikilocytosis|not specified|Spherocytosis type 3","Conflicting interpretations of pathogenicity(Last reviewed: Jan 11, 2019)","criteria provided, conflicting interpretations","VCV000258954","1",158587858,"1",158618068,258954,249428,"rs28525570","NC_000001.11:158618067:G:A"
"NM_000350.3(ABCA4):c.3377T>C (p.Leu1126Pro)","ABCA4","L1126P","Stargardt disease 1","Likely pathogenic(Last reviewed: Jan 1, 2016)","criteria provided, single submitter","VCV000236101","1",94506910,"1",94041354,236101,237679,"rs1047376","NC_000001.11:94041353:A:G"
"NM_000570.4(FCGR3B):c.316A= (p.Ile106=)","FCGR3B","","","no interpretation for the single variant","no interpretation for the single variant","VCV000242687","1",161599571,"1",161629781,242687,45585,"rs2290834","NC_000001.11:161629780:T:T"
"NM_015074.3(KIF1B):c.3260A>G (p.Tyr1087Cys)","KIF1B","Y1087C, Y1133C","Charcot-Marie-Tooth disease, type 2A1|Charcot-Marie-Tooth disease, type 2|Neuroblastoma|Charcot-Marie-Tooth disease","Benign(Last reviewed: Nov 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000291567","1",10397567,"1",10337509,291567,275799,"rs2297881","NC_000001.11:10337508:A:G"
"NM_000186.3(CFH):c.1204C>T (p.His402Tyr)","CFH","H402Y","Atypical hemolytic-uremic syndrome 1|Basal laminar drusen|Age-related macular degeneration 4|not provided|CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000294490","1",196659237,"1",196690107,294490,278205,"rs1061170","NC_000001.11:196690106:C:T"
"NM_000143.3(FH):c.1302C>A (p.Cys434Ter)","FH","C434*","not provided","Likely pathogenic(Last reviewed: Nov 17, 2016)","criteria provided, single submitter","VCV000373513","1",241663825,"1",241500525,373513,359342,"rs2070080","NC_000001.11:241500524:G:T"
"NM_014625.3(NPHS2):c.586C>T (p.Arg196Ter)","NPHS2","R196*","Idiopathic nephrotic syndrome|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2019)","criteria provided, multiple submitters, no conflicts","VCV000188892","1",179526314,"1",179557179,188892,186604,"rs12568913","NC_000001.11:179557178:G:A"
"NM_014625.3(NPHS2):c.-51G>T","NPHS2","","Idiopathic nephrotic syndrome|not provided|not specified","Benign(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000225144","1",179545050,"1",179575915,225144,227036,"rs12406197","NC_000001.11:179575914:C:A"
"NM_020975.6(RET):c.2944C>T (p.Arg982Cys)","RET","R982C, R728C","not specified|Hereditary cancer-predisposing syndrome|not provided|Malignant tumor of breast|Multiple endocrine neoplasia, type 2|Hirschsprung disease|Familial medullary thyroid carcinoma|Renal hypodysplasia/aplasia 1|Hirschsprung disease 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2a","Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000013938","10",43620335,"10",43124887,13938,28977,"rs17158558","NC_000010.11:43124886:C:T"
"NM_001378373.1(MBL2):c.154C>T (p.Arg52Cys)","MBL2","","Mannose-binding protein deficiency|Cystic fibrosis","Pathogenic(Last reviewed: Dec 11, 2018)","criteria provided, single submitter","VCV000014352","10",54531242,"10",52771482,14352,29391,"rs5030737","NC_000010.11:52771481:G:A"
"NM_001083116.3(PRF1):c.673C>T (p.Arg225Trp)","PRF1","R225W","Familial hemophagocytic lymphohistiocytosis 2","Pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000013711","10",72358804,"10",70599048,13711,28750,"rs28933973","NC_000010.11:70599047:G:A"
"NM_001083116.3(PRF1):c.1034C>T (p.Pro345Leu)","PRF1","P345L","Familial hemophagocytic lymphohistiocytosis 2","Pathogenic(Last reviewed: Dec 3, 1999)","no assertion criteria provided","VCV000013713","10",72358443,"10",70598687,13713,28752,"rs28933374","NC_000010.11:70598686:G:A"
"NM_000043.6(FAS):c.779A>T (p.Asp260Val)","FAS","D244V, D260V, D239V","Autoimmune lymphoproliferative syndrome, type 1a","Pathogenic(Last reviewed: Nov 1, 1998)","no assertion criteria provided","VCV000016504","10",90773978,"10",89014221,16504,31543,"rs28929498","NC_000010.11:89014220:A:T"
"CYP2C19*4A","CYP2C19","M1V","Mephenytoin, poor metabolism of|CYP2C19: no function|clopidogrel response - Efficacy|not provided","drug response","practice guideline","VCV000016900","10",96522463,"10",94762706,16900,31939,"rs28399504","NC_000010.11:94762705:A:G"
"CYP2C19*4A/*27","CYP2C19|LOC110599570","","Sertraline response|Voriconazole response|Escitalopram response|Citalopram response","drug response","practice guideline","VCV000634305","10",96521422,"10",94761665,634305,622275,"rs7902257","NC_000010.11:94761664:G:A"
"CYP2C19*4A/*15","CYP2C19","I19L","Citalopram response|Voriconazole response|Escitalopram response|Sertraline response","drug response","practice guideline","VCV000634363","10",96522517,"10",94762760,634363,622281,"rs17882687","NC_000010.11:94762759:A:C"
"NM_006257.5(PRKCQ):c.989C>T (p.Pro330Leu)","PRKCQ","P205L, P294L, P330L","Inflammatory bowel disease 1","Pathogenic","no assertion criteria provided","VCV000586982","10",6527143,"10",6485181,586982,578028,"rs2236379","NC_000010.11:6485180:G:A"
"CYP2C19*4A/*22","CYP2C19","R186P","Escitalopram response|Voriconazole response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000634017","10",96540331,"10",94780574,634017,622289,"rs140278421","NC_000010.11:94780573:G:C"
"NM_001081.3(CUBN):c.3G>T (p.Met1Ile)","CUBN","M1I","Imerslund-Gräsbeck syndrome|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2020)","criteria provided, conflicting interpretations","VCV000373456","10",17171762,"10",17129763,373456,359953,"rs11254385","NC_000010.11:17129762:C:A"
"NM_000392.5(ABCC2):c.2901C>A (p.Tyr967Ter)","ABCC2","Y967*","not provided","Pathogenic(Last reviewed: May 19, 2015)","criteria provided, single submitter","VCV000195649","10",101591385,"10",99831628,195649,192810,"rs17222547","NC_000010.11:99831627:C:A"
"NM_000518.5(HBB):c.93G>T (p.Arg31Ser)","LOC106099062|LOC107133510|HBB","R31S","Heinz body anemia|not specified|not provided","Uncertain significance(Last reviewed: Nov 11, 2019)","criteria provided, multiple submitters, no conflicts","VCV000015368","11",5248029,"11",5226799,15368,30407,"rs1135071","NC_000011.10:5226798:C:A"
"NM_001382.4(DPAGT1):c.509A>G (p.Tyr170Cys)","DPAGT1","Y170C","DPAGT1-CDG|Congenital myasthenic syndrome 13|DPAGT1-CDG|Congenital disorder of glycosylation","Uncertain significance(Last reviewed: Nov 21, 2018)","criteria provided, single submitter","VCV000012296","11",118971106,"11",119100396,12296,27335,"rs28934876","NC_000011.10:119100395:T:C"
"NM_000260.4(MYO7A):c.635G>A (p.Arg212His)","MYO7A","R212H, R201H","Deafness, autosomal recessive 2|Usher syndrome type 1|Rare genetic deafness|not provided|Usher syndrome, type 1B|Retinal dystrophy","Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000011850","11",76867950,"11",77156904,11850,26889,"rs28934610","NC_000011.10:77156903:G:A"
"NM_000506.5(F2):c.*97G>A","F2","","not provided|Prothrombin deficiency, congenital|Hereditary factor II deficiency disease|Pregnancy loss, recurrent, susceptibility to, 2|Ischemic stroke, susceptibility to|Thrombophilia due to thrombin defect|Venous thromboembolism","Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Oct 31, 2020)","criteria provided, conflicting interpretations","VCV000013310","11",46761055,"11",46739505,13310,28349,"rs1799963","NC_000011.10:46739504:G:A"
"NM_000207.3(INS):c.266G>A (p.Arg89His)","INS|INS-IGF2","R89H","not provided|Hyperproinsulinemia","Pathogenic(Last reviewed: Jan 1, 2020)","criteria provided, single submitter","VCV000013380","11",2181149,"11",2159919,13380,28419,"rs28933985","NC_000011.10:2159918:C:T"
"NM_000207.3(INS):c.266G>T (p.Arg89Leu)","INS-IGF2|INS","R89L","Hyperproinsulinemia","Pathogenic(Last reviewed: Jun 1, 1992)","no assertion criteria provided","VCV000013382","11",2181149,"11",2159919,13382,28421,"rs28933985","NC_000011.10:2159918:C:A"
"NM_000207.3(INS):c.266G>C (p.Arg89Pro)","INS|INS-IGF2","R89P","Hyperproinsulinemia","Pathogenic(Last reviewed: May 1, 1997)","no assertion criteria provided","VCV000013383","11",2181149,"11",2159919,13383,28422,"rs28933985","NC_000011.10:2159918:C:G"
"NM_021961.6(TEAD1):c.1261T>C (p.Tyr421His)","TEAD1","Y421H","Sveinsson chorioretinal atrophy","Pathogenic(Last reviewed: Oct 5, 2007)","no assertion criteria provided","VCV000012630","11",12958749,"11",12937202,12630,27669,"rs11567847","NC_000011.10:12937201:T:C"
"NM_000256.3(MYBPC3):c.2992C>G (p.Gln998Glu)","MYBPC3","Q998E","Primary familial hypertrophic cardiomyopathy|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Cardiomyopathy|Left ventricular noncompaction 10|Primary dilated cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy|none provided|Familial hypertrophic cardiomyopathy 4|not specified","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000036610","11",47355475,"11",47333924,36610,45272,"rs11570112","NC_000011.10:47333923:G:C"
"NM_000480.3(AMPD3):c.1744C>T (p.Arg582Cys)","AMPD3","R573C, R582C, R580C, R414C","Erythrocyte AMP deaminase deficiency","Pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000018270","11",10521792,"11",10500245,18270,33309,"rs3741040","NC_000011.10:10500244:C:T"
"NM_003476.5(CSRP3):c.336G>A (p.Ala112=)","CSRP3","R56Q","Familial hypertrophic cardiomyopathy 12|Cardiovascular phenotype|Cardiomyopathy|Primary dilated cardiomyopathy|none provided|Dilated cardiomyopathy 1M|Familial hypertrophic cardiomyopathy 12|not specified|not provided","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000044696","11",19207841,"11",19186294,44696,53863,"rs13451","NC_000011.10:19186293:C:T"
"NM_001567.4(INPPL1):c.2415+1G>A","INPPL1","","Opsismodysplasia","Pathogenic(Last reviewed: Jan 10, 2013)","no assertion criteria provided","VCV000039476","11",71945660,"11",72234616,39476,48075,"rs655423","NC_000011.10:72234615:G:A"
"NM_000244.3(MEN1):c.76G>A (p.Glu26Lys)","MEN1","E26K","not provided|Multiple endocrine neoplasia, type 1|Parathyroid adenoma, somatic","Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2019)","criteria provided, conflicting interpretations","VCV000016689","11",64577506,"11",64810034,16689,31728,"rs28931612","NC_000011.10:64810033:C:T"
"NM_000510.3(FSHB):c.205T>G (p.Cys69Gly)","FSHB|ARL14EP-DT","C69G","Hypogonadotropic hypogonadism 24 without anosmia","Pathogenic(Last reviewed: Nov 25, 2010)","no assertion criteria provided","VCV000016241","11",30255162,"11",30233615,16241,31280,"rs5030776","NC_000011.10:30233614:T:G"
"NM_000039.2(APOA1):c.589C>T (p.Arg197Cys)","APOA1","R197C, R88C","APOLIPOPROTEIN A-I (MILANO)","Pathogenic(Last reviewed: Nov 5, 2003)","no assertion criteria provided","VCV000017909","11",116706739,"11",116836023,17909,32948,"rs28931573","NC_000011.10:116836022:G:A"
"NM_000039.2(APOA1):c.101G>T (p.Arg34Leu)","APOA1|APOA1-AS","R34L","not provided|APOLIPOPROTEIN A-I (BALTIMORE)","Uncertain significance(Last reviewed: Aug 5, 2020)","criteria provided, single submitter","VCV000017920","11",116707816,"11",116837100,17920,32959,"rs28929476","NC_000011.10:116837099:C:A"
"NM_018389.4(SLC35C1):c.923C>G (p.Thr308Arg)","SLC35C1","T308R, T295R","Leukocyte adhesion deficiency type II","Pathogenic(Last reviewed: Jun 15, 2002)","no assertion criteria provided","VCV000004740","11",45832714,"11",45811163,4740,19779,"rs28937886","NC_000011.10:45811162:C:G"
"NM_001814.6(CTSC):c.1235A>G (p.Tyr412Cys)","CTSC","Y412C","Periodontitis, aggressive, 1","Pathogenic(Last reviewed: Mar 1, 2004)","no assertion criteria provided","VCV000007300","11",88027331,"11",88294163,7300,22339,"rs28937571","NC_000011.10:88294162:T:C"
"NM_003356.4(UCP3):c.208C>T (p.Arg70Trp)","UCP3","R70W","Obesity, severe, and type II diabetes","Pathogenic(Last reviewed: Sep 2, 2008)","no assertion criteria provided","VCV000007579","11",73717343,"11",74006298,7579,22618,"rs17848368","NC_000011.10:74006297:G:A"
"NM_002716.5(PPP2R1B):c.269G>A (p.Gly90Asp)","PPP2R1B","G90D","Lung carcinoma","Pathogenic(Last reviewed: Apr 1, 2002)","no assertion criteria provided","VCV000006621","11",111635566,"11",111764842,6621,21660,"rs1805076","NC_000011.10:111764841:C:T"
"NM_004183.4(BEST1):c.355G>C (p.Glu119Gln)","BEST1","E119Q, E13Q, E59Q","not provided|Vitelliform macular dystrophy type 2","Uncertain significance(Last reviewed: Sep 12, 2020)","criteria provided, single submitter","VCV000002735","11",61723297,"11",61955825,2735,17774,"rs1805142","NC_000011.10:61955824:G:C"
"NM_000051.3(ATM):c.2250G>A (p.Lys750=)","ATM","","Malignant tumor of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Ataxia-telangiectasia syndrome|not provided|Familial cancer of breast|Ataxia-telangiectasia syndrome","Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000003044","11",108127067,"11",108256340,3044,18083,"rs1137887","NC_000011.10:108256339:G:A"
"NM_000218.3(KCNQ1):c.1552C>T (p.Arg518Ter)","KCNQ1","R518*, R391*","not provided|Conduction disorder of the heart|Long QT syndrome|Arrhythmia|KCNQ1-Related Disorders|Cardiovascular phenotype|Congenital long QT syndrome|not specified|Atrial fibrillation, familial, 3|Short QT syndrome 2|Long QT syndrome 1, recessive|Long QT syndrome 1","Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2020)","criteria provided, conflicting interpretations","VCV000003131","11",2790111,"11",2768881,3131,18170,"rs17215500","NC_000011.10:2768880:C:T"
"NM_181798.1(KCNQ1):c.651G>A (p.Ala217=)","KCNQ1","","Cardiovascular phenotype|Long QT syndrome 1|not provided|Long QT syndrome|Long QT syndrome 2","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000003135","11",2604775,"11",2583545,3135,18174,"rs1800171","NC_000011.10:2583544:G:A"
"NM_181798.1(KCNQ1):c.1366C>T (p.Arg456Cys)","KCNQ1","R583C, R456C","not provided|Congenital long QT syndrome|Short QT syndrome 2|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1|Atrial fibrillation, familial, 3|Beckwith-Wiedemann syndrome|Acquired susceptibility to long QT syndrome 1|Long QT syndrome 1","Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)","criteria provided, multiple submitters, no conflicts","VCV000003142","11",2799220,"11",2777990,3142,18181,"rs17221854","NC_000011.10:2777989:C:T"
"NM_000256.3(MYBPC3):c.2459G>A (p.Arg820Gln)","MYBPC3","R820Q","Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Cardiomyopathy|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008617","11",47359085,"11",47337534,8617,23656,"rs2856655","NC_000011.10:47337533:C:T"
"NM_000256.3(MYBPC3):c.208G>T (p.Glu70Ter)","MYBPC3","E70*","not provided","Likely pathogenic(Last reviewed: Nov 5, 2015)","criteria provided, single submitter","VCV000429923","11",47372874,"11",47351323,429923,421860,"rs11570045","NC_000011.10:47351322:C:A"
"NM_000051.3(ATM):c.6108T>A (p.Tyr2036Ter)","ATM|C11orf65","Y2036*","Ataxia telangiectasi","Pathogenic(Last reviewed: May 15, 2019)","criteria provided, single submitter","VCV000635341","11",108186750,"11",108316023,635341,623153,"rs3092826","NC_000011.10:108316022:T:A"
"NM_000051.3(ATM):c.6108T>G (p.Tyr2036Ter)","ATM|C11orf65","Y2036*","Ataxia-telangiectasia syndrome","Pathogenic(Last reviewed: Jul 11, 2018)","criteria provided, single submitter","VCV000664270","11",108186750,"11",108316023,664270,639571,"rs3092826","NC_000011.10:108316022:T:G"
"NM_000518.5(HBB):c.93G>C (p.Arg31Ser)","HBB|LOC106099062|LOC107133510","R31S","beta Thalassemia","Pathogenic(Last reviewed: Nov 25, 2019)","no assertion criteria provided","VCV000869321","11",5248029,"11",5226799,869321,857494,"","NC_000011.10:5226798:C:G"
"NM_007103.4(NDUFV1):c.1312C>A (p.Leu438Met)","NDUFV1","L438M, L429M","Mitochondrial complex 1 deficiency, nuclear type 4","Likely pathogenic(Last reviewed: Sep 26, 2019)","no assertion criteria provided","VCV000800963","11",67379846,"11",67612375,800963,788853,"rs1127511","NC_000011.10:67612374:C:A"
"NM_181798.1(KCNQ1):c.651G>T (p.Ala217=)","KCNQ1","","Long QT syndrome","Likely pathogenic(Last reviewed: Nov 11, 2015)","no assertion criteria provided","VCV000560649","11",2604775,"11",2583545,560649,551716,"rs1800171","NC_000011.10:2583544:G:T"
"NM_000051.3(ATM):c.8786+1G>A","ATM|C11orf65","","Malignant glioma|Ataxia-telangiectasia syndrome|Familial cancer of breast|not provided|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome","Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2020)","criteria provided, multiple submitters, no conflicts","VCV000127463","11",108224608,"11",108353881,127463,132920,"rs17174393","NC_000011.10:108353880:G:A"
"NM_000256.3(MYBPC3):c.2459G>C (p.Arg820Pro)","MYBPC3","R820P","not specified","Uncertain significance(Last reviewed: May 19, 2017)","criteria provided, single submitter","VCV000180970","11",47359085,"11",47337534,180970,179254,"rs2856655","NC_000011.10:47337533:C:G"
"NM_000256.3(MYBPC3):c.2992C>T (p.Gln998Ter)","MYBPC3","Q998*","not provided|Hypertrophic cardiomyopathy","Pathogenic(Last reviewed: Feb 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000180993","11",47355475,"11",47333924,180993,179222,"rs11570112","NC_000011.10:47333923:G:A"
"NM_000256.3(MYBPC3):c.1147C>G (p.Leu383Val)","MYBPC3","L383V","Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Nov 8, 2019)","criteria provided, conflicting interpretations","VCV000181062","11",47365119,"11",47343568,181062,179338,"rs11570077","NC_000011.10:47343567:G:C"
"NM_001173990.3(TMEM216):c.253C>T (p.Arg85Ter)","TMEM216","R24*, R85*","Joubert syndrome 2|Joubert syndrome|TMEM216-Related Disorders|Meckel syndrome, type 2|not provided|Meckel syndrome, type 2|Joubert syndrome 2","Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000056384","11",61165269,"11",61397797,56384,71023,"rs11230683","NC_000011.10:61397796:C:T"
"NM_004588.5(SCN2B):c.82C>T (p.Arg28Trp)","SCN2B","R28W","not provided|Atrial fibrillation, familial, 14","Uncertain significance(Last reviewed: Feb 6, 2017)","criteria provided, single submitter","VCV000060769","11",118039455,"11",118168740,60769,75311,"rs17121819","NC_000011.10:118168739:G:A"
"NM_181798.1(KCNQ1):c.651G>C (p.Ala217=)","KCNQ1","","not provided","Pathogenic(Last reviewed: Jul 26, 2013)","criteria provided, single submitter","VCV000052939","11",2604775,"11",2583545,52939,67607,"rs1800171","NC_000011.10:2583544:G:C"
"NM_181798.1(KCNQ1):c.704A>G (p.Lys235Arg)","KCNQ1","K362R, K235R","Jervell and Lange-Nielsen syndrome 1|Atrial fibrillation, familial, 3|Short QT syndrome 2|Beckwith-Wiedemann syndrome|Long QT syndrome 1|Long QT syndrome 1|Toe clinodactyly|Congenital microcephaly|Polyhydramnios|Decreased fetal movement|Diffuse white matter abnormalities|Abnormality of the cerebral white matter|Generalized hypotonia|Enlarged naris|Generalized neonatal hypotonia|High palate|Neonatal hypotonia|Postnatal microcephaly|Abnormality of the nares|Arrhythmia|Long QT syndrome|Congenital long QT syndrome|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Mar 31, 2021)","criteria provided, conflicting interpretations","VCV000052953","11",2606494,"11",2585264,52953,67621,"rs12720458","NC_000011.10:2585263:A:G"
"NM_181798.1(KCNQ1):c.1171C>G (p.Arg391Gly)","KCNQ1","R518G, R391G","Long QT syndrome 1|Long QT syndrome|Congenital long QT syndrome","Likely pathogenic(Last reviewed: May 15, 2019)","criteria provided, multiple submitters, no conflicts","VCV000052991","11",2790111,"11",2768881,52991,67659,"rs17215500","NC_000011.10:2768880:C:G"
"NM_004183.4(BEST1):c.889C>G (p.Pro297Ala)","BEST1","P297A, P191A, P237A","not provided","not provided","no assertion provided","VCV000099765","11",61726991,"11",61959519,99765,105654,"rs1805143","NC_000011.10:61959518:C:G"
"NM_004183.4(BEST1):c.889C>T (p.Pro297Ser)","BEST1","P297S, P237S, P191S","Vitelliform macular dystrophy type 2|not provided","Pathogenic(Last reviewed: Sep 1, 2019)","criteria provided, single submitter","VCV000099766","11",61726991,"11",61959519,99766,105655,"rs1805143","NC_000011.10:61959518:C:T"
"NM_001173990.3(TMEM216):c.253C>A (p.Arg85=)","TMEM216","","Meckel syndrome, type 2|not specified|Joubert syndrome 2|Joubert syndrome|not provided","Benign/Likely benign(Last reviewed: May 4, 2021)","criteria provided, multiple submitters, no conflicts","VCV000282947","11",61165269,"11",61397797,282947,267184,"rs11230683","NC_000011.10:61397796:C:A"
"NM_000510.3(FSHB):c.298T>C (p.Cys100Arg)","FSHB|ARL14EP-DT","C100R","Hypogonadotropic hypogonadism 24 without anosmia","Pathogenic(Last reviewed: Nov 25, 2010)","no assertion criteria provided","VCV000189329","11",30255255,"11",30233708,189329,187217,"rs5030777","NC_000011.10:30233707:T:C"
"NM_000051.3(ATM):c.8786+1G>T","ATM|C11orf65","","Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome","Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000184741","11",108224608,"11",108353881,184741,183456,"rs17174393","NC_000011.10:108353880:G:T"
"NM_000051.3(ATM):c.6108T>C (p.Tyr2036=)","ATM|C11orf65","","not provided|Malignant tumor of breast|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000185724","11",108186750,"11",108316023,185724,183342,"rs3092826","NC_000011.10:108316022:T:C"
"NM_000051.3(ATM):c.8786+1G>C","ATM|C11orf65","","not provided|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia syndrome","Pathogenic(Last reviewed: Feb 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000187060","11",108224608,"11",108353881,187060,183455,"rs17174393","NC_000011.10:108353880:G:C"
"NM_005554.4(KRT6A):c.520T>G (p.Phe174Val)","KRT6A","F174V","not provided|Pachyonychia congenita 3","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000014635","12",52886453,"12",52492669,14635,29674,"rs28933087","NC_000012.12:52492668:A:C"
"NM_002834.5(PTPN11):c.922A>G (p.Asn308Asp)","PTPN11","N308D, N307D","Hereditary cancer-predisposing syndrome|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome 1|not specified|Inborn genetic diseases|Metachondromatosis|LEOPARD syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|Thrombocytopenia|Abnormal bleeding|LEOPARD syndrome 1|not provided|Rasopathy|Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype|LEOPARD syndrome 1|Noonan syndrome 1","Pathogenic(Last reviewed: Apr 3, 2017)","reviewed by expert panel","VCV000013326","12",112915523,"12",112477719,13326,28365,"rs28933386","NC_000012.12:112477718:A:G"
"NM_000690.4(ALDH2):c.1510G>A (p.Glu504Lys)","ALDH2","E504K, E457K","Alcohol dependence|Acute alcohol sensitivity|AMED syndrome, digenic|Susceptibility to hangover|Sublingual nitroglycerin, susceptibility to poor response to|Esophageal cancer, alcohol-related, susceptibility to","Pathogenic, drug response, protective, risk factor(Last reviewed: Feb 12, 2021)","no assertion criteria provided","VCV000018390","12",112241766,"12",111803962,18390,33429,"rs671","NC_000012.12:111803961:G:A"
"NM_000075.4(CDK4):c.70C>T (p.Arg24Cys)","CDK4","R24C","Multiple myeloma|Malignant melanoma of skin|Cutaneous malignant melanoma 3|Hereditary cancer-predisposing syndrome|Lung adenocarcinoma|not provided|Hereditary melanoma","Pathogenic(Last reviewed: Apr 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000016928","12",58145431,"12",57751648,16928,31967,"rs11547328","NC_000012.12:57751647:G:A"
"NM_000017.4(ACADS):c.511C>T (p.Arg171Trp)","ACADS","R171W","not provided|Deficiency of butyryl-CoA dehydrogenase","Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2020)","criteria provided, conflicting interpretations","VCV000003830","12",121175678,"12",120737875,3830,18869,"rs1800556","NC_000012.12:120737874:C:T"
"NM_000277.3(PAH):c.727C>T (p.Arg243Ter)","PAH","R243*","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 7, 2018)","reviewed by expert panel","VCV000000588","12",103246708,"12",102852930,588,15627,"rs5030846","NC_000012.12:102852929:G:A"
"NM_000277.3(PAH):c.842C>T (p.Pro281Leu)","PAH","P281L","not provided|Inborn genetic diseases|Phenylketonuria","Likely pathogenic(Last reviewed: Aug 27, 2018)","reviewed by expert panel","VCV000000589","12",103246593,"12",102852815,589,15628,"rs5030851","NC_000012.12:102852814:G:A"
"NM_000277.3(PAH):c.842+1G>A","PAH","","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000000599","12",103246592,"12",102852814,599,15638,"rs5030852","NC_000012.12:102852813:C:T"
"NM_000552.4(VWF):c.4751A>G (p.Tyr1584Cys)","VWF","Y1584C","not provided|not specified|von Willebrand disorder|von Willebrand disease, type 1, susceptibility to|Inborn genetic diseases|none provided|von Willebrand disease type 2","Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2021)","criteria provided, conflicting interpretations","VCV000000310","12",6127833,"12",6018667,310,15349,"rs1800386","NC_000012.12:6018666:T:C"
"NM_000785.4(CYP27B1):c.320G>A (p.Arg107His)","CYP27B1","R107H","Vitamin D-dependent rickets type 1A|Vitamin D-dependent rickets, type 1","Likely pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000001658","12",58159856,"12",57766073,1658,16697,"rs28934604","NC_000012.12:57766072:C:T"
"NM_000785.4(CYP27B1):c.374G>A (p.Gly125Glu)","CYP27B1","G125E","Vitamin D-dependent rickets type 1A","Pathogenic(Last reviewed: Mar 5, 1998)","no assertion criteria provided","VCV000001659","12",58159802,"12",57766019,1659,16698,"rs28934605","NC_000012.12:57766018:C:T"
"NM_000785.4(CYP27B1):c.1144C>T (p.Pro382Ser)","CYP27B1","P382S","Vitamin D-dependent rickets type 1A","Pathogenic(Last reviewed: Mar 5, 1998)","no assertion criteria provided","VCV000001661","12",58157952,"12",57764169,1661,16700,"rs28934607","NC_000012.12:57764168:G:A"
"NM_000020.2(ACVRL1):c.1127T>G (p.Met376Arg)","ACVRL1","M376R","Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic(Last reviewed: Jun 1, 1996)","no assertion criteria provided","VCV000008244","12",52309898,"12",51916114,8244,23283,"rs28936399","NC_000012.12:51916113:T:G"
"NM_000020.2(ACVRL1):c.1120C>T (p.Arg374Trp)","ACVRL1","R374W","not provided|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008249","12",52309891,"12",51916107,8249,23288,"rs28936401","NC_000012.12:51916106:C:T"
"NM_000020.3(ACVRL1):c.1031G>A (p.Cys344Tyr)","ACVRL1","C344Y","Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008254","12",52309267,"12",51915483,8254,23293,"rs28936688","NC_000012.12:51915482:G:A"
"NM_020297.3(ABCC9):c.3650G>A (p.Arg1217Lys)","ABCC9","R1217K","Hypertrichotic osteochondrodysplasia Cantu type","Likely pathogenic(Last reviewed: Dec 8, 2016)","criteria provided, single submitter","VCV000545440","12",21981911,"12",21828977,545440,535704,"rs12298510","NC_000012.12:21828976:C:T"
"NM_000075.4(CDK4):c.70C>A (p.Arg24Ser)","CDK4","R24S","Multiple myeloma|Malignant melanoma of skin|Lung adenocarcinoma","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376378","12",58145431,"12",57751648,376378,363257,"rs11547328","NC_000012.12:57751647:G:T"
"NM_002905.4(RDH5):c.208C>T (p.Arg70Trp)","RDH5|BLOC1S1-RDH5","R70W","not provided|Retinitis pigmentosa|Pigmentary retinal dystrophy","Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2020)","criteria provided, conflicting interpretations","VCV000636196","12",56115176,"12",55721392,636196,623998,"rs1058635","NC_000012.12:55721391:C:T"
"NM_002206.3(ITGA7):c.427C>T (p.Arg143Ter)","ITGA7","R143*, R46*, R30*","Muscular dystrophy, congenital, due to integrin alpha-7 deficiency","Pathogenic(Last reviewed: Jul 25, 2019)","criteria provided, multiple submitters, no conflicts","VCV000638329","12",56094926,"12",55701142,638329,626218,"rs17854600","NC_000012.12:55701141:G:A"
"NM_000020.2(ACVRL1):c.1031G>T (p.Cys344Phe)","ACVRL1","C344F","Telangiectasia, hereditary hemorrhagic, type 2","Likely pathogenic(Last reviewed: Oct 16, 2018)","criteria provided, single submitter","VCV000658228","12",52309267,"12",51915483,658228,641250,"rs28936688","NC_000012.12:51915482:G:T"
"NM_000618.5(IGF1):c.285C>A (p.Cys95Ter)","IGF1","C95*, C79*","Growth delay due to insulin-like growth factor type 1 deficiency","Likely pathogenic(Last reviewed: Apr 16, 2019)","no assertion criteria provided","VCV000829837","12",102813404,"12",102419626,829837,818294,"rs3730193","NC_000012.12:102419625:G:T"
"NM_000618.5(IGF1):c.285C>T (p.Cys95=)","IGF1","","not provided|Growth delay due to insulin-like growth factor type 1 deficiency","Likely benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000731380","12",102813404,"12",102419626,731380,738394,"rs3730193","NC_000012.12:102419625:G:A"
"NM_002429.6(MMP19):c.13C>T (p.Gln5Ter)","MMP19","Q5*","not provided","Benign(Last reviewed: Dec 31, 2019)","criteria provided, single submitter","VCV000776900","12",56236602,"12",55842818,776900,702418,"rs17844787","NC_000012.12:55842817:G:A"
"NM_000020.3(ACVRL1):c.1120C>A (p.Arg374=)","ACVRL1","","not provided","Uncertain significance(Last reviewed: Sep 1, 2018)","criteria provided, single submitter","VCV000806892","12",52309891,"12",51916107,806892,796796,"rs28936401","NC_000012.12:51916106:C:A"
"NM_005002.5(NDUFA9):c.1078C>T (p.Arg360Cys)","NDUFA9","R360C","Mitochondrial complex 1 deficiency, nuclear type 26","Pathogenic(Last reviewed: Dec 13, 2018)","no assertion criteria provided","VCV000587683","12",4796218,"12",4687052,587683,578641,"rs3210083","NC_000012.12:4687051:C:T"
"NM_000277.3(PAH):c.842+1G>T","PAH","","Phenylketonuria|not provided","Pathogenic(Last reviewed: Apr 9, 2019)","reviewed by expert panel","VCV000102869","12",103246592,"12",102852814,102869,108605,"rs5030852","NC_000012.12:102852813:C:A"
"NM_000552.4(VWF):c.3379+1G>A","VWF","","von Willebrand disorder|not provided|Von Willebrand disease, recessive form","Pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000100257","12",6132796,"12",6023630,100257,106134,"rs2363337","NC_000012.12:6023629:C:T"
"NM_000277.3(PAH):c.1208C>T (p.Ala403Val)","PAH","A403V","not provided|Inborn genetic diseases|Phenylketonuria","Pathogenic(Last reviewed: Aug 10, 2018)","reviewed by expert panel","VCV000092731","12",103234285,"12",102840507,92731,98638,"rs5030857","NC_000012.12:102840506:G:A"
"NM_000277.3(PAH):c.735G>A (p.Val245=)","PAH","","not specified|not provided|Phenylketonuria","Benign(Last reviewed: Apr 24, 2018)","reviewed by expert panel","VCV000092748","12",103246700,"12",102852922,92748,98655,"rs1042503","NC_000012.12:102852921:C:T"
"NM_004004.6(GJB2):c.35G>T (p.Gly12Val)","GJB2","G12V","Nonsyndromic hearing loss and deafness|not provided|none provided|Hearing impairment|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Rare genetic deafness","Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021387","13",20763686,"13",20189547,21387,34239,"rs1801002","NC_000013.11:20189546:C:A"
"NM_000059.4(BRCA2):c.9117G>A (p.Pro3039=)","BRCA2","","Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Medulloblastoma|Glioma susceptibility 3|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Wilms tumor 1|Tracheoesophageal fistula|Familial cancer of breast|not provided|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Medulloblastoma|Glioma susceptibility 3|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Wilms tumor 1|Familial cancer of breast|Breast-ovarian cancer, familial 1","Pathogenic(Last reviewed: Nov 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000038215","13",32954050,"13",32379913,38215,46771,"rs28897756","NC_000013.11:32379912:G:A"
"NM_000059.3(BRCA2):c.9302T>G (p.Leu3101Arg)","BRCA2","L3101R","Hereditary breast and ovarian cancer syndrome|none provided|Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)","criteria provided, conflicting interpretations","VCV000038230","13",32968871,"13",32394734,38230,46786,"rs28897758","NC_000013.11:32394733:T:G"
"NM_000059.4(BRCA2):c.9371A>T (p.Asn3124Ile)","BRCA2","N3124I","Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2|Breast and/or ovarian cancer|Malignant tumor of breast|Familial cancer of breast|Breast-ovarian cancer, familial 1|not provided","Pathogenic(Last reviewed: Jun 18, 2019)","reviewed by expert panel","VCV000038233","13",32968940,"13",32394803,38233,46789,"rs28897759","NC_000013.11:32394802:A:T"
"NM_004004.6(GJB2):c.148G>A (p.Asp50Asn)","GJB2","D50N","Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Sensorineural hearing loss|Hearing loss|not provided|Hystrix-like ichthyosis with deafness","Pathogenic(Last reviewed: Jun 14, 2017)","criteria provided, multiple submitters, no conflicts","VCV000017020","13",20763573,"13",20189434,17020,32059,"rs28931594","NC_000013.11:20189433:C:T"
"NM_004004.6(GJB2):c.535G>A (p.Asp179Asn)","GJB2","D179N","Deafness, autosomal dominant 3a","Pathogenic(Last reviewed: Dec 22, 2016)","no assertion criteria provided","VCV000017026","13",20763186,"13",20189047,17026,32065,"rs28931595","NC_000013.11:20189046:C:T"
"NM_004004.6(GJB2):c.224G>A (p.Arg75Gln)","GJB2","R75Q","not provided|Autosomal recessive nonsyndromic deafness|Deafness, autosomal dominant 3a|Rare genetic deafness|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|Hereditary palmoplantar keratoderma|Palmoplantar keratoderma-deafness syndrome","Pathogenic(Last reviewed: Aug 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017027","13",20763497,"13",20189358,17027,32066,"rs28931593","NC_000013.11:20189357:C:T"
"NM_004004.6(GJB2):c.148G>T (p.Asp50Tyr)","GJB2","D50Y","Keratitis-ichthyosis-deafness syndrome, autosomal dominant","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000017028","13",20763573,"13",20189434,17028,32067,"rs28931594","NC_000013.11:20189433:C:A"
"NM_001110219.3(GJB6):c.263C>T (p.Ala88Val)","GJB6","A88V","Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Hidrotic ectodermal dysplasia syndrome|Hidrotic ectodermal dysplasia syndrome","Pathogenic(Last reviewed: Aug 10, 2018)","criteria provided, single submitter","VCV000005545","13",20797357,"13",20223218,5545,20584,"rs28937872","NC_000013.11:20223217:G:A"
"NM_000059.3(BRCA2):c.8375T>G (p.Leu2792Arg)","BRCA2","L2792R","Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2020)","criteria provided, conflicting interpretations","VCV000481525","13",32944582,"13",32370445,481525,477236,"rs28897751","NC_000013.11:32370444:T:G"
"NM_004004.6(GJB2):c.535G>C (p.Asp179His)","GJB2","D179H","Deafness, autosomal recessive 1A","Uncertain significance(Last reviewed: Feb 24, 2017)","criteria provided, single submitter","VCV000550847","13",20763186,"13",20189047,550847,547296,"rs28931595","NC_000013.11:20189046:C:G"
"NM_004004.6(GJB2):c.35G>A (p.Gly12Asp)","GJB2","G12D","Deafness, autosomal recessive 1A","Uncertain significance(Last reviewed: Apr 4, 2017)","criteria provided, single submitter","VCV000551229","13",20763686,"13",20189547,551229,547105,"rs1801002","NC_000013.11:20189546:C:T"
"NM_000059.3(BRCA2):c.9302T>A (p.Leu3101Gln)","BRCA2","L3101Q","Hereditary breast and ovarian cancer syndrome","Uncertain significance(Last reviewed: Oct 30, 2019)","criteria provided, single submitter","VCV000573951","13",32968871,"13",32394734,573951,566097,"rs28897758","NC_000013.11:32394733:T:A"
"NM_000059.3(BRCA2):c.9117G>C (p.Pro3039=)","BRCA2","","not specified","Uncertain significance(Last reviewed: Sep 11, 2017)","criteria provided, single submitter","VCV000632708","13",32954050,"13",32379913,632708,621449,"rs28897756","NC_000013.11:32379912:G:C"
"NM_000059.3(BRCA2):c.2786T>C (p.Leu929Ser)","BRCA2","","not provided|Hereditary breast and ovarian cancer syndrome|Fanconi anemia, complementation group D1|not specified|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|none provided","Benign(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000051343","13",32911278,"13",32337141,51343,66011,"rs2227943","NC_000013.11:32337140:T:C"
"NM_000059.3(BRCA2):c.8057T>C (p.Leu2686Pro)","BRCA2","L2686P","Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000052489","13",32937396,"13",32363259,52489,67157,"rs28897746","NC_000013.11:32363258:T:C"
"NM_000059.3(BRCA2):c.8375T>C (p.Leu2792Pro)","BRCA2","L2792P","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Apr 20, 2020)","criteria provided, conflicting interpretations","VCV000052568","13",32944582,"13",32370445,52568,67236,"rs28897751","NC_000013.11:32370444:T:C"
"NM_000059.4(BRCA2):c.9924C>G (p.Tyr3308Ter)","BRCA2","Y3308*","Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Malignant tumor of breast|Breast and/or ovarian cancer","Pathogenic(Last reviewed: Apr 22, 2016)","reviewed by expert panel","VCV000052916","13",32972574,"13",32398437,52916,67584,"rs4987049","NC_000013.11:32398436:C:G"
"NM_000059.3(BRCA2):c.9924C>T (p.Tyr3308=)","BRCA2","","Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Fanconi anemia, complementation group D1|not provided|not specified|Breast-ovarian cancer, familial 2","Benign(Last reviewed: Jun 29, 2017)","reviewed by expert panel","VCV000052917","13",32972574,"13",32398437,52917,67585,"rs4987049","NC_000013.11:32398436:C:T"
"NM_000059.3(BRCA2):c.9924C>A (p.Tyr3308Ter)","BRCA2","Y3308*","Breast-ovarian cancer, familial 2|not provided","Pathogenic(Last reviewed: Oct 18, 2016)","reviewed by expert panel","VCV000267177","13",32972574,"13",32398437,267177,261561,"rs4987049","NC_000013.11:32398436:C:A"
"NM_000059.3(BRCA2):c.9117G>T (p.Pro3039=)","BRCA2","","Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2021)","criteria provided, conflicting interpretations","VCV000267715","13",32954050,"13",32379913,267715,262852,"rs28897756","NC_000013.11:32379912:G:T"
"NM_000059.3(BRCA2):c.9302T>C (p.Leu3101Pro)","BRCA2","L3101P","not specified|Hereditary breast and ovarian cancer syndrome","Uncertain significance(Last reviewed: Aug 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000216263","13",32968871,"13",32394734,216263,213090,"rs28897758","NC_000013.11:32394733:T:C"
"NM_020529.2(NFKBIA):c.95G>T (p.Ser32Ile)","NFKBIA","S32I","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Sep 6, 2004)","no assertion criteria provided","VCV000014003","14",35873756,"14",35404550,14003,29042,"rs28933100","NC_000014.9:35404549:C:A"
"NM_000257.4(MYH7):c.1207C>T (p.Arg403Trp)","MYH7","R403W","not provided|Cardiomyopathy|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype|MYH7-related late-onset scapuloperoneal muscular dystrophy|Congenital myopathy with fiber type disproportion|Myopathy, myosin storage, autosomal recessive|Familial hypertrophic cardiomyopathy 1|Myopathy, distal, 1|Dilated cardiomyopathy 1S|Myosin storage myopathy","Pathogenic(Last reviewed: Dec 15, 2016)","reviewed by expert panel","VCV000014102","14",23898488,"14",23429279,14102,29141,"rs3218714","NC_000014.9:23429278:G:A"
"NM_006194.3(PAX9):c.76C>T (p.Arg26Trp)","PAX9","R26W","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Aug 1, 2009)","no assertion criteria provided","VCV000013774","14",37132173,"14",36662968,13774,28813,"rs28933972","NC_000014.9:36662967:C:T"
"NM_001127701.1(SERPINA1):c.187C>T (p.Arg63Cys)","SERPINA1","R63C","Alpha-1-antitrypsin deficiency|PI I|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017974","14",94849388,"14",94383051,17974,33013,"rs28931570","NC_000014.9:94383050:G:A"
"NM_000295.4(SERPINA1):c.1078G>A (p.Ala360Thr)","SERPINA1","A360T","Alpha-1-antitrypsin deficiency|not provided|PI W(BETHESDA)","Uncertain significance(Last reviewed: Aug 28, 2018)","criteria provided, single submitter","VCV000017985","14",94844965,"14",94378628,17985,33024,"rs1802959","NC_000014.9:94378627:C:T"
"NM_001127701.1(SERPINA1):c.415G>A (p.Gly139Ser)","SERPINA1","G139S","Alpha-1-antitrypsin deficiency|PI NULL(NEWPORT)|PI Q0(NEWPORT)|PI NULL(DEVON)|PI Q0(DEVON)","Pathogenic, other(Last reviewed: Jul 15, 2016)","no assertion criteria provided","VCV000017986","14",94849160,"14",94382823,17986,33025,"rs11558261","NC_000014.9:94382822:C:T"
"NM_001127701.1(SERPINA1):c.347T>A (p.Ile116Asn)","SERPINA1","I116N","Alpha-1-antitrypsin deficiency|PI NULL(LUDWIGSHAFEN)|PI Q0(LUDWIGSHAFEN)","Pathogenic, other(Last reviewed: Jul 20, 2016)","no assertion criteria provided","VCV000017987","14",94849228,"14",94382891,17987,33026,"rs28931572","NC_000014.9:94382890:A:T"
"NM_001085.5(SERPINA3):c.233T>C (p.Leu78Pro)","SERPINA3","L55P, L78P","ANTICHYMOTRYPSIN BOCHUM 1","Pathogenic(Last reviewed: Sep 1, 1993)","no assertion criteria provided","VCV000018049","14",95081011,"14",94614674,18049,33088,"rs1800463","NC_000014.9:94614673:T:C"
"NM_000021.4(PSEN1):c.1229G>A (p.Cys410Tyr)","PSEN1","C410Y, C406Y","Frontotemporal dementia|Alzheimer disease, type 3|Acne inversa, familial, 3|Pick disease|not provided|Alzheimer disease, type 3","Pathogenic(Last reviewed: Nov 16, 2017)","criteria provided, single submitter","VCV000018127","14",73683933,"14",73217225,18127,33166,"rs661","NC_000014.9:73217224:G:A"
"NM_000257.4(MYH7):c.2389G>A (p.Ala797Thr)","MYH7","A797T","Wolff-Parkinson-White pattern|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Abnormality of cellular immune system|Immunodeficiency|Abnormality of T cell physiology|Severe combined immunodeficiency disease|Lymphopenia|Combined T and B cell immunodeficiency|not provided|Primary familial hypertrophic cardiomyopathy|Primary familial dilated cardiomyopathy|Myopathy, myosin storage, autosomal recessive|Myopathy, distal, 1|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|MYH7-related late-onset scapuloperoneal muscular dystrophy|Dilated cardiomyopathy 1S|Congenital myopathy with fiber type disproportion","Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2021)","criteria provided, multiple submitters, no conflicts","VCV000042901","14",23894525,"14",23425316,42901,52071,"rs3218716","NC_000014.9:23425315:C:T"
"NM_001127701.1(SERPINA1):c.863A>T (p.Glu288Val)","SERPINA1","E288V","not specified|not provided|Cystic fibrosis|Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI S|Alpha-1-antitrypsin deficiency","Conflicting interpretations of pathogenicity, other(Last reviewed: Oct 25, 2020)","criteria provided, conflicting interpretations","VCV000017969","14",94847262,"14",94380925,17969,33008,"rs17580","NC_000014.9:94380924:T:A"
"NM_000369.5(TSHR):c.1897G>C (p.Asp633His)","TSHR","D633H","THYROID CARCINOMA WITH THYROTOXICOSIS, SOMATIC","Pathogenic(Last reviewed: Mar 1, 1997)","no assertion criteria provided","VCV000006437","14",81610299,"14",81143955,6437,21476,"rs28937584","NC_000014.9:81143954:G:C"
"NM_000257.4(MYH7):c.1207C>G (p.Arg403Gly)","MYH7","R403G","Hypertrophic cardiomyopathy","Likely pathogenic(Last reviewed: Jan 9, 2017)","criteria provided, single submitter","VCV000505562","14",23898488,"14",23429279,505562,497452,"rs3218714","NC_000014.9:23429278:G:C"
"NM_020529.2(NFKBIA):c.95G>A (p.Ser32Asn)","NFKBIA","S32N","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Nov 15, 2018)","no assertion criteria provided","VCV000590311","14",35873756,"14",35404550,590311,581252,"rs28933100","NC_000014.9:35404549:C:T"
"NM_001126106.2(SLC7A7):c.475C>T (p.Arg159Cys)","SLC7A7","R159C","not provided|Lysinuric protein intolerance","Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)","criteria provided, conflicting interpretations","VCV000203944","14",23282133,"14",22812924,203944,200280,"rs11568437","NC_000014.9:22812923:G:A"
"NM_002435.3(MPI):c.884G>A (p.Arg295His)","MPI","R295H, R245H, R234H, R275H","MPI-CDG","Pathogenic(Last reviewed: Nov 1, 2002)","no assertion criteria provided","VCV000014349","15",75189391,"15",74897050,14349,29388,"rs28928906","NC_000015.10:74897049:G:A"
"NM_000137.3(FAH):c.1021C>T (p.Arg341Trp)","FAH","R341W","not provided|Fumarylacetoacetase pseudodeficiency|Tyrosinemia type I","Benign/Likely benign, other(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000011868","15",80472526,"15",80180184,11868,26907,"rs11555096","NC_000015.10:80180183:C:T"
"NM_000138.5(FBN1):c.529T>C (p.Cys177Arg)","FBN1","C177R","Marfan syndrome","Likely pathogenic(Last reviewed: Oct 4, 2012)","criteria provided, single submitter","VCV000042380","15",48888489,"15",48596292,42380,51550,"rs363853","NC_000015.10:48596291:A:G"
"NM_000138.5(FBN1):c.5863C>T (p.Gln1955Ter)","FBN1","Q1955*","not provided|Marfan syndrome","Pathogenic(Last reviewed: Jul 2, 2013)","criteria provided, multiple submitters, no conflicts","VCV000042393","15",48737627,"15",48445430,42393,51563,"rs363807","NC_000015.10:48445429:G:A"
"NM_000138.4(FBN1):c.3037G>C (p.Gly1013Arg)","FBN1","G1013R","Marfan syndrome","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000016455","15",48782093,"15",48489896,16455,31494,"rs140593","NC_000015.10:48489895:C:G"
"NM_207581.4(DUOXA2):c.738C>G (p.Tyr246Ter)","DUOXA2","Y246*","Thyroglobulin synthesis defect","Pathogenic(Last reviewed: Feb 1, 2008)","no assertion criteria provided","VCV000000444","15",45409472,"15",45117274,444,15483,"rs4774518","NC_000015.10:45117273:C:G"
"NM_000520.6(HEXA):c.598G>A (p.Val200Met)","HEXA","V200M, V211M","Tay-Sachs disease","Uncertain significance(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000446383","15",72643548,"15",72351207,446383,38431,"rs1800429","NC_000015.10:72351206:C:T"
"NM_000138.4(FBN1):c.2986T>C (p.Cys996Arg)","FBN1","C996R","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Likely pathogenic(Last reviewed: Aug 24, 2017)","criteria provided, single submitter","VCV000527151","15",48782144,"15",48489947,527151,529346,"rs140592","NC_000015.10:48489946:A:G"
"NM_000138.4(FBN1):c.5826C>A (p.Cys1942Ter)","FBN1","C1942*","Weill-Marchesani syndrome|Acromicric dysplasia|Stiff skin syndrome|Familial thoracic aortic aneurysm and aortic dissection|Ectopia lentis, isolated, autosomal dominant|Marfan syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2017)","criteria provided, conflicting interpretations","VCV000547334","15",48737664,"15",48445467,547334,538046,"rs363806","NC_000015.10:48445466:G:T"
"NM_000138.4(FBN1):c.7498T>C (p.Cys2500Arg)","FBN1","C2500R","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome","Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000547346","15",48714221,"15",48422024,547346,538034,"rs363810","NC_000015.10:48422023:A:G"
"NM_000138.4(FBN1):c.3338A>G (p.Asp1113Gly)","FBN1","D1113G","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome","Pathogenic(Last reviewed: Dec 20, 2018)","criteria provided, single submitter","VCV000549158","15",48779634,"15",48487437,549158,539763,"rs140597","NC_000015.10:48487436:T:C"
"NM_000138.4(FBN1):c.5015G>C (p.Cys1672Ser)","FBN1","C1672S","Marfan syndrome","Pathogenic(Last reviewed: Nov 7, 2017)","no assertion criteria provided","VCV000549257","15",48756146,"15",48463949,549257,539675,"rs140627","NC_000015.10:48463948:C:G"
"NM_000138.5(FBN1):c.7498T>A (p.Cys2500Ser)","FBN1","C2500S","Marfan syndrome","Likely pathogenic(Last reviewed: Jun 22, 2016)","criteria provided, single submitter","VCV000504529","15",48714221,"15",48422024,504529,497066,"rs363810","NC_000015.10:48422023:A:T"
"NM_000138.4(FBN1):c.496T>A (p.Cys166Ser)","FBN1","C166S","Cardiovascular phenotype|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000519737","15",48888522,"15",48596325,519737,510639,"rs363852","NC_000015.10:48596324:A:T"
"NM_000138.4(FBN1):c.3963A>G (p.Thr1321=)","FBN1","","Marfan syndrome|Cardiovascular phenotype","Likely pathogenic(Last reviewed: Sep 17, 2015)","criteria provided, single submitter","VCV000520237","15",48773853,"15",48481656,520237,510594,"rs140648","NC_000015.10:48481655:T:C"
"NM_000138.4(FBN1):c.306C>A (p.Cys102Ter)","FBN1","C102*","not provided","Likely pathogenic(Last reviewed: Aug 30, 2016)","criteria provided, single submitter","VCV000388980","15",48902965,"15",48610768,388980,374628,"rs25388","NC_000015.10:48610767:G:T"
"NM_000138.4(FBN1):c.6113G>A (p.Cys2038Tyr)","FBN1","C2038Y","not provided|Marfan syndrome","Likely pathogenic(Last reviewed: Oct 9, 2015)","criteria provided, single submitter","VCV000431924","15",48733968,"15",48441771,431924,426107,"rs363804","NC_000015.10:48441770:C:T"
"NM_000138.4(FBN1):c.5015G>T (p.Cys1672Phe)","FBN1","C1672F","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic(Last reviewed: Jan 27, 2019)","criteria provided, single submitter","VCV000640108","15",48756146,"15",48463949,640108,643359,"rs140627","NC_000015.10:48463948:C:A"
"NM_000138.5(FBN1):c.6113G>C (p.Cys2038Ser)","FBN1","C2038S","Marfan syndrome","Likely pathogenic(Last reviewed: Dec 6, 2019)","criteria provided, single submitter","VCV000810672","15",48733968,"15",48441771,810672,798958,"rs363804","NC_000015.10:48441770:C:G"
"NM_000138.5(FBN1):c.496T>C (p.Cys166Arg)","FBN1","C166R","Marfan syndrome","Likely pathogenic(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000803098","15",48888522,"15",48596325,803098,791475,"rs363852","NC_000015.10:48596324:A:G"
"NM_018668.4(VPS33B):c.151C>T (p.Arg51Ter)","VPS33B","R51*","Arthrogryposis, renal dysfunction, and cholestasis 1","Pathogenic(Last reviewed: Aug 7, 2018)","criteria provided, single submitter","VCV000587506","15",91561061,"15",91017831,587506,578522,"rs11542638","NC_000015.10:91017830:G:A"
"NM_001271.4(CHD2):c.3564C>G (p.Tyr1188Ter)","CHD2","Y1188*","not provided","Pathogenic(Last reviewed: May 3, 2018)","criteria provided, single submitter","VCV000633515","15",93536197,"15",92992967,633515,621980,"rs2272457","NC_000015.10:92992966:C:G"
"NM_000138.5(FBN1):c.306C>T (p.Cys102=)","FBN1","","not specified|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Acromicric dysplasia|none provided|Familial thoracic aortic aneurysm and aortic dissection|Connective tissue disease|Stiff skin syndrome|Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|Cardiovascular phenotype|Weill-Marchesani syndrome|Geleophysic dysplasia","Benign/Likely benign(Last reviewed: Dec 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000137314","15",48902965,"15",48610768,137314,141017,"rs25388","NC_000015.10:48610767:G:A"
"NM_000138.5(FBN1):c.3037G>A (p.Gly1013Arg)","FBN1","G1013R","Marfan syndrome|not provided|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic(Last reviewed: Feb 15, 2020)","criteria provided, multiple submitters, no conflicts","VCV000177648","15",48782093,"15",48489896,177648,175987,"rs140593","NC_000015.10:48489895:C:T"
"NM_000138.5(FBN1):c.6509G>A (p.Cys2170Tyr)","FBN1","C2170Y","Marfan syndrome","Likely pathogenic(Last reviewed: Mar 15, 2018)","criteria provided, single submitter","VCV000163467","15",48726898,"15",48434701,163467,176125,"rs363821","NC_000015.10:48434700:C:T"
"NM_001271.4(CHD2):c.3564C>T (p.Tyr1188=)","CHD2","","not specified|not provided|History of neurodevelopmental disorder|Developmental and epileptic encephalopathy 94","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000257709","15",93536197,"15",92992967,257709,255446,"rs2272457","NC_000015.10:92992966:C:T"
"NM_018668.4(VPS33B):c.151C>A (p.Arg51=)","VPS33B","","Arthrogryposis, renal dysfunction, and cholestasis 1|not specified","Benign(Last reviewed: Mar 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000261040","15",91561061,"15",91017831,261040,255440,"rs11542638","NC_000015.10:91017830:G:T"
"NM_000138.4(FBN1):c.2581C>T (p.Arg861Ter)","FBN1","R861*","not specified|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Isolated thoracic aortic aneurysm|Stiff skin syndrome|Marfan syndrome|Weill-Marchesani syndrome 2|MASS syndrome|Marfan lipodystrophy syndrome|Ectopia lentis, isolated, autosomal dominant|Geleophysic dysplasia 2|Acromicric dysplasia|Familial thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype|not provided|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome","Pathogenic/Likely pathogenic(Last reviewed: May 11, 2020)","criteria provided, multiple submitters, no conflicts","VCV000265401","15",48787416,"15",48495219,265401,260073,"rs140583","NC_000015.10:48495218:G:A"
"NM_000138.4(FBN1):c.4930C>T (p.Arg1644Ter)","FBN1","R1644*","Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Marfan syndrome|not provided|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Isolated thoracic aortic aneurysm|Cardiovascular phenotype","Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2020)","criteria provided, multiple submitters, no conflicts","VCV000200186","15",48757777,"15",48465580,200186,197685,"rs140630","NC_000015.10:48465579:G:A"
"NM_000138.4(FBN1):c.5015G>A (p.Cys1672Tyr)","FBN1","C1672Y","not provided","Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)","criteria provided, multiple submitters, no conflicts","VCV000200187","15",48756146,"15",48463949,200187,197683,"rs140627","NC_000015.10:48463948:C:T"
"NM_002386.3(MC1R):c.880G>C (p.Asp294His)","MC1R","D294H","Skin/hair/eye pigmentation 2, red hair/fair skin|Cutaneous malignant melanoma 5|Skin and Hair Hypopigmentation|Melanoma|not provided|Tyrosinase-positive oculocutaneous albinism|not specified","Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Dec 6, 2020)","criteria provided, conflicting interpretations","VCV000014307","16",89986546,"16",89920138,14307,29346,"rs1805009","NC_000016.10:89920137:G:C"
"NM_002386.3(MC1R):c.451C>T (p.Arg151Cys)","MC1R","R151C","Cutaneous malignant melanoma 5|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Skin/hair/eye pigmentation 2, red hair/fair skin|not provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000014312","16",89986117,"16",89919709,14312,29351,"rs1805007","NC_000016.10:89919708:C:T"
"NM_000418.4(IL4R):c.223A>G (p.Ile75Val)","IL4R","I75V, I60V","Atopy, resistance to|Acquired immunodeficiency syndrome, slow progression to","Pathogenic, protective(Last reviewed: Oct 1, 2005)","no assertion criteria provided","VCV000014666","16",27356203,"16",27344882,14666,29705,"rs1805010","NC_000016.10:27344881:A:G"
"NM_003361.3(UMOD):c.443G>A (p.Cys148Tyr)","UMOD","C148Y, C181Y","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Dec 1, 2002)","no assertion criteria provided","VCV000012255","16",20360180,"16",20348858,12255,27294,"rs28934582","NC_000016.10:20348857:C:T"
"NM_003361.3(UMOD):c.649T>C (p.Cys217Arg)","UMOD","C217R, C250R","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Dec 17, 2004)","no assertion criteria provided","VCV000012256","16",20359974,"16",20348652,12256,27295,"rs28934583","NC_000016.10:20348651:A:G"
"NM_000196.4(HSD11B2):c.637C>T (p.Arg213Cys)","HSD11B2","R213C","Apparent mineralocorticoid excess","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000012094","16",67470018,"16",67436115,12094,27133,"rs28934591","NC_000016.10:67436114:C:T"
"NM_000548.5(TSC2):c.1832G>A (p.Arg611Gln)","TSC2","R611Q, R411Q, R622Q, R574Q, R562Q","Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Tuberous sclerosis 2|Focal cortical dysplasia type II|Lymphangiomyomatosis","Pathogenic(Last reviewed: Sep 29, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012397","16",2120572,"16",2070571,12397,27436,"rs28934872","NC_000016.10:2070570:G:A"
"NM_000558.5(HBA1):c.223G>A (p.Asp75Asn)","HBA1|LOC106804613","D75N","HEMOGLOBIN G (PEST)","other(Last reviewed: Jul 20, 2016)","no assertion criteria provided","VCV000015732","16",227055,"16",177056,15732,30771,"rs28928875","NC_000016.10:177055:G:A"
"NM_003361.3(UMOD):c.649T>G (p.Cys217Gly)","UMOD","C217G, C250G","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Jan 6, 2012)","no assertion criteria provided","VCV000039418","16",20359974,"16",20348652,39418,48017,"rs28934583","NC_000016.10:20348651:A:C"
"NM_000903.3(NQO1):c.559C>T (p.Pro187Ser)","NQO1","P187S, P115S, P149S, P153S","Alkylating Agents, anthracyclines and related substances, fluorouracil, and Platinum compounds response - Efficacy|Lung carcinoma|Benzene toxicity, susceptibility to|Leukemia, post-chemotherapy, susceptibility to|Breast cancer, post-chemotherapy poor survival in","drug response(Last reviewed: Oct 20, 2015)","reviewed by expert panel","VCV000016809","16",69745145,"16",69711242,16809,31848,"rs1800566","NC_000016.10:69711241:G:A"
"NM_000558.5(HBA1):c.223G>C (p.Asp75His)","HBA1|LOC106804613","D75H","none provided|not provided|HEMOGLOBIN Q (THAILAND)|HEMOGLOBIN MAHIDOL|HEMOGLOBIN ASABARA|HEMOGLOBIN KURASHIKI|HEMOGLOBIN G (TAICHUNG)|HEMOGLOBIN Q|alpha Thalassemia","Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2019)","criteria provided, conflicting interpretations","VCV000015733","16",227055,"16",177056,15733,30772,"rs28928875","NC_000016.10:177055:G:C"
"NM_000558.3(HBA1):c.179G>T (p.Gly60Val)","HBA1|LOC106804613","G60V","HEMOGLOBIN TOTTORI","other(Last reviewed: Jul 20, 2016)","no assertion criteria provided","VCV000015827","16",227011,"16",177012,15827,30866,"rs28928878","NC_000016.10:177011:G:T"
"NM_000558.3(HBA1):c.179G>A (p.Gly60Asp)","HBA1|LOC106804613","G60D","Hemoglobin H disease, nondeletional|HEMOGLOBIN ADANA|not provided","Pathogenic(Last reviewed: Mar 19, 2019)","criteria provided, multiple submitters, no conflicts","VCV000015849","16",227011,"16",177012,15849,30888,"rs28928878","NC_000016.10:177011:G:A"
"NM_000078.3(CETP):c.1321+1G>A","CETP","","Hyperalphalipoproteinemia 1","Pathogenic(Last reviewed: Nov 1, 1990)","no assertion criteria provided","VCV000017524","16",57016150,"16",56982238,17524,32563,"rs5742907","NC_000016.10:56982237:G:A"
"NM_021615.5(CHST6):c.521A>G (p.Lys174Arg)","CHST6","K174R","Macular corneal dystrophy","Pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000005071","16",75513206,"16",75479308,5071,20110,"rs28937877","NC_000016.10:75479307:T:C"
"NM_021615.5(CHST6):c.599T>G (p.Leu200Arg)","CHST6","L200R","not provided|Macular corneal dystrophy|Macular corneal dystrophy, type II","Pathogenic(Last reviewed: Sep 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000005075","16",75513128,"16",75479230,5075,20114,"rs28937879","NC_000016.10:75479229:A:C"
"NM_001370466.1(NOD2):c.2717+158C>T","NOD2","","Blau syndrome|Autoinflammatory syndrome|Inflammatory bowel disease 1|Inflammatory bowel disease 1|Blau syndrome|Yao syndrome|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)","criteria provided, conflicting interpretations","VCV000004697","16",50756774,"16",50722863,4697,19736,"rs5743289","NC_000016.10:50722862:C:T"
"NM_000101.4(CYBA):c.214T>C (p.Tyr72His)","CYBA","Y72H","not specified|Very early onset inflammatory bowel disease|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|CYBA POLYMORPHISM","Benign(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000002263","16",88713236,"16",88646828,2263,17302,"rs4673","NC_000016.10:88646827:A:G"
"NM_001126108.2(SLC12A3):c.625C>T (p.Arg209Trp)","SLC12A3","R209W, R208W","not provided|Familial hypokalemia-hypomagnesemia","Pathogenic(Last reviewed: Jun 6, 2020)","criteria provided, single submitter","VCV000008586","16",56904031,"16",56870119,8586,23625,"rs28936388","NC_000016.10:56870118:C:T"
"NM_001039.4(SCNN1G):c.589G>A (p.Glu197Lys)","SCNN1G","E197K","not provided|Autosomal recessive pseudohypoaldosteronism type 1|Bronchiectasis with or without elevated sweat chloride 3|Liddle syndrome 2|not specified","Benign/Likely benign(Last reviewed: May 15, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008829","16",23200963,"16",23189642,8829,23868,"rs5738","NC_000016.10:23189641:G:A"
"NM_001009944.3(PKD1):c.1396G>A (p.Val466Met)","PKD1","V466M","not provided|Autosomal dominant polycystic kidney disease|Polycystic kidney disease","Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2019)","criteria provided, conflicting interpretations","VCV000447971","16",2167044,"16",2117043,447971,441874,"rs2855341","NC_000016.10:2117042:C:T"
"NM_201400.4(EEF2KMT):c.*804G>A","ALG1|EEF2KMT","R337*","not provided|ALG1-CDG","Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2018)","criteria provided, conflicting interpretations","VCV000382581","16",5134829,"16",5084828,382581,377609,"rs1047747","NC_000016.10:5084827:C:T"
"NM_000558.5(HBA1):c.207C>A (p.Asn69Lys)","HBA1|LOC106804613","N69K","alpha Thalassemia","Pathogenic(Last reviewed: Dec 29, 2016)","no assertion criteria provided","VCV000375748","16",227039,"16",177040,375748,362634,"rs1060339","NC_000016.10:177039:C:A"
"NM_000558.5(HBA1):c.207C>G (p.Asn69Lys)","HBA1|LOC106804613","N69K","none provided|not provided","Likely benign(Last reviewed: Jul 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000439095","16",227039,"16",177040,439095,432867,"rs1060339","NC_000016.10:177039:C:G"
"NM_004608.3(TBX6):c.-49+34G>T","TBX6","","","no interpretation for the single variant","no interpretation for the single variant","VCV000427809","16",30103160,"16",30091839,427809,185945,"rs3809627","NC_000016.10:30091838:C:A"
"NM_019109.5(ALG1):c.1312C>T (p.Arg438Trp)","ALG1|EEF2KMT","R327W, R438W","Congenital disorder of glycosylation","Likely pathogenic(Last reviewed: May 25, 2017)","no assertion criteria provided","VCV000690315","16",5134799,"16",5084798,690315,678020,"rs16835020","NC_000016.10:5084797:C:T"
"NM_001009944.3(PKD1):c.2180T>A (p.Leu727Gln)","PKD1","L727Q","not provided","Uncertain significance(Last reviewed: Feb 1, 2018)","criteria provided, single submitter","VCV000586255","16",2164844,"16",2114843,586255,577527,"rs1616940","NC_000016.10:2114842:A:T"
"NM_001009944.3(PKD1):c.7288C>T (p.Arg2430Ter)","PKD1","R2430*","Autosomal dominant polycystic kidney disease|not provided|Polycystic kidney disease|Polycystic kidney disease, adult type","Pathogenic(Last reviewed: Jan 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000562262","16",2156600,"16",2106599,562262,553446,"rs2432403","NC_000016.10:2106598:G:A"
"NM_001009944.3(PKD1):c.2180T>C (p.Leu727Pro)","PKD1","L727P","Polycystic kidney disease, adult type|Autosomal dominant polycystic kidney disease|not provided|Polycystic kidney disease|Polycystic kidney disease 3","Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)","criteria provided, conflicting interpretations","VCV000562302","16",2164844,"16",2114843,562302,553486,"rs1616940","NC_000016.10:2114842:A:G"
"NM_002474.3(MYH11):c.4401C>T (p.Tyr1467=)","MYH11|NDE1","","not specified|Familial thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype|Lissencephaly, Recessive|Aortic aneurysm, familial thoracic 4|none provided","Benign/Likely benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000138343","16",15815456,"16",15721599,138343,142046,"rs8046180","NC_000016.10:15721598:G:A"
"NM_001009944.3(PKD1):c.7642G>C (p.Glu2548Gln)","PKD1","E2548Q","not specified|not provided|Polycystic kidney disease|Polycystic kidney disease, adult type","Benign/Likely benign(Last reviewed: Jun 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000257002","16",2156153,"16",2106152,257002,255584,"rs28369051","NC_000016.10:2106151:C:G"
"NM_002474.3(MYH11):c.4401C>G (p.Tyr1467Ter)","MYH11|NDE1","Y1467*, Y1474*","Aortic aneurysm, familial thoracic 4","Pathogenic(Last reviewed: Nov 16, 2019)","criteria provided, single submitter","VCV000201075","16",15815456,"16",15721599,201075,197866,"rs8046180","NC_000016.10:15721598:G:C"
"NM_004380.3(CREBBP):c.86-1G>T","CREBBP","","Rubinstein-Taybi syndrome 1","Pathogenic(Last reviewed: Jun 3, 2014)","criteria provided, single submitter","VCV000210790","16",3901011,"16",3851010,210790,208279,"rs11644721","NC_000016.10:3851009:C:A"
"NM_004448.3(ERBB2):c.2570A>G (p.Asn857Ser)","ERBB2","N857S, N827S, N842S","Ovarian Adenocarcinoma|Neoplasm of ovary","Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)","no assertion criteria provided","VCV000013880","17",37881378,"17",39725125,13880,28919,"rs28933370","NC_000017.11:39725124:A:G"
"NG_012123.1:g.2493A>G","CCL2","","Mycobacterium tuberculosis, susceptibility to|Spina bifida, susceptibility to|Coronary artery disease, modifier of|Coronary artery disease, development of, in hiv","Pathogenic, risk factor(Last reviewed: Jan 15, 2009)","no assertion criteria provided","VCV000014207","17",32579788,"17",34252769,14207,29246,"rs1024611","NC_000017.11:34252768:A:G"
"NM_000422.3(KRT17):c.274A>G (p.Asn92Asp)","KRT17","N92D","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Nov 3, 2016)","criteria provided, single submitter","VCV000014586","17",39780488,"17",41624236,14586,29625,"rs28928896","NC_000017.11:41624235:T:C"
"NM_000422.3(KRT17):c.292T>G (p.Tyr98Asp)","KRT17","Y98D","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Feb 1, 1997)","no assertion criteria provided","VCV000014588","17",39780470,"17",41624218,14588,29627,"rs28933088","NC_000017.11:41624217:A:C"
"NM_000422.3(KRT17):c.274A>C (p.Asn92His)","KRT17","N92H","not provided|Steatocystoma multiplex","Pathogenic(Last reviewed: Feb 1, 1997)","no assertion criteria provided","VCV000014589","17",39780488,"17",41624236,14589,29628,"rs28928896","NC_000017.11:41624235:T:G"
"NM_000422.3(KRT17):c.281G>A (p.Arg94His)","KRT17","R94H","not provided|Pachyonychia congenita 2|Steatocystoma multiplex","Pathogenic(Last reviewed: Dec 1, 2019)","criteria provided, single submitter","VCV000014590","17",39780481,"17",41624229,14590,29629,"rs28928897","NC_000017.11:41624228:C:T"
"NM_000422.3(KRT17):c.281G>C (p.Arg94Pro)","KRT17","R94P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 1, 2001)","no assertion criteria provided","VCV000014594","17",39780481,"17",41624229,14594,29633,"rs28928897","NC_000017.11:41624228:C:G"
"NM_000546.5(TP53):c.733G>T (p.Gly245Cys)","TP53","G245C, G113C, G206C, G86C","Uterine Carcinosarcoma|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|not provided|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Hepatocellular carcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Breast and/or ovarian cancer|Pancreatic adenocarcinoma|Breast neoplasm|Glioblastoma|Brainstem glioma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome","Pathogenic(Last reviewed: Aug 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012349","17",7577548,"17",7674230,12349,27388,"rs28934575","NC_000017.11:7674229:C:A"
"NM_000546.6(TP53):c.215C>G (p.Pro72Arg)","TP53","P72R, P33R","not specified|not provided|Li-Fraumeni syndrome|fluorouracil response - Efficacy, Toxicity/ADR|paclitaxel response - Efficacy, Toxicity/ADR|antineoplastic agents response - Efficacy, Toxicity/ADR|cisplatin response - Efficacy, Toxicity/ADR|cyclophosphamide response - Efficacy, Toxicity/ADR|Li-Fraumeni syndrome 1|CODON 72 POLYMORPHISM|none provided|Lip and oral cavity carcinoma|Hereditary cancer-predisposing syndrome","drug response(Last reviewed: Oct 17, 2016)","reviewed by expert panel","VCV000012351","17",7579472,"17",7676154,12351,27390,"rs1042522","NC_000017.11:7676153:G:C"
"NM_000546.5(TP53):c.398T>C (p.Met133Thr)","TP53","M133T, M1T, M94T","Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1","Pathogenic(Last reviewed: Sep 16, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012357","17",7578532,"17",7675214,12357,27396,"rs28934873","NC_000017.11:7675213:A:G"
"NM_000546.5(TP53):c.722C>T (p.Ser241Phe)","TP53","S241F, S109F, S202F, S82F","Carcinoma of gallbladder|Papillary renal cell carcinoma, sporadic|Uterine Carcinosarcoma|Lip and oral cavity carcinoma|Non-Hodgkin lymphoma|Renal cell carcinoma, papillary, 1|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Malignant melanoma of skin|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Breast neoplasm|Glioblastoma|Squamous cell carcinoma of the skin|Brainstem glioma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Hepatoblastoma|Osteosarcoma|Li-Fraumeni syndrome","Likely pathogenic(Last reviewed: May 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012359","17",7577559,"17",7674241,12359,27398,"rs28934573","NC_000017.11:7674240:G:A"
"NM_000151.4(G6PC1):c.247C>T (p.Arg83Cys)","G6PC1","R83C","not provided|Hypoglycemia|Short stature|Glycogen storage disease due to glucose-6-phosphatase deficiency type IA|Glycogen storage disease","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011998","17",41055964,"17",42903947,11998,27037,"rs1801175","NC_000017.11:42903946:C:T"
"NM_000546.6(TP53):c.733G>A (p.Gly245Ser)","TP53","G245S, G113S, G206S, G86S","Hereditary cancer-predisposing syndrome|Breast neoplasm|Glioblastoma|Pancreatic adenocarcinoma|Li-Fraumeni syndrome|Li-Fraumeni-like syndrome|not provided|Brainstem glioma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Li-Fraumeni syndrome 1|Hepatocellular carcinoma|Neoplasm of ovary|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Atypical teratoid/rhabdoid tumor|Astrocytoma, anaplastic|Familial ovarian cancer|Uterine Carcinosarcoma|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Neoplasm|Neoplasm of the large intestine|Neoplasm of brain|Colorectal cancer|Adenocarcinoma|Carcinoma of esophagus","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000012365","17",7577548,"17",7674230,12365,27404,"rs28934575","NC_000017.11:7674229:C:T"
"NM_000546.6(TP53):c.818G>A (p.Arg273His)","TP53","R273H, R141H, R234H, R114H","Hereditary cancer-predisposing syndrome|Breast neoplasm|not specified|Glioblastoma|Nasopharyngeal carcinoma|Carcinoma of colon|Li-Fraumeni syndrome 1|Carcinoma of pancreas|Choroid plexus papilloma|Osteosarcoma|Glioma susceptibility 1|Familial cancer of breast|Adrenocortical carcinoma, hereditary|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Pancreatic adenocarcinoma|not provided|Li-Fraumeni syndrome|Medulloblastoma|Chronic lymphocytic leukemia|Multiple myeloma|Brainstem glioma|Transitional cell carcinoma of the bladder|Small cell lung carcinoma|Acute myeloid leukemia|Thyroid gland undifferentiated (anaplastic) carcinoma|Lung adenocarcinoma|Malignant melanoma of skin|Hepatocellular carcinoma|Neoplasm of ovary|Squamous cell lung carcinoma|Malignant tumor of breast|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Familial cancer of breast|Colorectal cancer|Multiple myeloma|Uterine Carcinosarcoma|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Adrenocortical carcinoma|Neoplasm|Neoplasm of the large intestine|Neoplasm of brain|Rhabdomyosarcoma (disease)|Carcinoma of esophagus","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000012366","17",7577120,"17",7673802,12366,27405,"rs28934576","NC_000017.11:7673801:C:T"
"NM_000546.6(TP53):c.524G>A (p.Arg175His)","TP53","R175H, R136H, R43H, R16H","Li-Fraumeni syndrome 1|Osteosarcoma|Glioma susceptibility 1|Hepatocellular carcinoma|Carcinoma of colon|Familial cancer of breast|Choroid plexus papilloma|Li-Fraumeni syndrome 1|Carcinoma of pancreas|Basal cell carcinoma, susceptibility to, 7|Adrenocortical carcinoma, hereditary|Nasopharyngeal carcinoma|Hereditary cancer-predisposing syndrome|Breast neoplasm|not provided|Colorectal cancer|Lip and oral cavity carcinoma|Neoplasm|Li-Fraumeni syndrome|Neoplasm of ovary|Malignant tumor of esophagus|Squamous cell carcinoma of the head and neck|Familial cancer of breast","Pathogenic(Last reviewed: Jan 4, 2021)","criteria provided, multiple submitters, no conflicts","VCV000012374","17",7578406,"17",7675088,12374,27413,"rs28934578","NC_000017.11:7675087:C:T"
"NM_000346.4(SOX9):c.507C>T (p.His169=)","SOX9","","not specified|Camptomelic dysplasia|none provided","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021164","17",70118935,"17",72122794,21164,34016,"rs2229989","NC_000017.11:72122793:C:T"
"NM_000151.4(G6PC1):c.248G>A (p.Arg83His)","G6PC1","R83H","Glycogen storage disease due to glucose-6-phosphatase deficiency type IA","Pathogenic(Last reviewed: Oct 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000038300","17",41055965,"17",42903948,38300,27048,"rs1801176","NC_000017.11:42903947:G:A"
"NM_007294.4(BRCA1):c.5434C>G (p.Pro1812Ala)","BRCA1","P1812A, A683G, P1833A, P1765A, P708A","Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial 1|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jan 19, 2021)","criteria provided, multiple submitters, no conflicts","VCV000037670","17",41199693,"17",43047676,37670,46226,"rs1800751","NC_000017.11:43047675:G:C"
"NM_002055.5(GFAP):c.1055T>C (p.Leu352Pro)","GFAP","L352P","not provided|Alexander Disease","Pathogenic(Last reviewed: Jan 8, 2015)","no assertion criteria provided","VCV000016178","17",42988676,"17",44911308,16178,31217,"rs28932769","NC_000017.11:44911307:A:G"
"NM_000342.3(SLC4A1):c.268G>A (p.Glu90Lys)","SLC4A1","E90K","Spherocytosis type 4","Pathogenic(Last reviewed: Jun 1, 2001)","no assertion criteria provided","VCV000017775","17",42338084,"17",44260716,17775,32814,"rs28929480","NC_000017.11:44260715:C:T"
"NM_000342.3(SLC4A1):c.1462G>A (p.Val488Met)","SLC4A1","V488M","Renal tubular acidosis, distal, with hemolytic anemia|Spherocytosis type 4","Pathogenic(Last reviewed: Feb 27, 2018)","criteria provided, multiple submitters, no conflicts","VCV000017773","17",42334882,"17",44257514,17773,32812,"rs28931584","NC_000017.11:44257513:C:T"
"NM_007294.4(BRCA1):c.3748G>T (p.Glu1250Ter)","BRCA1","E1250*, E1203*","not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial 1","Pathogenic(Last reviewed: Sep 8, 2016)","reviewed by expert panel","VCV000017672","17",41243800,"17",43091783,17672,32711,"rs28897686","NC_000017.11:43091782:C:A"
"NM_000342.4(SLC4A1):c.166A>G (p.Lys56Glu)","SLC4A1","K56E","not provided|not specified|Hemolytic anemia|none provided|Spherocytosis type 4|Band 3 memphis|Autosomal dominant distal renal tubular acidosis","Benign/Likely benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017752","17",42338945,"17",44261577,17752,32791,"rs5036","NC_000017.11:44261576:T:C"
"NM_018127.7(ELAC2):c.650C>T (p.Ser217Leu)","ELAC2","S217L","not specified|Combined oxidative phosphorylation deficiency 17|Prostate cancer, hereditary, 2|not provided","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005055","17",12915009,"17",13011692,5055,20094,"rs4792311","NC_000017.11:13011691:G:A"
"NM_018127.7(ELAC2):c.1621G>A (p.Ala541Thr)","ELAC2","A541T, A501T, A540T","Prostate cancer, hereditary, 2|not specified|not provided|Combined oxidative phosphorylation deficiency 17","Benign(Last reviewed: Dec 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005056","17",12899902,"17",12996585,5056,20095,"rs5030739","NC_000017.11:12996584:C:T"
"NM_000152.3(GAA):c.2065G>A (p.Glu689Lys)","GAA","E689K","not specified|not provided|Glycogen storage disease, type II|Acid alpha-glucosidase, allele 4","Benign, other(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004030","17",78087041,"17",80113242,4030,19069,"rs1800309","NC_000017.11:80113241:G:A"
"NM_005450.5(NOG):c.103C>G (p.Pro35Ala)","NOG","P35A","Brachydactyly type B2","Pathogenic(Last reviewed: Aug 1, 2007)","no assertion criteria provided","VCV000006708","17",54671687,"17",56594326,6708,21747,"rs28937580","NC_000017.11:56594325:C:G"
"NM_005450.5(NOG):c.103C>T (p.Pro35Ser)","NOG","P35S","Symphalangism, proximal, 1A|Brachydactyly type B2|Stapes ankylosis with broad thumb and toes","Pathogenic(Last reviewed: Jul 1, 2008)","no assertion criteria provided","VCV000006703","17",54671687,"17",56594326,6703,21742,"rs28937580","NC_000017.11:56594325:C:T"
"NM_000286.3(PEX12):c.959C>T (p.Ser320Phe)","PEX12","S320F","not provided|Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder 3A","Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)","criteria provided, conflicting interpretations","VCV000007775","17",33902922,"17",35575903,7775,22814,"rs28936697","NC_000017.11:35575902:G:A"
"NM_000286.3(PEX12):c.273A>T (p.Arg91Ser)","PEX12","R91S","Peroxisomal biogenesis disorder 3b","Pathogenic(Last reviewed: Feb 1, 2004)","no assertion criteria provided","VCV000007778","17",33904464,"17",35577445,7778,22817,"rs28936698","NC_000017.11:35577444:T:A"
"NM_000546.5(TP53):c.329G>T (p.Arg110Leu)","TP53","R110L, R71L","Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm of ovary","Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2021)","criteria provided, multiple submitters, no conflicts","VCV000406597","17",7579358,"17",7676040,406597,402569,"rs11540654","NC_000017.11:7676039:C:A"
"NM_000546.5(TP53):c.733G>C (p.Gly245Arg)","TP53","G113R, G206R, G245R, G86R","Uterine Carcinosarcoma|Ovarian Serous Cystadenocarcinoma|Glioblastoma|Carcinoma of esophagus|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|Breast neoplasm|Neoplasm of brain|Pancreatic adenocarcinoma|Hepatocellular carcinoma|Lung adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Brainstem glioma|Transitional cell carcinoma of the bladder","Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2019)","criteria provided, conflicting interpretations","VCV000376604","17",7577548,"17",7674230,376604,363483,"rs28934575","NC_000017.11:7674229:C:G"
"NM_000546.5(TP53):c.832C>T (p.Pro278Ser)","TP53","P146S, P239S, P278S, P119S","Ovarian Serous Cystadenocarcinoma|Carcinoma of esophagus|Malignant neoplasm of body of uterus|Neoplasm of the large intestine|Breast neoplasm|Neoplasm of brain|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|Neoplasm of ovary|Multiple myeloma|Malignant melanoma of skin|Lung adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin","Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2019)","criteria provided, conflicting interpretations","VCV000376642","17",7577106,"17",7673788,376642,363521,"rs17849781","NC_000017.11:7673787:G:A"
"NM_000546.5(TP53):c.832C>A (p.Pro278Thr)","TP53","P146T, P239T, P278T, P119T","Squamous cell lung carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the head and neck|Breast neoplasm|Multiple myeloma|Poly (ADP-Ribose) polymerase inhibitor response|Neoplasm of ovary|Lung adenocarcinoma|Malignant neoplasm of body of uterus|Neoplasm of brain|Squamous cell carcinoma of the skin|Ovarian Serous Cystadenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Malignant melanoma of skin","Likely pathogenic, drug response(Last reviewed: Dec 1, 2018)","no assertion criteria provided","VCV000376643","17",7577106,"17",7673788,376643,363522,"rs17849781","NC_000017.11:7673787:G:T"
"NM_000546.5(TP53):c.832C>G (p.Pro278Ala)","TP53","P146A, P239A, P278A, P119A","Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Breast neoplasm|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Multiple myeloma|Neoplasm of ovary|Malignant melanoma of skin|Lung adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin","Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2019)","criteria provided, conflicting interpretations","VCV000376645","17",7577106,"17",7673788,376645,363524,"rs17849781","NC_000017.11:7673787:G:C"
"NM_000546.5(TP53):c.818G>T (p.Arg273Leu)","TP53","R141L, R234L, R273L, R114L","Transitional cell carcinoma of the bladder|Brainstem glioma|Small cell lung carcinoma|not provided|Li-Fraumeni syndrome|Metastatic pancreatic neuroendocrine tumours|Multiple myeloma|Glioblastoma|Malignant melanoma of skin|Neoplasm of ovary|Carcinoma of esophagus|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Chronic lymphocytic leukemia|Medulloblastoma|Lung adenocarcinoma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of the large intestine|Acute myeloid leukemia|Neoplasm of brain","Pathogenic(Last reviewed: Oct 16, 2020)","criteria provided, multiple submitters, no conflicts","VCV000376655","17",7577120,"17",7673802,376655,363534,"rs28934576","NC_000017.11:7673801:C:A"
"NM_000546.5(TP53):c.722C>A (p.Ser241Tyr)","TP53","S109Y, S202Y, S241Y, S82Y","Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Breast neoplasm|Renal cell carcinoma, papillary, 1|Squamous cell carcinoma of the skin|Brainstem glioma|Glioblastoma|Carcinoma of esophagus|Neoplasm of ovary|Pancreatic adenocarcinoma|Malignant melanoma of skin|Neoplasm of brain|Non-Hodgkin lymphoma|Lung adenocarcinoma|Carcinoma of gallbladder|Uterine Carcinosarcoma|Papillary renal cell carcinoma, sporadic|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Transitional cell carcinoma of the bladder|Li-Fraumeni syndrome","Pathogenic(Last reviewed: Jul 16, 2020)","criteria provided, single submitter","VCV000376663","17",7577559,"17",7674241,376663,363542,"rs28934573","NC_000017.11:7674240:G:T"
"NM_001614.5(ACTG1):c.430G>A (p.Ala144Thr)","ACTG1","A144T","Baraitser-Winter Syndrome 2","Likely pathogenic(Last reviewed: May 3, 2016)","criteria provided, single submitter","VCV000434079","17",79478586,"17",81511560,434079,430029,"rs11549196","NC_000017.11:81511559:C:T"
"NM_000546.5(TP53):c.1015G>T (p.Glu339Ter)","TP53","E207*, E300*, E339*, E180*","Li-Fraumeni syndrome|Li-Fraumeni syndrome 1","Pathogenic(Last reviewed: Feb 16, 2018)","criteria provided, single submitter","VCV000438708","17",7574012,"17",7670694,438708,432338,"rs17882252","NC_000017.11:7670693:C:A"
"NM_007294.3(BRCA1):c.5075-1G>C","BRCA1","","Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome","Pathogenic(Last reviewed: Dec 29, 2019)","criteria provided, multiple submitters, no conflicts","VCV000125759","17",41215969,"17",43063952,125759,131297,"rs1800747","NC_000017.11:43063951:C:G"
"NM_000546.6(TP53):c.329G>A (p.Arg110His)","TP53","R110H, R71H","Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|not specified","Likely benign(Last reviewed: Aug 11, 2020)","reviewed by expert panel","VCV000127808","17",7579358,"17",7676040,127808,133265,"rs11540654","NC_000017.11:7676039:C:T"
"NM_000546.5(TP53):c.215= (p.Pro72=)","TP53","","not specified","Benign(Last reviewed: Aug 15, 2013)","criteria provided, single submitter","VCV000165560","17",7579472,"17",7676154,165560,176504,"rs1042522","NC_000017.11:7676153:G:G"
"NM_000546.6(TP53):c.722C>G (p.Ser241Cys)","TP53","S109C, S202C, S241C, S82C","Lung adenocarcinoma|Non-Hodgkin lymphoma|Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Malignant melanoma of skin|Li-Fraumeni syndrome|Neoplasm of the large intestine|Breast neoplasm|Neoplasm of brain|Transitional cell carcinoma of the bladder|Brainstem glioma|Squamous cell carcinoma of the skin|not provided|Uterine Carcinosarcoma|Carcinoma of gallbladder|Glioblastoma|Carcinoma of esophagus|Renal cell carcinoma, papillary, 1|Pancreatic adenocarcinoma|Malignant neoplasm of body of uterus|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma|Squamous cell carcinoma of the head and neck","Likely pathogenic(Last reviewed: Oct 30, 2018)","criteria provided, multiple submitters, no conflicts","VCV000177791","17",7577559,"17",7674241,177791,176503,"rs28934573","NC_000017.11:7674240:G:C"
"NM_000546.5(TP53):c.524G>T (p.Arg175Leu)","TP53","R136L, R175L, R43L, R16L","Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome","Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182963","17",7578406,"17",7675088,182963,181010,"rs28934578","NC_000017.11:7675087:C:A"
"NM_000546.5(TP53):c.1015G>C (p.Glu339Gln)","TP53","E207Q, E300Q, E339Q, E180Q","not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Likely benign(Last reviewed: Sep 1, 2020)","reviewed by expert panel","VCV000141893","17",7574012,"17",7670694,141893,151607,"rs17882252","NC_000017.11:7670693:C:G"
"NM_000546.5(TP53):c.1015G>A (p.Glu339Lys)","TP53","E207K, E300K, E339K, E180K","Li-Fraumeni syndrome|Hereditary breast and ovarian cancer syndrome|Li-Fraumeni syndrome 1|not provided|Hereditary cancer-predisposing syndrome|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000142846","17",7574012,"17",7670694,142846,152560,"rs17882252","NC_000017.11:7670693:C:T"
"NM_007294.3(BRCA1):c.5075-1G>T","BRCA1","","Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1|Familial cancer of breast","Pathogenic(Last reviewed: Jan 30, 2019)","criteria provided, single submitter","VCV000055378","17",41215969,"17",43063952,55378,70045,"rs1800747","NC_000017.11:43063951:C:A"
"NM_007294.4(BRCA1):c.5425G>T (p.Val1809Phe)","BRCA1","V1809F, V705F, G680V, V1762F, V1830F","Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial 1","Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2020)","criteria provided, conflicting interpretations","VCV000055573","17",41199702,"17",43047685,55573,70240,"rs28897698","NC_000017.11:43047684:C:A"
"NM_007294.4(BRCA1):c.5075-1G>A","BRCA1","","Breast-ovarian cancer, familial 1|not provided|Breast neoplasm|Hereditary breast and ovarian cancer syndrome|Familial cancer of breast|Hereditary cancer-predisposing syndrome","Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000055377","17",41215969,"17",43063952,55377,70044,"rs1800747","NC_000017.11:43063951:C:T"
"NM_007294.4(BRCA1):c.3748G>A (p.Glu1250Lys)","BRCA1","E1250K, E1203K","Malignant tumor of breast|Hereditary cancer-predisposing syndrome|none provided|Breast-ovarian cancer, familial 1|Breast neoplasm|not specified|Breast and/or ovarian cancer|Hereditary breast and ovarian cancer syndrome","Benign(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000054987","17",41243800,"17",43091783,54987,69654,"rs28897686","NC_000017.11:43091782:C:T"
"NM_007294.4(BRCA1):c.5425G>A (p.Val1809Ile)","BRCA1","V1809I, V705I, V1830I, G680D, V1762I","Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1","Uncertain significance(Last reviewed: Jul 7, 2020)","criteria provided, single submitter","VCV000240822","17",41199702,"17",43047685,240822,242756,"rs28897698","NC_000017.11:43047684:C:T"
"NM_000346.4(SOX9):c.507C>G (p.His169Gln)","SOX9","H169Q","not provided|Camptomelic dysplasia|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)","criteria provided, conflicting interpretations","VCV000235914","17",70118935,"17",72122794,235914,237540,"rs2229989","NC_000017.11:72122793:C:G"
"NM_000180.4(GUCY2D):c.3139-1G>C","GUCY2D","","not provided","Pathogenic(Last reviewed: Sep 29, 2016)","criteria provided, single submitter","VCV000280359","17",7919522,"17",8016204,280359,264708,"rs12602083","NC_000017.11:8016203:G:C"
"NM_000546.5(TP53):c.215C>A (p.Pro72His)","TP53","P33H, P72H","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1","Likely benign(Last reviewed: Apr 19, 2021)","reviewed by expert panel","VCV000185120","17",7579472,"17",7676154,185120,185405,"rs1042522","NC_000017.11:7676153:G:T"
"NM_000546.5(TP53):c.818G>C (p.Arg273Pro)","TP53","R141P, R234P, R273P, R114P","Small cell lung carcinoma|Multiple myeloma|Li-Fraumeni syndrome|Medulloblastoma|Neoplasm of ovary|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Breast neoplasm|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Glioblastoma|Squamous cell lung carcinoma|Lung adenocarcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Brainstem glioma|Transitional cell carcinoma of the bladder|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adrenocortical carcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin|Hepatocellular carcinoma|Acute myeloid leukemia","Pathogenic(Last reviewed: Sep 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000231060","17",7577120,"17",7673802,231060,236461,"rs28934576","NC_000017.11:7673801:C:G"
"NM_000546.5(TP53):c.329G>C (p.Arg110Pro)","TP53","R110P, R71P","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Sep 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000233627","17",7579358,"17",7676040,233627,236497,"rs11540654","NC_000017.11:7676039:C:G"
"NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)","MC4R","Y35*","Schizophrenia|not provided|Obesity","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000014318","18",58039478,"18",60372245,14318,29357,"rs13447324","NC_000018.10:60372244:G:T"
"NM_005912.2(MC4R):c.110A>T (p.Asp37Val)","MC4R","D37V","not specified|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20|Obesity","Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2019)","criteria provided, conflicting interpretations","VCV000014319","18",58039473,"18",60372240,14319,29358,"rs13447325","NC_000018.10:60372239:T:A"
"NM_005912.3(MC4R):c.380C>T (p.Ser127Leu)","MC4R","S127L","not provided|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20|Obesity","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2020)","criteria provided, conflicting interpretations","VCV000014336","18",58039203,"18",60371970,14336,29375,"rs13447331","NC_000018.10:60371969:G:A"
"NM_000371.3(TTR):c.185A>G (p.Glu62Gly)","TTR","E42G, E62G","Amyloidogenic transthyretin amyloidosis","Pathogenic(Last reviewed: Aug 1, 1992)","no assertion criteria provided","VCV000013428","18",29172974,"18",31593011,13428,28467,"rs11541796","NC_000018.10:31593010:A:G"
"NM_000140.4(FECH):c.315-48T>C","FECH","","not provided|Erythema|Jaundice|Autosomal erythropoietic protoporphyria|Protoporphyria, erythropoietic, 1","Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2020)","criteria provided, conflicting interpretations","VCV000000562","18",55238820,"18",57571588,562,15601,"rs2272783","NC_000018.10:57571587:A:G"
"NM_000371.3(TTR):c.130C>T (p.Pro44Ser)","TTR","P44S","not provided|Amyloidogenic transthyretin amyloidosis","Pathogenic(Last reviewed: Oct 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000181693","18",29172919,"18",31592956,181693,179804,"rs11541790","NC_000018.10:31592955:C:T"
"NM_000894.2(LHB):c.221A>G (p.Gln74Arg)","LHB","Q74R","Isolated lutropin deficiency","Pathogenic(Last reviewed: Jan 16, 1992)","no assertion criteria provided","VCV000014413","19",49519530,"19",49016273,14413,29452,"rs5030773","NC_000019.10:49016272:T:C"
"NM_000540.3(RYR1):c.7372C>T (p.Arg2458Cys)","RYR1","R2458C","enflurane response - Toxicity/ADR|sevoflurane response - Toxicity/ADR|succinylcholine response - Toxicity/ADR|methoxyflurane response - Toxicity/ADR|isoflurane response - Toxicity/ADR|desflurane response - Toxicity/ADR|halothane response - Toxicity/ADR|RYR1-Related Disorders|not provided|Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility","drug response","reviewed by expert panel","VCV000012971","19",38991294,"19",38500654,12971,28010,"rs28933397","NC_000019.10:38500653:C:T"
"NM_020956.2(PRX):c.*2156G>A","PRX","D651N","Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, demyelinating, type 4F","Uncertain significance(Last reviewed: Aug 20, 2019)","criteria provided, single submitter","VCV000038452","19",40902308,"19",40396401,38452,47011,"rs3814290","NC_000019.10:40396400:C:T"
"NM_001972.4(ELANE):c.211T>C (p.Cys71Arg)","ELANE","C71R","Neutropenia, severe congenital 1, autosomal dominant","Pathogenic(Last reviewed: Nov 1, 2001)","no assertion criteria provided","VCV000016746","19",853019,"19",853019,16746,31785,"rs28931611","NC_000019.10:853018:T:C"
"NM_000041.4(APOE):c.178A>G (p.Thr60Ala)","APOE","T60A, T86A","APOE3(-)-FREIBURG","Pathogenic(Last reviewed: Aug 5, 2016)","no assertion criteria provided","VCV000017871","19",45411151,"19",44907894,17871,32910,"rs28931576","NC_000019.10:44907893:A:G"
"NM_000041.2(APOE):c.526C>T (p.Arg176Cys)","APOE","R176C, R202C","not specified|not provided|atorvastatin response - Efficacy|Warfarin response|Hypercholesterolemia|Familial type 3 hyperlipoproteinemia","drug response(Last reviewed: Feb 26, 2016)","reviewed by expert panel","VCV000017848","19",45412079,"19",44908822,17848,32887,"rs7412","NC_000019.10:44908821:C:T"
"NM_000041.4(APOE):c.487C>T (p.Arg163Cys)","APOE","R163C, R189C","not provided|Familial type 3 hyperlipoproteinemia","Benign(Last reviewed: Dec 31, 2019)","criteria provided, single submitter","VCV000017851","19",45412040,"19",44908783,17851,32890,"rs769455","NC_000019.10:44908782:C:T"
"NM_001013257.2(BCAM):c.711C>A (p.Cys237Ter)","BCAM","C237*","BLOOD GROUP--LUTHERAN NULL","Pathogenic(Last reviewed: Mar 1, 2007)","no assertion criteria provided","VCV000000442","19",45316804,"19",44813547,442,15481,"rs3810141","NC_000019.10:44813546:C:A"
"NM_000483.5(APOC2):c.229A>C (p.Lys77Gln)","APOC2|APOC4-APOC2","K77Q","not provided|Apolipoprotein C2 deficiency|APOLIPOPROTEIN C-II (AFRICAN)","Benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000002573","19",45452429,"19",44949172,2573,17612,"rs5126","NC_000019.10:44949171:A:C"
"NM_000095.3(COMP):c.1358A>G (p.Asn453Ser)","COMP","N453S","Epiphyseal dysplasia, multiple, 1, severe","Pathogenic(Last reviewed: Feb 1, 1998)","no assertion criteria provided","VCV000009190","19",18896906,"19",18786096,9190,24229,"rs28936668","NC_000019.10:18786095:T:C"
"NM_000095.3(COMP):c.1418A>G (p.Asp473Gly)","COMP","D473G","Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000009191","19",18896846,"19",18786036,9191,24230,"rs28936669","NC_000019.10:18786035:T:C"
"NM_000095.3(COMP):c.2152C>T (p.Arg718Trp)","COMP","R718W","not provided|Carpal tunnel syndrome 2|Multiple epiphyseal dysplasia 1","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009198","19",18893939,"19",18783129,9198,24237,"rs28936368","NC_000019.10:18783128:G:A"
"NM_000435.3(NOTCH3):c.213G>T (p.Trp71Cys)","NOTCH3","W71C","Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: Nov 22, 1997)","no assertion criteria provided","VCV000009218","19",15303315,"19",15192504,9218,24257,"rs28937321","NC_000019.10:15192503:C:A"
"NM_000435.3(NOTCH3):c.505C>T (p.Arg169Cys)","NOTCH3","R169C","Stroke|Migraine without aura|none provided|not provided|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: Jun 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009219","19",15302945,"19",15192134,9219,24258,"rs28933696","NC_000019.10:15192133:G:A"
"NM_000435.3(NOTCH3):c.544C>T (p.Arg182Cys)","NOTCH3","R182C","not specified|not provided|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009220","19",15302906,"19",15192095,9220,24259,"rs28933697","NC_000019.10:15192094:G:A"
"NM_000435.3(NOTCH3):c.1363T>C (p.Cys455Arg)","NOTCH3","C455R","not provided|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: May 25, 2017)","criteria provided, single submitter","VCV000009223","19",15299815,"19",15189004,9223,24262,"rs28933698","NC_000019.10:15189003:A:G"
"NM_000041.4(APOE):c.349G>A (p.Ala117Thr)","APOE","A117T, A143T","","no interpretation for the single variant","no interpretation for the single variant","VCV000478851","19",45411902,"19",44908645,478851,32912,"rs28931577","NC_000019.10:44908644:G:A"
"NM_000095.3(COMP):c.2152C>A (p.Arg718=)","COMP","","Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|Multiple epiphyseal dysplasia 1","Benign(Last reviewed: Oct 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000769450","19",18893939,"19",18783129,769450,704863,"rs28936368","NC_000019.10:18783128:G:T"
"NM_000215.3(JAK3):c.2164G>A (p.Val722Ile)","JAK3","V722I","not specified|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative|not provided|Lymphoblastic leukemia, acute, with lymphomatous features|Acute megakaryoblastic leukemia","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000134573","19",17945696,"19",17834887,134573,138312,"rs3213409","NC_000019.10:17834886:C:T"
"NM_000215.3(JAK3):c.394C>A (p.Pro132Thr)","JAK3","P132T","Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative|not specified|Lymphoblastic leukemia, acute, with lymphomatous features|Acute megakaryoblastic leukemia","Benign/Likely benign(Last reviewed: Nov 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000134580","19",17954215,"19",17843406,134580,138319,"rs3212723","NC_000019.10:17843405:G:T"
"NM_000527.5(LDLR):c.81C>A (p.Cys27Ter)","LDLR","C27*","Familial hypercholesterolemia 1|Familial hypercholesterolemia","Pathogenic(Last reviewed: Oct 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000251009","19",11210912,"19",11100236,251009,245364,"rs2228671","NC_000019.10:11100235:C:A"
"NM_000527.5(LDLR):c.81C>T (p.Cys27=)","LDLR","","Smith-Lemli-Opitz syndrome|not specified|Familial hypercholesterolemia|Familial hypercholesterolemia 1","Benign(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000251010","19",11210912,"19",11100236,251010,245365,"rs2228671","NC_000019.10:11100235:C:T"
"NM_024407.5(NDUFS7):c.343C>T (p.Arg115Cys)","NDUFS7","R115C","not provided","Likely pathogenic(Last reviewed: Sep 25, 2014)","criteria provided, single submitter","VCV000214834","19",1390984,"19",1390985,214834,211859,"rs11551664","NC_000019.10:1390984:C:T"
"NM_002361.4(MAG):c.399C>G (p.Ser133Arg)","MAG","S133R, S108R","Spastic paraplegia 75, autosomal recessive","Pathogenic(Last reviewed: Sep 1, 2015)","no assertion criteria provided","VCV000218187","19",35786868,"19",35295965,218187,214840,"rs2301600","NC_000019.10:35295964:C:G"
"NM_000527.5(LDLR):c.81C>G (p.Cys27Trp)","LDLR","C27W","not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1","Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2021)","criteria provided, conflicting interpretations","VCV000226304","19",11210912,"19",11100236,226304,228117,"","NC_000019.10:11100235:C:G"
"NM_000523.4(HOXD13):c.916C>T (p.Arg306Trp)","HOXD13","R306W","Synpolydactyly 1","Pathogenic(Last reviewed: Nov 1, 2002)","no assertion criteria provided","VCV000014872","2",176959342,"2",176094614,14872,29911,"rs28933082","NC_000002.12:176094613:C:T"
"UGT1A1*6","UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3","G71R","not provided|not specified|Irinotecan response|SN-38 response - Other|irinotecan response - Other|Lucey-Driscoll syndrome|Bilirubin, serum level of, quantitative trait locus 1|Gilbert syndrome|Crigler-Najjar syndrome, type II","drug response(Last reviewed: Aug 28, 2017)","reviewed by expert panel","VCV000012280","2",234669144,"2",233760498,12280,27319,"rs4148323","NC_000002.12:233760497:G:A"
"NM_001072.4(UGT1A6):c.862-8098=","UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3","","Lucey-Driscoll syndrome","Pathogenic(Last reviewed: Nov 1, 2000)","no assertion criteria provided","VCV000012282","2",234667582,"2",233758936,12282,27321,"rs3755319","NC_000002.12:233758935:A:A"
"NM_001072.4(UGT1A6):c.862-10021T>G","UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3","","Gilbert syndrome|none provided|Gilbert syndrome, susceptibility to","Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2020)","criteria provided, conflicting interpretations","VCV000012288","2",234665659,"2",233757013,12288,27327,"rs4124874","NC_000002.12:233757012:T:G"
"NM_000179.3(MSH6):c.642C>T (p.Tyr214=)","MSH6","","Hereditary cancer-predisposing syndrome|Lynch syndrome|not specified|Carcinoma of colon|Hereditary nonpolyposis colorectal cancer type 5|Hereditary nonpolyposis colorectal neoplasms|none provided","Benign(Last reviewed: Sep 5, 2013)","reviewed by expert panel","VCV000036599","2",48025764,"2",47798625,36599,45261,"rs1800937","NC_000002.12:47798624:C:T"
"NM_006891.4(CRYGD):c.70C>A (p.Pro24Thr)","CRYGD|LOC100507443","P24T","Congenital cataract|Cataract 4|Aculeiform cataract","Pathogenic(Last reviewed: Feb 5, 2019)","criteria provided, single submitter","VCV000016940","2",208989018,"2",208124294,16940,31979,"rs28931605","NC_000002.12:208124293:G:T"
"NM_000821.7(GGCX):c.1502G>C (p.Trp501Ser)","GGCX","W501S, W444S","Vitamin K-dependent clotting factors, combined deficiency of, 1","Pathogenic(Last reviewed: Nov 15, 2000)","no assertion criteria provided","VCV000016195","2",85779042,"2",85551919,16195,31234,"rs28928872","NC_000002.12:85551918:C:G"
"NM_006891.4(CRYGD):c.70C>T (p.Pro24Ser)","CRYGD|LOC100507443","P24S","Cataract 4","Pathogenic(Last reviewed: Sep 1, 2007)","no assertion criteria provided","VCV000016942","2",208989018,"2",208124294,16942,31981,"rs28931605","NC_000002.12:208124293:G:A"
"NM_000145.3(FSHR):c.1346C>T (p.Thr449Ile)","FSHR","T449I, T423I","Ovarian hyperstimulation syndrome","Pathogenic(Last reviewed: May 13, 2019)","no assertion criteria provided","VCV000016249","2",49190614,"2",48963475,16249,31288,"rs28928870","NC_000002.12:48963474:G:A"
"NM_022437.3(ABCG8):c.55G>C (p.Asp19His)","ABCG5|ABCG8","D19H","Sitosterolemia 1|not specified|Sitosterolemia|Gallbladder disease 4","Benign/Likely benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004975","2",44066247,"2",43839108,4975,20014,"rs11887534","NC_000002.12:43839107:G:C"
"NM_000104.3(CYP1B1):c.1405C>T (p.Arg469Trp)","CYP1B1","R469W","Glaucoma 3, primary congenital, A|not provided","Pathogenic(Last reviewed: Jan 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000007733","2",38298092,"2",38070949,7733,22772,"rs28936701","NC_000002.12:38070948:G:A"
"NM_001372051.1(CASP8):c.742C>T (p.Arg248Trp)","CASP8","R248W, R265W, R307W, R233W, T226M","Autoimmune lymphoproliferative syndrome type 2B","Pathogenic(Last reviewed: Sep 26, 2002)","no assertion criteria provided","VCV000007760","2",202141631,"2",201276908,7760,22799,"rs17860424","NC_000002.12:201276907:C:T"
"NM_022336.4(EDAR):c.1109T>C (p.Val370Ala)","EDAR","V370A","Autosomal recessive hypohidrotic ectodermal dysplasia syndrome|Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant|not specified|Non-syndromic oligodontia|Hypohidrotic Ectodermal Dysplasia, Dominant|Hair morphology 1, hair thickness|Hypohidrotic ectodermal dysplasia","Benign(Last reviewed: Nov 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005858","2",109513601,"2",108897145,5858,20897,"rs3827760","NC_000002.12:108897144:A:G"
"NM_001079866.2(BCS1L):c.232A>G (p.Ser78Gly)","BCS1L","S78G","Mitochondrial complex III deficiency, nuclear type 1|Leigh syndrome|Pili torti-deafness syndrome|GRACILE syndrome|not provided|GRACILE syndrome|Mitochondrial complex III deficiency, nuclear type 1","Pathogenic(Last reviewed: Jan 17, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006167","2",219525942,"2",218661219,6167,21206,"rs28937590","NC_000002.12:218661218:A:G"
"NM_000251.2(MSH2):c.1915C>T (p.His639Tyr)","MSH2","H639Y, H573Y","Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Lynch syndrome I|Hereditary nonpolyposis colorectal neoplasms","Pathogenic(Last reviewed: Sep 5, 2013)","reviewed by expert panel","VCV000001756","2",47702319,"2",47475180,1756,16795,"rs28929484","NC_000002.12:47475179:C:T"
"NM_032977.3(CASP10):c.853C>T (p.Leu285Phe)","CASP10","L285F, P254L, L242F","Autoimmune lymphoproliferative syndrome type 2|Autoimmune lymphoproliferative syndrome, type 2A|Autoimmune lymphoproliferative syndrome, type 2A","Uncertain significance(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000007764","2",202072837,"2",201208114,7764,22803,"rs17860403","NC_000002.12:201208113:C:T"
"NM_032976.3(CASP10):c.*327C>T","CASP10","A414V, A347V, A371V","Non-Hodgkin lymphoma","Pathogenic(Last reviewed: Jun 1, 2002)","no assertion criteria provided","VCV000007765","2",202074111,"2",201209388,7765,22804,"rs28936699","NC_000002.12:201209387:C:T"
"NM_000348.4(SRD5A2):c.607G>A (p.Gly203Ser)","SRD5A2","G203S","3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency","Pathogenic(Last reviewed: Mar 5, 2018)","criteria provided, single submitter","VCV000459640","2",31754468,"2",31529398,459640,450863,"rs9332961","NC_000002.12:31529397:C:T"
"NM_003742.4(ABCB11):c.167C>T (p.Ser56Leu)","ABCB11","S56L","not provided|not specified|Progressive familial intrahepatic cholestasis 2","Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2018)","criteria provided, conflicting interpretations","VCV000382469","2",169870004,"2",169013494,382469,365697,"rs11568361","NC_000002.12:169013493:G:A"
"NM_001267550.2(TTN):c.95032T>G (p.Cys31678Gly)","TTN|TTN-AS1","C30037G, C31678G, C29110G, C22613G, C22805G, C22738G","not provided","Likely pathogenic(Last reviewed: Feb 23, 2017)","criteria provided, single submitter","VCV000423780","2",179411026,"2",178546299,423780,405435,"rs2555818","NC_000002.12:178546298:A:C"
"NM_001201543.2(FAM161A):c.1212T>A (p.Cys404Ter)","FAM161A","C404*","Retinitis pigmentosa|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000425201","2",62066927,"2",61839792,425201,413535,"rs4672457","NC_000002.12:61839791:A:T"
"NM_003742.4(ABCB11):c.1774G>C (p.Glu592Gln)","ABCB11","E592Q","Cholestasis, intrahepatic, of pregnancy 3|not provided","Uncertain significance(Last reviewed: Apr 19, 2018)","criteria provided, single submitter","VCV000596905","2",169826590,"2",168970080,596905,587966,"rs11568370","NC_000002.12:168970079:C:G"
"NM_003742.4(ABCB11):c.167C>G (p.Ser56Ter)","ABCB11","S56*","not provided","Pathogenic(Last reviewed: Jul 20, 2017)","criteria provided, single submitter","VCV000593338","2",169870004,"2",169013494,593338,584402,"rs11568361","NC_000002.12:169013493:G:C"
"NM_004304.5(ALK):c.4381A>G (p.Ile1461Val)","ALK","I1461V, I393V","not specified|not provided|Neuroblastoma 3|Hereditary cancer-predisposing syndrome|Squamous cell lung carcinoma","Benign(Last reviewed: Dec 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133472","2",29416572,"2",29193706,133472,137211,"rs1670283","NC_000002.12:29193705:T:C"
"NM_014795.4(ZEB2):c.930C>A (p.Tyr310Ter)","ZEB2","Y310*, Y286*","not provided","Pathogenic(Last reviewed: Feb 25, 2014)","criteria provided, single submitter","VCV000167857","2",145157824,"2",144400257,167857,178162,"rs6711223","NC_000002.12:144400256:G:T"
"NM_001365536.1(SCN9A):c.3004G>T (p.Val1002Leu)","SCN9A|SCN1A-AS1","V1002L","none provided|Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not provided|not specified|Small fiber neuropathy|Paroxysmal extreme pain disorder|Primary erythromelalgia|Indifference to pain, congenital, autosomal recessive","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000094090","2",167129256,"2",166272746,94090,39316,"rs4369876","NC_000002.12:166272745:C:A"
"NM_014795.4(ZEB2):c.930C>T (p.Tyr310=)","ZEB2","","Mowat-Wilson syndrome|History of neurodevelopmental disorder|not provided|not specified","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000095643","2",145157824,"2",144400257,95643,101541,"rs6711223","NC_000002.12:144400256:G:A"
"NM_001201543.2(FAM161A):c.1212T>C (p.Cys404=)","FAM161A","","not provided|Retinitis pigmentosa 28|Retinitis pigmentosa|not specified","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000096217","2",62066927,"2",61839792,96217,102111,"rs4672457","NC_000002.12:61839791:A:G"
"NM_001365536.1(SCN9A):c.2827A>C (p.Met943Leu)","SCN9A|SCN1A-AS1","M943L","Hereditary sensory and autonomic neuropathy type IIA|none provided|Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not specified|not provided|Paroxysmal extreme pain disorder|Primary erythromelalgia|Indifference to pain, congenital, autosomal recessive","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000094089","2",167133540,"2",166277030,94089,39315,"rs12478318","NC_000002.12:166277029:T:G"
"NM_000179.2(MSH6):c.642C>A (p.Tyr214Ter)","MSH6","Y214*, Y84*","Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms","Pathogenic(Last reviewed: Sep 5, 2013)","reviewed by expert panel","VCV000089546","2",48025764,"2",47798625,89546,95020,"rs1800937","NC_000002.12:47798624:C:A"
"NM_000179.2(MSH6):c.642C>G (p.Tyr214Ter)","MSH6","Y214*, Y84*","Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided","Pathogenic(Last reviewed: Sep 5, 2013)","reviewed by expert panel","VCV000089547","2",48025764,"2",47798625,89547,95021,"rs1800937","NC_000002.12:47798624:C:G"
"NM_000523.4(HOXD13):c.916C>G (p.Arg306Gly)","HOXD13","R306G","Synpolydactyly 1","Pathogenic(Last reviewed: Aug 12, 2016)","no assertion criteria provided","VCV000225656","2",176959342,"2",176094614,225656,227492,"rs28933082","NC_000002.12:176094613:C:G"
"NM_000311.5(PRNP):c.598G>A (p.Glu200Lys)","PRNP","E200K","Fatal familial insomnia|Creutzfeldt-Jakob Disease, Familial|Huntington disease-like 1|none provided|not provided","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013398","20",4680464,"20",4699818,13398,28437,"rs28933385","NC_000020.11:4699817:G:A"
"NM_001250.6(CD40):c.247T>C (p.Cys83Arg)","CD40","C83R","Hyper-IgM syndrome type 3","Pathogenic(Last reviewed: Dec 23, 2010)","no assertion criteria provided","VCV000017749","20",44750988,"20",46122349,17749,32788,"rs28931586","NC_000020.11:46122348:T:C"
"NM_018848.3(MKKS):c.155G>A (p.Gly52Asp)","MKKS","G52D","Bardet-Biedl syndrome 6","Pathogenic(Last reviewed: Feb 12, 2018)","no assertion criteria provided","VCV000005311","20",10394008,"20",10413360,5311,20350,"rs28937875","NC_000020.11:10413359:C:T"
"NM_000308.3(CTSA):c.247T>C (p.Trp83Arg)","CTSA","W65R, W83R","Combined deficiency of sialidase AND beta galactosidase","Pathogenic(Last reviewed: Jun 1, 1993)","no assertion criteria provided","VCV000000378","20",44520400,"20",45891761,378,15417,"rs28934603","NC_000020.11:45891760:T:C"
"NM_000557.5(GDF5):c.517A>G (p.Met173Val)","GDF5","M173V","Brachydactyly type C","Pathogenic(Last reviewed: Feb 1, 2004)","no assertion criteria provided","VCV000008384","20",34025192,"20",35437412,8384,23423,"rs28936397","NC_000020.11:35437411:T:C"
"NM_000961.4(PTGIS):c.1358+2T>C","PTGIS","","Essential hypertension","Pathogenic(Last reviewed: Oct 11, 2002)","no assertion criteria provided","VCV000007864","20",48127563,"20",49511026,7864,22903,"rs13306026","NC_000020.11:49511025:A:G"
"NM_000214.3(JAG1):c.765C>T (p.Tyr255=)","JAG1","","Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease|not specified|Alagille syndrome 1|not provided","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000143063","20",10633237,"20",10652589,143063,152781,"rs1131695","NC_000020.11:10652588:G:A"
"NM_000214.3(JAG1):c.765= (p.Tyr255=)","JAG1","","not specified","Benign(Last reviewed: Mar 30, 2016)","criteria provided, single submitter","VCV000163705","20",10633237,"20",10652589,163705,176595,"rs1131695","NC_000020.11:10652588:G:G"
"NM_000214.3(JAG1):c.765C>G (p.Tyr255Ter)","JAG1","Y255*","not provided","Pathogenic(Last reviewed: Oct 1, 2015)","criteria provided, single submitter","VCV000234555","20",10633237,"20",10652589,234555,232108,"rs1131695","NC_000020.11:10652588:G:C"
"NM_000219.6(KCNE1):c.20C>T (p.Thr7Ile)","KCNE1","T7I","Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 2","Pathogenic(Last reviewed: Nov 1, 1997)","no assertion criteria provided","VCV000013476","21",35821913,"21",34449615,13476,28515,"rs28933384","NC_000021.9:34449614:G:A"
"NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)","KCNE1","D85N","not provided|none provided|Long QT syndrome|Cardiovascular phenotype|Congenital long QT syndrome|Cardiomyopathy|Long QT syndrome 2/5|Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Long QT syndrome 5, acquired, susceptibility to|not specified","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000013479","21",35821680,"21",34449382,13479,28518,"rs1805128","NC_000021.9:34449381:C:T"
"NM_000071.3(CBS):c.833T>C (p.Ile278Thr)","CBS","I278T, I173T","Homocystinuria|Classic homocystinuria|Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|none provided|Intellectual disability|Cardiovascular phenotype|not provided","Pathogenic(Last reviewed: Oct 31, 2020)","criteria provided, multiple submitters, no conflicts","VCV000000120","21",44483184,"21",43063074,120,15159,"rs5742905","NC_000021.9:43063073:A:G"
"NM_000071.2(CBS):c.1265C>T (p.Pro422Leu)","CBS","P422L, P317L","Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED","Uncertain significance(Last reviewed: Nov 26, 2018)","criteria provided, multiple submitters, no conflicts","VCV000000129","21",44479037,"21",43058927,129,15168,"rs28934892","NC_000021.9:43058926:G:A"
"NM_000211.5(ITGB2):c.1756C>T (p.Arg586Trp)","ITGB2","R586W, R517W","Leukocyte adhesion deficiency 1","Benign/Likely benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009463","21",46309312,"21",44889397,9463,24502,"rs5030672","NC_000021.9:44889396:G:A"
"NM_000454.4(SOD1):c.420C>A (p.Asn140Lys)","SOD1","N140K","not provided","Pathogenic(Last reviewed: Dec 30, 2017)","criteria provided, single submitter","VCV000586635","21",33040846,"21",31668533,586635,577885,"rs1804449","NC_000021.9:31668532:C:A"
"NM_007194.4(CHEK2):c.470T>C (p.Ile157Thr)","CHEK2","I157T, I200T","not specified|not provided|Malignant tumor of breast|none provided|Familial cancer of breast|Cancer of multiple types, susceptibility to|Li-Fraumeni syndrome 2|Breast and colorectal cancer, susceptibility to|Colorectal cancer, susceptibility to|Breast cancer, susceptibility to|Colon cancer, susceptibility to|Breast cancer, susceptibility to|CHEK2-Related Cancer Susceptibility|Prostate cancer, susceptibility to|Hereditary cancer-predisposing syndrome|Gastrointestinal carcinoma|Adrenocortical carcinoma","Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Jul 7, 2021)","criteria provided, conflicting interpretations","VCV000005591","22",29121087,"22",28725099,5591,20630,"rs17879961","NC_000022.11:28725098:A:G"
"NM_016335.5(PRODH):c.1322T>C (p.Leu441Pro)","PRODH","L441P, L333P","not provided|Schizophrenia 4|Proline dehydrogenase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2020)","criteria provided, conflicting interpretations","VCV000004008","22",18905934,"22",18918421,4008,19047,"rs2904551","NC_000022.11:18918420:A:G"
"NM_016335.6(PRODH):c.1562= (p.Arg521=)","PRODH","","Proline dehydrogenase deficiency|not provided|Schizophrenia 4","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000004010","22",18901004,"22",18913491,4010,19049,"rs450046","NC_000022.11:18913490:C:C"
"NM_016335.5(PRODH):c.1292G>A (p.Arg431His)","PRODH","R431H, R323H","Proline dehydrogenase deficiency|Schizophrenia 4","Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)","criteria provided, conflicting interpretations","VCV000004011","22",18905964,"22",18918451,4011,19050,"rs2904552","NC_000022.11:18918450:C:T"
"NM_007194.4(CHEK2):c.254C>T (p.Pro85Leu)","CHEK2","P85L","not specified|not provided|Osteosarcoma|Familial cancer of breast|none provided|Hereditary cancer-predisposing syndrome|Malignant tumor of breast","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005594","22",29130456,"22",28734468,5594,20633,"rs17883862","NC_000022.11:28734467:G:A"
"NM_001429.4(EP300):c.6662C>A (p.Pro2221Gln)","EP300","P2221Q, P2195Q","Carcinoma of colon","Pathogenic(Last reviewed: Mar 1, 2000)","no assertion criteria provided","VCV000006881","22",41574377,"22",41178373,6881,21920,"rs28937578","NC_000022.11:41178372:C:A"
"NM_152299.4(NCAPH2):c.*639C>T","SCO2|NCAPH2","C133Y","Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency","Pathogenic(Last reviewed: Mar 15, 2004)","no assertion criteria provided","VCV000005684","22",50962443,"22",50524014,5684,20723,"rs28937868","NC_000022.11:50524013:C:T"
"NM_007194.4(CHEK2):c.254C>A (p.Pro85His)","CHEK2","P85H","Familial cancer of breast|Hereditary cancer-predisposing syndrome","Uncertain significance(Last reviewed: May 30, 2019)","criteria provided, multiple submitters, no conflicts","VCV000460819","22",29130456,"22",28734468,460819,471874,"rs17883862","NC_000022.11:28734467:G:T"
"NM_007194.4(CHEK2):c.470T>G (p.Ile157Ser)","CHEK2","I157S, I200S","not provided|Malignant tumor of breast","Likely pathogenic(Last reviewed: Apr 17, 2015)","criteria provided, single submitter","VCV000265327","22",29121087,"22",28725099,265327,260261,"rs17879961","NC_000022.11:28725098:A:C"
"NM_007194.4(CHEK2):c.254C>G (p.Pro85Arg)","CHEK2","P85R","not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome","Uncertain significance(Last reviewed: Sep 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000233261","22",29130456,"22",28734468,233261,236695,"rs17883862","NC_000022.11:28734467:G:C"
"NM_000174.4(GP9):c.70T>C (p.Cys24Arg)","GP9","C24R","not provided|Bernard Soulier syndrome|Bernard-Soulier syndrome type C","Pathogenic(Last reviewed: May 11, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013533","3",128780652,"3",129061809,13533,28572,"rs28933378","NC_000003.12:129061808:T:C"
"NM_000174.4(GP9):c.182A>G (p.Asn61Ser)","GP9","N61S","Thrombocytopenia|Bernard Soulier syndrome|not provided|Macrothrombocytopenia|Bernard-Soulier syndrome type C","Pathogenic/Likely pathogenic(Last reviewed: Oct 28, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013529","3",128780764,"3",129061921,13529,28568,"rs5030764","NC_000003.12:129061920:A:G"
"NM_000174.4(GP9):c.167T>C (p.Leu56Pro)","GP9","L40P, L56P","Bernard-Soulier syndrome type C","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000013532","3",128780749,"3",129061906,13532,28571,"rs28933377","NC_000003.12:129061905:T:C"
"NM_000387.6(SLC25A20):c.713A>G (p.Gln238Arg)","SLC25A20","Q238R","Carnitine acylcarnitine translocase deficiency|not provided","Pathogenic(Last reviewed: Dec 17, 2013)","criteria provided, multiple submitters, no conflicts","VCV000012138","3",48896530,"3",48859097,12138,27177,"rs28934589","NC_000003.12:48859096:T:C"
"NM_000539.3(RHO):c.173C>G (p.Thr58Arg)","RHO","T58R","not provided|Retinal dystrophy|Retinitis pigmentosa 4","Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013016","3",129247749,"3",129528906,13016,28055,"rs28933394","NC_000003.12:129528905:C:G"
"NM_000925.4(PDHB):c.395A>G (p.Tyr132Cys)","PDHB","Y132C, Y114C","Pyruvate dehydrogenase E1-beta deficiency","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000013188","3",58416578,"3",58430851,13188,28227,"rs28935769","NC_000003.12:58430850:T:C"
"NM_000055.2(BCHE):c.812C>T (p.Thr271Met)","BCHE","T271M","Deficiency of butyrylcholine esterase|BCHE, flouride 1","Likely pathogenic(Last reviewed: Feb 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013218","3",165548010,"3",165830222,13218,28257,"rs28933389","NC_000003.12:165830221:G:A"
"NM_000055.2(BCHE):c.1253G>T (p.Gly418Val)","BCHE","G418V","BCHE, fluoride 2|Deficiency of butyrylcholine esterase","Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2020)","criteria provided, conflicting interpretations","VCV000013219","3",165547569,"3",165829781,13219,28258,"rs28933390","NC_000003.12:165829780:C:A"
"NM_003242.6(TGFBR2):c.923T>C (p.Leu308Pro)","TGFBR2","L308P, L333P","Loeys-Dietz syndrome 2","Pathogenic(Last reviewed: Apr 1, 2010)","no assertion criteria provided","VCV000012505","3",30713598,"3",30672106,12505,27544,"rs28934568","NC_000003.12:30672105:T:C"
"NM_001354712.2(THRB):c.1357C>A (p.Pro453Thr)","THRB","P453T, P422T","not provided|Thyroid hormone resistance, generalized, autosomal dominant","Pathogenic(Last reviewed: Sep 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012550","3",24164404,"3",24122913,12550,27589,"rs28933408","NC_000003.12:24122912:G:T"
"NM_001337.4(CX3CR1):c.839C>T (p.Thr280Met)","CX3CR1","T280M, T312M","","no interpretation for the single variant","no interpretation for the single variant","VCV000025511","3",39307162,"3",39265671,25511,36774,"rs3732378","NC_000003.12:39265670:G:A"
"NM_033337.3(CAV3):c.99C>T (p.Asn33=)","SSUH2|CAV3","","not provided|Caveolinopathy|Limb-Girdle Muscular Dystrophy, Dominant|Congenital long QT syndrome|Cardiovascular phenotype|not specified|Long QT syndrome|none provided","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000031709","3",8775661,"3",8733975,31709,40369,"rs1008642","NC_000003.12:8733974:C:T"
"NM_000551.4(VHL):c.463+2T>G","VHL|LOC107303340","","Von Hippel-Lindau syndrome","Likely pathogenic(Last reviewed: Nov 30, 2009)","no assertion criteria provided","VCV000043602","3",10188322,"3",10146638,43602,52771,"rs5030814","NC_000003.12:10146637:T:G"
"NM_000551.4(VHL):c.464-1G>A","VHL|LOC107303340","","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Feb 19, 2019)","criteria provided, multiple submitters, no conflicts","VCV000043603","3",10191470,"3",10149786,43603,52772,"rs5030817","NC_000003.12:10149785:G:A"
"NM_000340.2(SLC2A2):c.1268T>A (p.Val423Glu)","SLC2A2","V423E, V250E, V304E","Fanconi-Bickel syndrome","Pathogenic(Last reviewed: Nov 1, 2000)","no assertion criteria provided","VCV000016101","3",170716088,"3",170998299,16101,31140,"rs28928874","NC_000003.12:170998298:A:T"
"NM_016362.5(GHRL):c.214C>A (p.Leu72Met)","GHRLOS|GHRL","L72M, L60M, L59M, L71M","Metabolic syndrome, susceptibility to|Obesity, age at onset of","Pathogenic, risk factor(Last reviewed: Dec 1, 2005)","no assertion criteria provided","VCV000005062","3",10331457,"3",10289773,5062,20101,"rs696217","NC_000003.12:10289772:G:T"
"NM_003865.3(HESX1):c.478C>T (p.Arg160Cys)","HESX1","R160C","Septo-optic dysplasia sequence","Pathogenic(Last reviewed: Jun 1, 1998)","no assertion criteria provided","VCV000007691","3",57232305,"3",57198277,7691,22730,"rs28936702","NC_000003.12:57198276:G:A"
"NM_003865.3(HESX1):c.541A>G (p.Thr181Ala)","HESX1","T181A","Growth hormone deficiency with pituitary anomalies|Septo-optic dysplasia sequence|not provided","Uncertain significance(Last reviewed: Apr 27, 2017)","criteria provided, multiple submitters, no conflicts","VCV000007693","3",57232242,"3",57198214,7693,22732,"rs28936704","NC_000003.12:57198213:T:C"
"NM_001457.4(FLNB):c.2251G>C (p.Gly751Arg)","FLNB","G751R","not specified|Atelosteogenesis type III","Likely pathogenic(Last reviewed: Jan 30, 2017)","criteria provided, single submitter","VCV000006402","3",58095354,"3",58109627,6402,21441,"rs28937587","NC_000003.12:58109626:G:C"
"NM_000404.4(GLB1):c.1370G>A (p.Arg457Gln)","GLB1","R457Q, R427Q, R505Q, R326Q","GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis","Likely pathogenic(Last reviewed: Jan 14, 2020)","criteria provided, single submitter","VCV000000930","3",33058310,"3",33016818,930,15969,"rs28934886","NC_000003.12:33016817:C:T"
"NM_000551.3(VHL):c.548C>A (p.Ser183Ter)","VHL|LOC107303340","S183*, S142*","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Renal cell carcinoma, papillary, 1|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Mar 28, 2018)","criteria provided, single submitter","VCV000002215","3",10191555,"3",10149871,2215,17254,"rs5030823","NC_000003.12:10149870:C:A"
"NM_000551.3(VHL):c.292T>C (p.Tyr98His)","VHL","Y98H","Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Apr 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000002223","3",10183823,"3",10142139,2223,17262,"rs5030809","NC_000003.12:10142138:T:C"
"NM_033337.2(CAV3):c.99C>G (p.Asn33Lys)","CAV3|SSUH2","N33K","Long QT syndrome|Distal myopathy, Tateyama type","Uncertain significance(Last reviewed: Sep 20, 2019)","criteria provided, single submitter","VCV000008289","3",8775661,"3",8733975,8289,23328,"rs1008642","NC_000003.12:8733974:C:G"
"NM_001354669.1(PPARG):c.-180C>A","PPARG","P85Q, P113Q","Morbid obesity","Pathogenic(Last reviewed: Dec 1, 1999)","no assertion criteria provided","VCV000008130","3",12422848,"3",12381349,8130,23169,"rs1800571","NC_000003.12:12381348:C:A"
"NM_001330615.1(PPARG):c.735+10750G>A","PPARG","R288H, R77H, R316H","Carcinoma of colon","Pathogenic(Last reviewed: Jun 1, 1999)","no assertion criteria provided","VCV000008135","3",12458330,"3",12416831,8135,23174,"rs28936407","NC_000003.12:12416830:G:A"
"NM_198056.2(SCN5A):c.4931G>A (p.Arg1644His)","SCN5A","R1644H, R1643H, R1590H, R1611H, R1625H, R1626H","Congenital long QT syndrome|Long QT syndrome 3|not provided|Brugada syndrome|Cardiovascular phenotype","Pathogenic(Last reviewed: Mar 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009369","3",38592932,"3",38551441,9369,24408,"rs28937316","NC_000003.12:38551440:C:T"
"NM_000335.4(SCN5A):c.3971A>G (p.Asn1324Ser)","SCN5A","N1325S, N1324S, N1271S","Brugada syndrome|Congenital long QT syndrome|Long QT syndrome 3","Pathogenic(Last reviewed: Oct 29, 2020)","criteria provided, single submitter","VCV000009370","3",38601909,"3",38560418,9370,24409,"rs28937317","NC_000003.12:38560417:T:C"
"NM_198056.2(SCN5A):c.1100G>A (p.Arg367His)","SCN5A","R367H","Brugada syndrome|Brugada syndrome 1|Arrhythmia","Pathogenic(Last reviewed: Jul 15, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009390","3",38648200,"3",38606709,9390,24429,"rs28937318","NC_000003.12:38606708:C:T"
"NM_000335.5(SCN5A):c.3305C>A (p.Ser1102Tyr)","SCN5A|LOC110121269","S1103Y, S1102Y","Left ventricular noncompaction|none provided|Brugada syndrome|Cardiac arrhythmia|Cardiovascular phenotype|Arrhythmia|Congenital long QT syndrome|not specified|not provided|Paroxysmal familial ventricular fibrillation 1|Progressive familial heart block, type 1A|Long qt syndrome 3, acquired, susceptibility to|SUDDEN INFANT DEATH SYNDROME|Dilated cardiomyopathy 1E|Brugada syndrome 1|Sick sinus syndrome 1, autosomal recessive|Long QT syndrome 3","Benign/Likely benign, risk factor(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009393","3",38620907,"3",38579416,9393,24432,"rs7626962","NC_000003.12:38579415:G:T"
"NM_033337.2(CAV3):c.99C>A (p.Asn33Lys)","CAV3|SSUH2","N33K","Long QT syndrome","Uncertain significance(Last reviewed: May 25, 2017)","criteria provided, single submitter","VCV000457133","3",8775661,"3",8733975,457133,453192,"rs1008642","NC_000003.12:8733974:C:A"
"NM_001354712.2(THRB):c.1357C>G (p.Pro453Ala)","THRB","P453A, P422A","not provided|Thyroid hormone resistance, generalized, autosomal dominant","Pathogenic(Last reviewed: Dec 13, 2019)","criteria provided, single submitter","VCV000492924","3",24164404,"3",24122913,492924,485714,"rs28933408","NC_000003.12:24122912:G:C"
"NM_000313.3(PROS1):c.1351C>T (p.Arg451Ter)","PROS1","R451*, R483*","Thrombophilia due to protein S deficiency, autosomal recessive|not provided|Protein S deficiency disease","Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000503726","3",93603713,"3",93884869,503726,495151,"rs5017717","NC_000003.12:93884868:G:A"
"NM_000551.4(VHL):c.548C>T (p.Ser183Leu)","VHL|LOC107303340","S183L, S142L","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Uncertain significance(Last reviewed: Oct 9, 2020)","criteria provided, single submitter","VCV000411985","3",10191555,"3",10149871,411985,393224,"rs5030823","NC_000003.12:10149870:C:T"
"NM_000551.3(VHL):c.533T>C (p.Leu178Pro)","VHL|LOC107303340","L178P, L137P","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, multiple submitters, no conflicts","VCV000428795","3",10191540,"3",10149856,428795,420453,"rs5030822","NC_000003.12:10149855:T:C"
"NM_000551.3(VHL):c.583C>T (p.Gln195Ter)","VHL|LOC107303340","Q195*, Q154*","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Oct 23, 2018)","criteria provided, multiple submitters, no conflicts","VCV000428794","3",10191590,"3",10149906,428794,420456,"rs5030825","NC_000003.12:10149905:C:T"
"NM_001354712.2(THRB):c.1357C>T (p.Pro453Ser)","THRB","P453S, P422S","not provided|Thyroid hormone resistance, generalized, autosomal dominant","Pathogenic(Last reviewed: Nov 19, 2016)","criteria provided, single submitter","VCV000439310","3",24164404,"3",24122913,439310,432550,"rs28933408","NC_000003.12:24122912:G:A"
"NM_000551.3(VHL):c.239G>T (p.Ser80Ile)","VHL","S80I","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: May 2, 2019)","criteria provided, multiple submitters, no conflicts","VCV000625229","3",10183770,"3",10142086,625229,613562,"rs5030805","NC_000003.12:10142085:G:T"
"NM_000551.3(VHL):c.533T>A (p.Leu178Gln)","VHL|LOC107303340","L178Q, L137Q","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625260","3",10191540,"3",10149856,625260,613591,"rs5030822","NC_000003.12:10149855:T:A"
"NM_000551.3(VHL):c.533T>G (p.Leu178Arg)","VHL|LOC107303340","L178R, L137R","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625261","3",10191540,"3",10149856,625261,613592,"rs5030822","NC_000003.12:10149855:T:G"
"NM_000551.3(VHL):c.463+2T>C","VHL|LOC107303340","","not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Pathogenic(Last reviewed: Jun 5, 2018)","criteria provided, single submitter","VCV000569414","3",10188322,"3",10146638,569414,561087,"rs5030814","NC_000003.12:10146637:T:C"
"NM_000335.4(SCN5A):c.1100G>T (p.Arg367Leu)","SCN5A","R367L","Brugada syndrome","not provided","no assertion provided","VCV000067634","3",38648200,"3",38606709,67634,78530,"rs28937318","NC_000003.12:38606708:C:A"
"NM_000551.3(VHL):c.233A>G (p.Asn78Ser)","VHL","N78S","Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided","Pathogenic(Last reviewed: Oct 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093326","3",10183764,"3",10142080,93326,99233,"rs5030804","NC_000003.12:10142079:A:G"
"NM_001337.4(CX3CR1):c.745G>A (p.Val249Ile)","CX3CR1","V249I, V281I","","no interpretation for the single variant","no interpretation for the single variant","VCV000242801","3",39307256,"3",39265765,242801,23191,"rs3732379","NC_000003.12:39265764:C:T"
"NM_000551.3(VHL):c.233A>C (p.Asn78Thr)","VHL","N78T","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2019)","criteria provided, conflicting interpretations","VCV000223168","3",10183764,"3",10142080,223168,224899,"rs5030804","NC_000003.12:10142079:A:C"
"NM_000551.3(VHL):c.548C>G (p.Ser183Trp)","VHL|LOC107303340","S183W, S142W","Pheochromocytoma","Likely pathogenic(Last reviewed: Dec 1, 2015)","no assertion criteria provided","VCV000219158","3",10191555,"3",10149871,219158,217071,"rs5030823","NC_000003.12:10149870:C:G"
"NM_000551.3(VHL):c.337C>T (p.Arg113Ter)","VHL","R113*","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Nov 26, 2016)","criteria provided, single submitter","VCV000220414","3",10183868,"3",10142184,220414,221350,"rs5030810","NC_000003.12:10142183:C:T"
"NM_000551.3(VHL):c.233A>T (p.Asn78Ile)","VHL","N78I","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Likely pathogenic(Last reviewed: Nov 27, 2018)","criteria provided, single submitter","VCV000223169","3",10183764,"3",10142080,223169,224900,"rs5030804","NC_000003.12:10142079:A:T"
"NM_000551.3(VHL):c.362A>G (p.Asp121Gly)","VHL|LOC107303340","D121G","Von Hippel-Lindau syndrome|not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)","criteria provided, multiple submitters, no conflicts","VCV000223200","3",10188219,"3",10146535,223200,224931,"rs5030832","NC_000003.12:10146534:A:G"
"NM_000551.3(VHL):c.464-1G>C","VHL|LOC107303340","","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jul 31, 2019)","criteria provided, single submitter","VCV000223220","3",10191470,"3",10149786,223220,224951,"rs5030817","NC_000003.12:10149785:G:C"
"NM_000551.3(VHL):c.464-1G>T","VHL|LOC107303340","","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Feb 26, 2016)","no assertion criteria provided","VCV000223221","3",10191470,"3",10149786,223221,224952,"rs5030817","NC_000003.12:10149785:G:T"
"NM_000128.3(F11):c.1782C>A (p.Ser594Arg)","F11|F11-AS1","S594R","Hereditary factor XI deficiency disease","Pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000011900","4",187209672,"4",186288518,11900,26939,"rs28934609","NC_000004.12:186288517:C:A"
"NM_003102.3(SOD3):c.691C>G (p.Arg231Gly)","SOD3","R213G, R231G","Superoxide dismutase, elevated extracellular","Pathogenic(Last reviewed: Jan 6, 2004)","no assertion criteria provided","VCV000012777","4",24801834,"4",24800212,12777,27816,"rs1799895","NC_000004.12:24800211:C:G"
"NM_000142.5(FGFR3):c.1950G>T (p.Lys650Asn)","FGFR3","K650N, K652N, K538N, K651N","Hypochondroplasia","Pathogenic(Last reviewed: Sep 26, 2013)","no assertion criteria provided","VCV000016346","4",1807891,"4",1806164,16346,31385,"rs28928868","NC_000004.12:1806163:G:T"
"NM_000142.5(FGFR3):c.1950G>C (p.Lys650Asn)","FGFR3","K650N, K652N, K651N, K538N","Craniosynostosis syndrome|not provided|Hypochondroplasia","Pathogenic(Last reviewed: Sep 27, 2017)","criteria provided, multiple submitters, no conflicts","VCV000016347","4",1807891,"4",1806164,16347,31386,"rs28928868","NC_000004.12:1806163:G:C"
"NM_000142.5(FGFR3):c.1620C>G (p.Asn540Lys)","FGFR3","N540K, N542K, N541K, N428K","Craniosynostosis syndrome|Short stature|Hypochondroplasia|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Cancer of cervix|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Malignant tumor of testis|Muenke syndrome|Carcinoma of colon|Hypochondroplasia|Thanatophoric dysplasia type 1|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Epidermal nevus|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Inborn genetic diseases|Achondroplasia|not provided","Pathogenic(Last reviewed: Feb 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000016338","4",1807371,"4",1805644,16338,31377,"rs28933068","NC_000004.12:1805643:C:G"
"NM_000406.3(GNRHR):c.851A>G (p.Tyr284Cys)","GNRHR","Y284C","Hypogonadotropic hypogonadism 7 with or without anosmia","Pathogenic(Last reviewed: Jan 1, 1998)","no assertion criteria provided","VCV000016025","4",68606334,"4",67740616,16025,31064,"rs28933074","NC_000004.12:67740615:T:C"
"NM_000142.5(FGFR3):c.1138G>A","FGFR3","G380R, G382R","Inborn genetic diseases|Craniosynostosis syndrome|not provided|none provided|Achondroplasia|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Cancer of cervix|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Malignant tumor of testis|Muenke syndrome|Carcinoma of colon|Hypochondroplasia|Thanatophoric dysplasia type 1|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Epidermal nevus|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Epidermal nevus","Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2020)","criteria provided, conflicting interpretations","VCV000016327","4",1806119,"4",1804392,16327,31366,"rs28931614","NC_000004.12:1804391:G:A"
"NM_000142.5(FGFR3):c.1138G>C (p.Gly380Arg)","FGFR3","G380R, G382R","not provided|Achondroplasia|Craniosynostosis syndrome|Hypochondroplasia","Pathogenic(Last reviewed: Aug 15, 2019)","criteria provided, multiple submitters, no conflicts","VCV000016328","4",1806119,"4",1804392,16328,31367,"rs28931614","NC_000004.12:1804391:G:C"
"NM_000142.5(FGFR3):c.1620C>A (p.Asn540Lys)","FGFR3","N540K, N542K, N428K, N541K","Craniosynostosis syndrome|not provided|none provided|Hypochondroplasia|Achondroplasia","Pathogenic(Last reviewed: Jan 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000016337","4",1807371,"4",1805644,16337,31376,"rs28933068","NC_000004.12:1805643:C:A"
"NM_002099.8(GYPA):c.232G>A (p.Gly78Arg)","GYPA","G78R, G45R, E78K","BLOOD GROUP ERIK","Pathogenic(Last reviewed: Dec 5, 1993)","no assertion criteria provided","VCV000017714","4",145040839,"4",144119686,17714,32753,"rs1800582","NC_000004.12:144119685:C:T"
"NM_006005.3(WFS1):c.461-9A>G","WFS1","","WFS1-Related Spectrum Disorders|not specified|none provided|not provided|Type 2 diabetes mellitus|Autosomal dominant nonsyndromic deafness 6","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004527","4",6292915,"4",6291188,4527,19566,"rs10010131","NC_000004.12:6291187:A:G"
"NM_005141.5(FGB):c.794C>T (p.Pro265Leu)","FGB","P265L, P206L","not provided|not specified|Afibrinogenemia, congenital|Thrombocytopenia|Abnormal bleeding|Hypofibrinogenemia|Abnormal bleeding","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000517313","4",155489608,"4",154568456,517313,496315,"rs6054","NC_000004.12:154568455:C:T"
"NM_000203.5(IDUA):c.1403-1G>T","IDUA","","Mucopolysaccharidosis type 1","Likely pathogenic(Last reviewed: Dec 21, 2018)","criteria provided, single submitter","VCV000652306","4",996823,"4",1003035,652306,651143,"rs4690223","NC_000004.12:1003034:G:T"
"NM_000203.5(IDUA):c.1225G>C (p.Gly409Arg)","IDUA","G409R, G277R","not provided|not specified|Mucopolysaccharidosis type 1|Hurler syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)","criteria provided, conflicting interpretations","VCV000092627","4",996555,"4",1002767,92627,26950,"rs11934801","NC_000004.12:1002766:G:C"
"NM_000200.3(HTN3):c.122G>A (p.Arg41Gln)","HTN3","R41Q","","no interpretation for the single variant","no interpretation for the single variant","VCV000242714","4",70898903,"4",70033186,242714,38467,"rs1136511","NC_000004.12:70033185:G:A"
"NM_000200.3(HTN3):c.141T>A (p.Tyr47Ter)","HTN3","Y47*","","no interpretation for the single variant","no interpretation for the single variant","VCV000242782","4",70898922,"4",70033205,242782,29952,"rs17147990","NC_000004.12:70033204:T:A"
"NM_000325.6(PITX2):c.*454C>T","PITX2","","PITX2-Related Eye Abnormalities|Irido-corneo-trabecular dysgenesis|Cataract (disease)|not provided|Axenfeld-Rieger syndrome type 1|Ring dermoid of cornea|Anterior segment dysgenesis 1|Hypoplasia of the iris","Benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000183253","4",111538827,"4",110617671,183253,181382,"rs6533526","NC_000004.12:110617670:G:A"
"NM_003122.4(SPINK1):c.101A>G (p.Asn34Ser)","SPINK1","N34S","not provided|Pancreatitis, chronic, susceptibility to|none provided|Finnish congenital nephrotic syndrome|Hereditary pancreatitis|Inborn genetic diseases","Conflicting interpretations of pathogenicity, association, risk factor(Last reviewed: Mar 12, 2021)","criteria provided, conflicting interpretations","VCV000013760","5",147207678,"5",147828115,13760,28799,"rs17107315","NC_000005.10:147828114:T:C"
"NM_007255.3(B4GALT7):c.808C>T (p.Arg270Cys)","B4GALT7","R270C","Lethal skeletal dysplasia|not provided|Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects|Ehlers-Danlos syndrome, spondylodysplastic type, 1","Pathogenic(Last reviewed: Aug 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005613","5",177035995,"5",177608994,5613,20652,"rs28937869","NC_000005.10:177608993:C:T"
"NM_006790.2(MYOT):c.170C>T (p.Thr57Ile)","MYOT|PKD2L2-DT","T57I","not provided|Myofibrillar myopathy 3","Pathogenic(Last reviewed: Aug 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005834","5",137206510,"5",137870821,5834,20873,"rs28937597","NC_000005.10:137870820:C:T"
"NM_000038.6(APC):c.3359G>A (p.Gly1120Glu)","APC","G1120E, G1102E, G1079E, G1130E, G1138E, G960E, G994E, G1019E, G1061E, G1029E, G1092E, G1095E, G837E","Neoplasm of stomach","Pathogenic(Last reviewed: Jun 1, 1992)","no assertion criteria provided","VCV000000802","5",112174650,"5",112838953,802,15841,"rs28933379","NC_000005.10:112838952:G:A"
"NM_004168.4(SDHA):c.1A>C (p.Met1Leu)","SDHA","M1L","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Mitochondrial complex II deficiency, nuclear type 1","Pathogenic(Last reviewed: Sep 11, 2020)","criteria provided, single submitter","VCV000008744","5",218471,"5",218356,8744,23783,"rs1061517","NC_000005.10:218355:A:C"
"NM_004387.4(NKX2-5):c.73C>T (p.Arg25Cys)","NKX2-5","R25C","not specified|Atrial septal defect 7 with or without atrioventricular conduction defects|Hypothyroidism, congenital, nongoitrous, 5|Truncus arteriosus|Congenital heart disease|Cardiovascular phenotype|Interrupted aortic arch|Tetralogy of Fallot|Hypoplastic left heart syndrome 2","Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)","criteria provided, conflicting interpretations","VCV000009008","5",172662014,"5",173235011,9008,24047,"rs28936670","NC_000005.10:173235010:G:A"
"NM_002109.6(HARS1):c.616G>T (p.Asp206Tyr)","HARS1","D132Y, D146Y, D166Y, D177Y, D186Y, D206Y, D92Y","Choreoathetosis|Cerebellar atrophy|Tremor|Peripheral neuropathy|Oculomotor apraxia|Intellectual disability|Nystagmus|Dysmetria|Dysarthria|Spastic ataxia","Pathogenic(Last reviewed: Jan 1, 2019)","criteria provided, single submitter","VCV000804285","5",140057507,"5",140677922,804285,792643,"rs1131040","NC_000005.10:140677921:C:A"
"NM_004168.4(SDHA):c.1A>G (p.Met1Val)","SDHA","M1V","Hereditary cancer-predisposing syndrome|not provided|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Paragangliomas 5","Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)","criteria provided, multiple submitters, no conflicts","VCV000239661","5",218471,"5",218356,239661,239796,"rs1061517","NC_000005.10:218355:A:G"
"NM_004168.4(SDHA):c.1A>T (p.Met1Leu)","SDHA","M1L","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Paragangliomas 5","Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000371794","5",218471,"5",218356,371794,358789,"rs1061517","NC_000005.10:218355:A:T"
"NM_000500.9(CYP21A2):c.713T>A (p.Val238Glu)","CYP21A2|LOC106780800","V238E, V103E, V208E","not provided","Pathogenic(Last reviewed: May 23, 2017)","criteria provided, single submitter","VCV000012173","6",32007587,"6",32039810,12173,27212,"rs12530380","NC_000006.12:32039809:T:A"
"NM_000500.9(CYP21A2):c.518T>A (p.Ile173Asn)","CYP21A2|LOC106780800","I173N, I143N, I38N","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Inborn genetic diseases","Pathogenic(Last reviewed: Jun 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012150","6",32007203,"6",32039426,12150,27189,"rs6475","NC_000006.12:32039425:T:A"
"NM_000500.9(CYP21A2):c.844G>T (p.Val282Leu)","CYP21A2|LOC106780800","V282L, V147L, V252L","Inborn genetic diseases|not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Adenoma, cortisol-producing|Carcinoma, adrenocortical, androgen-secreting","Pathogenic(Last reviewed: May 13, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012151","6",32007887,"6",32040110,12151,27190,"rs6471","NC_000006.12:32040109:G:T"
"NM_000500.9(CYP21A2):c.92C>T (p.Pro31Leu)","CYP21A2|LOC106780800","P31L","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Dec 17, 2019)","criteria provided, multiple submitters, no conflicts","VCV000012153","6",32006291,"6",32038514,12153,27192,"rs9378251","NC_000006.12:32038513:C:T"
"NM_000500.9(CYP21A2):c.293-13C>G","CYP21A2|LOC106780800","","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Inborn genetic diseases|Adrenal hyperplasia","Pathogenic(Last reviewed: Aug 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012155","6",32006858,"6",32039081,12155,27194,"rs6467","NC_000006.12:32039080:C:G"
"NM_000129.3(F13A1):c.-19+12=","F13A1","","Factor XIII, A subunit, deficiency of","Pathogenic(Last reviewed: Jul 1, 2011)","no assertion criteria provided","VCV000029695","6",6320808,"6",6320575,29695,38650,"rs2815822","NC_000006.12:6320574:T:T"
"NM_004415.4(DSP):c.4372C>G (p.Arg1458Gly)","DSP","R1458G","Cardiovascular phenotype|not specified|Arrhythmogenic right ventricular cardiomyopathy|Skin fragility-woolly hair-palmoplantar keratoderma syndrome|Arrhythmogenic right ventricular dysplasia 8|none provided|Primary familial dilated cardiomyopathy|Cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8|not provided|Cardiomyopathy, left ventricular noncompaction|Familial isolated arrhythmogenic right ventricular dysplasia|Lethal acantholytic epidermolysis bullosa","Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2020)","criteria provided, conflicting interpretations","VCV000044906","6",7580795,"6",7580562,44906,54073,"rs28763965","NC_000006.12:7580561:C:G"
"NM_001710.6(CFB):c.26T>A (p.Leu9His)","CFB|C2","L9H","Age-related macular degeneration 14|not provided|Atypical hemolytic uremic syndrome|Atypical hemolytic-uremic syndrome 4|not specified|Macular degeneration|Complement component 2 deficiency","Benign/Likely benign(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000016077","6",31914024,"6",31946247,16077,31116,"rs4151667","NC_000006.12:31946246:T:A"
"NM_000165.5(GJA1):c.427G>A (p.Gly143Ser)","GJA1","G143S","Syndactyly type 3","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000016987","6",121768420,"6",121447274,16987,32026,"rs28931600","NC_000006.12:121447273:G:A"
"NM_000165.5(GJA1):c.286G>A (p.Val96Met)","GJA1","V96M","Oculodentodigital dysplasia","Pathogenic(Last reviewed: Jun 1, 2004)","no assertion criteria provided","VCV000016988","6",121768279,"6",121447133,16988,32027,"rs28931601","NC_000006.12:121447132:G:A"
"NM_000165.5(GJA1):c.1085G>A (p.Arg362Gln)","GJA1","R362Q","not provided|Oculodentodigital dysplasia, autosomal recessive|Atrioventricular septal defect 3|Hypoplastic left heart syndrome 1","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000016990","6",121769078,"6",121447932,16990,32029,"rs2227885","NC_000006.12:121447931:G:A"
"NM_139003.3(HFE):c.340+250A>C","HFE","Q127H, Q104H, Q39H","Hemochromatosis type 1","Pathogenic(Last reviewed: Aug 1, 1999)","no assertion criteria provided","VCV000000017","6",26091582,"6",26091354,17,15056,"rs28934595","NC_000006.12:26091353:A:C"
"NM_001002255.2(SUMO4):c.163G>A (p.Val55Met)","TAB2|SUMO4","V55M","Diabetes mellitus, insulin-dependent, 5","Pathogenic(Last reviewed: Feb 1, 2005)","no assertion criteria provided","VCV000002062","6",149721690,"6",149400554,2062,17101,"rs237025","NC_000006.12:149400553:G:A"
"NM_004415.4(DSP):c.4372C>T (p.Arg1458Ter)","DSP","R1458*","Cardiomyopathy|Arrhythmogenic right ventricular dysplasia 8|Dilated cardiomyopathy with woolly hair and keratoderma","Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)","criteria provided, multiple submitters, no conflicts","VCV000534283","6",7580795,"6",7580562,534283,522201,"rs28763965","NC_000006.12:7580561:C:T"
"NM_004415.4(DSP):c.4372C>A (p.Arg1458=)","DSP","","Arrhythmogenic right ventricular dysplasia 8|Dilated cardiomyopathy with woolly hair and keratoderma|Cardiomyopathy","Likely benign(Last reviewed: Dec 29, 2019)","criteria provided, multiple submitters, no conflicts","VCV000534333","6",7580795,"6",7580562,534333,521836,"rs28763965","NC_000006.12:7580561:C:A"
"NM_178014.4(TUBB):c.647A>G (p.Lys216Arg)","TUBB","K216R, K236R, K144R, K172R","not provided","Likely pathogenic(Last reviewed: Jun 27, 2017)","no assertion criteria provided","VCV000545082","6",30691486,"6",30723709,545082,535306,"rs1059145","NC_000006.12:30723708:A:G"
"NM_000500.9(CYP21A2):c.293-13C>T","CYP21A2|LOC106780800","","Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","not provided","no assertion provided","VCV000430830","6",32006858,"6",32039081,430830,424373,"rs6467","NC_000006.12:32039080:C:T"
"NC_000006.12:g.151627231G>A","CCDC170","","Estrogen resistance","Likely pathogenic(Last reviewed: Mar 1, 2014)","no assertion criteria provided","VCV000155877","6",151948366,"6",151627231,155877,165626,"rs2046210","NC_000006.12:151627230:G:A"
"NM_025059.4(CCDC170):c.1810G>A (p.Val604Ile)","CCDC170","V604I","Estrogen resistance","Likely pathogenic(Last reviewed: Mar 1, 2014)","no assertion criteria provided","VCV000155873","6",151936677,"6",151615542,155873,165622,"rs6929137","NC_000006.12:151615541:G:A"
"NM_000500.9(CYP21A2):c.844G>C (p.Val282Leu)","CYP21A2|LOC106780800","V282L, V252L, V147L","Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Aug 29, 2013)","no assertion criteria provided","VCV000065610","6",32007887,"6",32040110,65610,76518,"rs6471","NC_000006.12:32040109:G:C"
"NM_000426.3(LAMA2):c.2750-1G>C","LAMA2","","not provided","Pathogenic(Last reviewed: Feb 12, 2013)","criteria provided, single submitter","VCV000092947","6",129612758,"6",129291613,92947,98854,"rs9492297","NC_000006.12:129291612:G:C"
"NM_000129.3(F13A1):c.-19+12A>C","F13A1","","Factor XIII, A subunit, deficiency of|not specified","Benign(Last reviewed: Jan 12, 2018)","criteria provided, single submitter","VCV000357680","6",6320808,"6",6320575,357680,300863,"rs2815822","NC_000006.12:6320574:T:G"
"NM_000500.9(CYP21A2):c.293-13C>A","CYP21A2|LOC106780800","","not specified|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: May 12, 2021)","criteria provided, conflicting interpretations","VCV000196278","6",32006858,"6",32039081,196278,193439,"rs6467","NC_000006.12:32039080:C:A"
"NM_000255.4(MMUT):c.828G>C (p.Glu276Asp)","MMUT","E276D","Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency","Pathogenic","criteria provided, single submitter","VCV000222921","6",49423876,"6",49456163,222921,224640,"rs12175488","NC_000006.12:49456162:C:G"
"NM_000603.5(NOS3):c.894T>G (p.Asp298Glu)","NOS3","D298E","Ischemic stroke, susceptibility to|Alzheimer disease, late-onset, susceptibility to|not specified|Hypertension resistant to conventional therapy|Ischemic heart disease, susceptibility to|Coronary artery spasm 1, susceptibility to|Hypertension, pregnancy-induced, susceptibility to","Benign(Last reviewed: Mar 28, 2016)","criteria provided, single submitter","VCV000014015","7",150696111,"7",150999023,14015,29054,"rs1799983","NC_000007.14:150999022:T:G"
"NM_001348946.2(ABCB1):c.554G>T (p.Gly185Val)","ABCB1","G185V, G255V","Colchicine resistance","Pathogenic(Last reviewed: Sep 1, 1990)","no assertion criteria provided","VCV000013698","7",87195534,"7",87566218,13698,28737,"rs1128501","NC_000007.14:87566217:C:A"
"NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro)","GLI3","A934P","Greig cephalopolysyndactyly syndrome, severe","Pathogenic(Last reviewed: Jun 1, 2006)","no assertion criteria provided","VCV000013825","7",42005871,"7",41966273,13825,28864,"rs28933372","NC_000007.14:41966272:C:G"
"NM_172056.2(KCNH2):c.1714G>C (p.Gly572Arg)","KCNH2","G572R, G232R","Long QT syndrome 2|Congenital long QT syndrome","Pathogenic(Last reviewed: Feb 1, 2000)","no assertion criteria provided","VCV000014429","7",150648767,"7",150951679,14429,29468,"rs9333649","NC_000007.14:150951678:C:G"
"NM_000420.3(KEL):c.1790T>C (p.Leu597Pro)","KEL","L597P","not provided|Kel6 antigen","Benign(Last reviewed: May 4, 2017)","criteria provided, single submitter","VCV000031082","7",142640113,"7",142943026,31082,40039,"rs8176038","NC_000007.14:142943025:A:G"
"NM_000492.4(CFTR):c.1684G>A (p.Val562Ile)","CFTR","V562I","not provided|none provided|CFTR-related disorders|Inborn genetic diseases|Cystic fibrosis|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 16, 2021)","criteria provided, conflicting interpretations","VCV000035830","7",117230411,"7",117590357,35830,44494,"rs1800097","NC_000007.14:117590356:G:A"
"NM_000492.4(CFTR):c.2002C>T (p.Arg668Cys)","CFTR","R668C","Cystic fibrosis|not specified|CFTR-related disorders|not provided|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|Cystic fibrosis|Lung disease, non-specific|Chronic sinusitis|Inborn genetic diseases|none provided","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000035835","7",117232223,"7",117592169,35835,44499,"rs1800100","NC_000007.14:117592168:C:T"
"NM_000941.3(POR):c.1475T>A (p.Val492Glu)","POR","V492E","Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis","Pathogenic(Last reviewed: Mar 1, 2004)","no assertion criteria provided","VCV000016901","7",75614973,"7",75985655,16901,31940,"rs28931606","NC_000007.14:75985654:T:A"
"NM_000941.3(POR):c.1370G>A (p.Arg457His)","POR","R457H","Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency","Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)","criteria provided, multiple submitters, no conflicts","VCV000016907","7",75614497,"7",75985179,16907,31946,"rs28931608","NC_000007.14:75985178:G:A"
"NM_001540.5(HSPB1):c.545C>T (p.Pro182Leu)","HSPB1","P182L","Distal hereditary motor neuronopathy type 2B","Pathogenic(Last reviewed: Jan 15, 2006)","no assertion criteria provided","VCV000007481","7",75933417,"7",76304100,7481,22520,"rs28937569","NC_000007.14:76304099:C:T"
"NM_000492.4(CFTR):c.3808G>A (p.Asp1270Asn)","CFTR","D1270N","CFTR-related disorders|Cystic fibrosis|ivacaftor response - Efficacy|Inborn genetic diseases|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|Hereditary pancreatitis|not specified","drug response(Last reviewed: Mar 23, 2018)","reviewed by expert panel","VCV000007164","7",117282582,"7",117642528,7164,22203,"rs11971167","NC_000007.14:117642527:G:A"
"NM_001540.5(HSPB1):c.452C>T (p.Thr151Ile)","HSPB1","T151I","Charcot-Marie-Tooth disease|Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease axonal type 2F","Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2018)","criteria provided, conflicting interpretations","VCV000007480","7",75933324,"7",76304007,7480,22519,"rs28937568","NC_000007.14:76304006:C:T"
"NM_000290.4(PGAM2):c.233G>A (p.Trp78Ter)","PGAM2|DBNL","W78*","not provided|Glycogen storage disease type X","Pathogenic(Last reviewed: Feb 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000000418","7",44104896,"7",44065297,418,15457,"rs10250779","NC_000007.14:44065296:C:T"
"NM_001001547.3(CD36):c.429+2T>C","CD36","","Susceptibility to malaria|Platelet glycoprotein IV deficiency|Coronary heart disease 7|Platelet glycoprotein IV deficiency","Likely pathogenic(Last reviewed: Jan 6, 2020)","no assertion criteria provided","VCV000417962","7",80290528,"7",80661212,417962,404771,"rs3211893","NC_000007.14:80661211:T:C"
"NM_000492.3(CFTR):c.4272C>A (p.Tyr1424Ter)","CFTR|LOC111674477","Y1424*","Cystic fibrosis","Pathogenic/Likely pathogenic(Last reviewed: May 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000555210","7",117306991,"7",117666937,555210,544496,"rs1800135","NC_000007.14:117666936:C:A"
"NM_172056.2(KCNH2):c.1714G>A (p.Gly572Ser)","KCNH2","G232S, G572S","not provided|Cardiovascular phenotype|Long QT syndrome 2|Long QT syndrome|Congenital long QT syndrome","Pathogenic(Last reviewed: Nov 8, 2019)","criteria provided, multiple submitters, no conflicts","VCV000067248","7",150648767,"7",150951679,67248,78144,"rs9333649","NC_000007.14:150951678:C:T"
"NM_172056.2(KCNH2):c.1714G>T (p.Gly572Cys)","KCNH2","G232C, G572C","Congenital long QT syndrome","not provided","no assertion provided","VCV000067249","7",150648767,"7",150951679,67249,78145,"rs9333649","NC_000007.14:150951678:C:A"
"NM_000492.3(CFTR):c.1684G>C (p.Val562Leu)","CFTR","V562L","Cystic fibrosis|not provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jul 30, 2020)","criteria provided, conflicting interpretations","VCV000053341","7",117230411,"7",117590357,53341,68009,"rs1800097","NC_000007.14:117590356:G:C"
"NM_000492.4(CFTR):c.509G>A (p.Arg170His)","CFTR","R170H","Cystic fibrosis|Inborn genetic diseases|not provided|not specified|CFTR-related disorders|none provided","Conflicting interpretations of pathogenicity(Last reviewed: Mar 26, 2021)","criteria provided, conflicting interpretations","VCV000053983","7",117174349,"7",117534295,53983,68650,"rs1800079","NC_000007.14:117534294:G:A"
"NM_000492.3(CFTR):c.4272C>T (p.Tyr1424=)","CFTR|LOC111674477","","none provided|CFTR-related disorders|not specified|Cystic fibrosis|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000093156","7",117306991,"7",117666937,93156,99063,"rs1800135","NC_000007.14:117666936:C:T"
"NM_000492.3(CFTR):c.4272C>G (p.Tyr1424Ter)","CFTR|LOC111674477","Y1424*","not specified|Cystic fibrosis","Likely pathogenic(Last reviewed: Nov 5, 2018)","criteria provided, multiple submitters, no conflicts","VCV000371349","7",117306991,"7",117666937,371349,357584,"rs1800135","NC_000007.14:117666936:C:G"
"NM_000492.4(CFTR):c.2900T>C (p.Leu967Ser)","CFTR","L967S","Cystic fibrosis|none provided|CFTR-related disorders|Inborn genetic diseases|not specified|not provided|Infertility","Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2021)","criteria provided, conflicting interpretations","VCV000219537","7",117243828,"7",117603774,219537,221666,"rs1800110","NC_000007.14:117603773:T:C"
"NM_006158.5(NEFL):c.64C>T (p.Pro22Ser)","NEFL","P22S","Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease type 2E|Peripheral demyelination|Hand muscle atrophy|Distal muscle weakness|Peripheral neuropathy|Decreased nerve conduction velocity|not provided|Peripheral neuropathy|Distal lower limb muscle weakness|Pes cavus|Charcot-Marie-Tooth disease, type 1C","Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000014029","8",24813966,"8",24956452,14029,29068,"rs28928910","NC_000008.11:24956451:G:A"
"NM_006158.4(NEFL):c.64C>A (p.Pro22Thr)","NEFL","P22T","Charcot-Marie-Tooth disease, demyelinating, type 1f|not provided","Pathogenic(Last reviewed: Oct 18, 2012)","no assertion criteria provided","VCV000041238","8",24813966,"8",24956452,41238,49662,"rs28928910","NC_000008.11:24956451:G:T"
"NM_002052.5(GATA4):c.1129A>G (p.Ser377Gly)","GATA4","S377G, S378G, S171G","Atrioventricular septal defect 4|Cardiovascular phenotype|not provided|not specified","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000044334","8",11614575,"8",11757066,44334,53501,"rs3729856","NC_000008.11:11757065:A:G"
"NM_000756.3(CRH):c.-669C>A","CRH","","Autosomal dominant nocturnal frontal lobe epilepsy","Pathogenic(Last reviewed: Feb 19, 2015)","no assertion criteria provided","VCV000038800","8",67091182,"8",66178947,38800,47403,"rs12721510","NC_000008.11:66178946:G:T"
"NM_020427.3(SLURP1):c.1A>C (p.Met1Leu)","SLURP1","M1L","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004604","8",143823803,"8",142742385,4604,19643,"rs28937889","NC_000008.11:142742384:T:G"
"NM_012082.4(ZFPM2):c.1969A>G (p.Ser657Gly)","ZFPM2|ZFPM2-AS1","S657G, S525G, S604G","Tetralogy of Fallot|46,XY sex reversal 9","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006127","8",106814279,"8",105802051,6127,21166,"rs28374544","NC_000008.11:105802050:A:G"
"NM_000067.3(CA2):c.754A>G (p.Asn252Asp)","CA2","N252D, N151D","not provided|CARBONIC ANHYDRASE II VARIANT|Osteopetrosis with renal tubular acidosis","Benign/Likely benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000000913","8",86392989,"8",85480760,913,15952,"rs2228063","NC_000008.11:85480759:A:G"
"NM_000497.3(CYP11B1):c.1343G>A (p.Arg448His)","CYP11B1|LOC106799833","R448H","not provided|Deficiency of steroid 11-beta-monooxygenase|Hyperaldosteronism, familial, type I","Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2019)","criteria provided, multiple submitters, no conflicts","VCV000001171","8",143956428,"8",142875012,1171,16210,"rs28934586","NC_000008.11:142875011:C:T"
"NM_000237.3(LPL):c.953A>G (p.Asn318Ser)","LPL","N318S","not provided|Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related|Hyperlipidemia, familial combined, susceptibility to","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000001550","8",19813529,"8",19956018,1550,16589,"rs268","NC_000008.11:19956017:A:G"
"NM_000127.2(EXT1):c.1065C>A (p.Cys355Ter)","EXT1","C355*","Multiple congenital exostosis","Pathogenic(Last reviewed: Apr 24, 2018)","criteria provided, single submitter","VCV000570990","8",118847782,"8",117835543,570990,564600,"rs11546829","NC_000008.11:117835542:G:T"
"NM_002052.5(GATA4):c.997+56C>A","GATA4","","not specified|Congenital heart disease|Atrioventricular septal defect 4|not provided","Benign(Last reviewed: Dec 7, 2020)","criteria provided, single submitter","VCV000139596","8",11612698,"8",11755189,139596,143221,"rs804280","NC_000008.11:11755188:C:A"
"NM_006269.2(RP1):c.5008G>A (p.Ala1670Thr)","RP1","A1670T","Autosomal recessive retinitis pigmentosa|not specified|not provided|Retinitis pigmentosa","Benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000095352","8",55541450,"8",54628890,95352,101251,"rs446227","NC_000008.11:54628889:G:A"
"NM_003235.5(TG):c.2443G>A (p.Gly815Arg)","TG","G815R","Iodotyrosyl coupling defect","Likely benign(Last reviewed: Jan 12, 2018)","criteria provided, single submitter","VCV000361924","8",133900495,"8",132888250,361924,304296,"rs16904774","NC_000008.11:132888249:G:A"
"NM_003235.5(TG):c.2443G>T (p.Gly815Ter)","TG","G815*","not provided","Pathogenic(Last reviewed: Oct 20, 2016)","criteria provided, single submitter","VCV000372918","8",133900495,"8",132888250,372918,359830,"rs16904774","NC_000008.11:132888249:G:T"
"NM_000127.2(EXT1):c.1065C>T (p.Cys355=)","EXT1","","Multiple exostoses type 1|Multiple congenital exostosis|not specified","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000196215","8",118847782,"8",117835543,196215,193376,"rs11546829","NC_000008.11:117835542:G:A"
"NM_003172.4(SURF1):c.371G>A (p.Gly124Glu)","SURF1","G124E, G15E","Mitochondrial complex IV deficiency","Pathogenic(Last reviewed: Feb 1, 2000)","no assertion criteria provided","VCV000012768","9",136220748,"9",133353893,12768,27807,"rs28933402","NC_000009.12:133353892:C:T"
"NM_000031.6(ALAD):c.177G>C (p.Lys59Asn)","ALAD","K59N, K51N, K88N","not provided|Porphobilinogen synthase deficiency|AMINOLEVULINATE DEHYDRATASE, ALAD*1/ALAD*2 POLYMORPHISM","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000016864","9",116153891,"9",113391611,16864,31903,"rs1800435","NC_000009.12:113391610:C:G"
"NM_003995.3(NPR2):c.343T>G (p.Trp115Gly)","NPR2","W115G","Acromesomelic dysplasia, Maroteaux type","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000017785","9",35792748,"9",35792751,17785,32824,"rs28931582","NC_000009.12:35792750:T:G"
"NM_003995.3(NPR2):c.528T>A (p.Asp176Glu)","NPR2","D176E","Acromesomelic dysplasia, Maroteaux type","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000017786","9",35792933,"9",35792936,17786,32825,"rs28929479","NC_000009.12:35792935:T:A"
"NM_001701.4(BAAT):c.226A>G (p.Met76Val)","BAAT","M76V","Bile acid conjugation defect 1","Pathogenic(Last reviewed: May 1, 2003)","no assertion criteria provided","VCV000006720","9",104133461,"9",101371179,6720,21759,"rs28937579","NC_000009.12:101371178:T:C"
"NM_004473.4(FOXE1):c.170G>A (p.Ser57Asn)","FOXE1","S57N","Bamforth-Lazarus syndrome","Pathogenic(Last reviewed: Mar 1, 2011)","no assertion criteria provided","VCV000006987","9",100616366,"9",97854084,6987,22026,"rs28937575","NC_000009.12:97854083:G:A"
"NM_005476.7(GNE):c.2135T>C (p.Met712Thr)","GNE","M712T, M743T, M602T, M638T, M653T, M661T","not provided|GNE myopathy|Sialuria|GNE myopathy","Pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006025","9",36217396,"9",36217399,6025,21064,"rs28937594","NC_000009.12:36217398:A:G"
"NM_000035.4(ALDOB):c.448G>C (p.Ala150Pro)","ALDOB","A150P","not provided|Hereditary fructosuria","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000000464","9",104189856,"9",101427574,464,15503,"rs1800546","NC_000009.12:101427573:C:G"
"NM_000155.4(GALT):c.940A>G (p.Asn314Asp)","GALT","N314D, N205D","not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|GALT POLYMORPHISM (DUARTE, D2)|Galactosemia|not specified","Conflicting interpretations of pathogenicity, other(Last reviewed: Jun 10, 2021)","criteria provided, conflicting interpretations","VCV000003613","9",34649442,"9",34649445,3613,18652,"rs2070074","NC_000009.12:34649444:A:G"
"NM_005502.4(ABCA1):c.1790A>G (p.Gln597Arg)","ABCA1","Q597R","Tangier disease","Pathogenic(Last reviewed: Aug 1, 1999)","no assertion criteria provided","VCV000009485","9",107593308,"9",104831027,9485,24524,"rs2853578","NC_000009.12:104831026:T:C"
"NM_005502.4(ABCA1):c.2804A>G (p.Asn935Ser)","ABCA1","N935S","Tangier disease","Pathogenic(Last reviewed: Aug 1, 1999)","no assertion criteria provided","VCV000009488","9",107584801,"9",104822520,9488,24527,"rs28937313","NC_000009.12:104822519:T:C"
"NM_005502.4(ABCA1):c.2803A>C (p.Asn935His)","ABCA1","N935H","Tangier disease","Pathogenic(Last reviewed: Jan 1, 2002)","no assertion criteria provided","VCV000009498","9",107584802,"9",104822521,9498,24537,"rs28937314","NC_000009.12:104822520:T:G"
"NM_000077.4(CDKN2A):c.242C>G (p.Pro81Arg)","CDKN2A","P81R, P30R","Hereditary melanoma|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2019)","criteria provided, conflicting interpretations","VCV000463492","9",21971116,"9",21971117,463492,459469,"rs11552823","NC_000009.12:21971116:G:C"
"NM_000077.4(CDKN2A):c.250G>T (p.Asp84Tyr)","CDKN2A","D84Y, R98L, D33Y","Neoplasm|Hereditary cancer-predisposing syndrome|Hereditary melanoma","Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2020)","criteria provided, conflicting interpretations","VCV000376306","9",21971108,"9",21971109,376306,363185,"rs11552822","NC_000009.12:21971108:C:A"
"NM_005502.4(ABCA1):c.2803A>G (p.Asn935Asp)","ABCA1","N935D","Tangier disease","Likely pathogenic(Last reviewed: May 1, 2016)","no assertion criteria provided","VCV000374312","9",107584802,"9",104822521,374312,361192,"rs28937314","NC_000009.12:104822520:T:C"
"NM_139025.4(ADAMTS13):c.1342C>G (p.Gln448Glu)","ADAMTS13","Q448E, Q417E","Upshaw-Schulman syndrome|not specified","Benign(Last reviewed: Jun 14, 2016)","criteria provided, multiple submitters, no conflicts","VCV000242806","9",136301982,"9",133436862,242806,20852,"rs2301612","NC_000009.12:133436861:C:G"
"NM_000077.4(CDKN2A):c.250G>A (p.Asp84Asn)","CDKN2A","D84N, R98Q, D33N","Hereditary melanoma|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2019)","criteria provided, conflicting interpretations","VCV000229806","9",21971108,"9",21971109,229806,233753,"rs11552822","NC_000009.12:21971108:C:T"
"NM_001110792.2(MECP2):c.334C>G (p.Leu112Val)","MECP2","L100V, L112V, L7V","not provided|Rett syndrome","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011835","X",153297737,"X",154032286,11835,26874,"rs28935168","NC_000023.11:154032285:G:C"
"NM_012084.4(GLUD2):c.1492T>G (p.Ser498Ala)","GLUD2","S445A, S498A","Parkinson disease, late-onset","Pathogenic(Last reviewed: Mar 1, 2010)","no assertion criteria provided","VCV000029936","X",120183030,"X",121049176,29936,38891,"rs9697983","NC_000023.11:121049175:T:G"
"NM_000402.4(G6PD):c.292G>A (p.Val98Met)","G6PD","V68M, V98M","Glucose 6 phosphate dehydrogenase deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD ASAHI|Inborn genetic diseases|not specified|chlorproguanil and dapsone response - Toxicity/ADR|not provided|Parkinsonism with spasticity, X-linked|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Glucose 6 phosphate dehydrogenase deficiency","drug response(Last reviewed: Oct 14, 2015)","reviewed by expert panel","VCV000037123","X",153764217,"X",154536002,37123,25400,"rs1050828","NC_000023.11:154536001:C:T"
"NM_000402.4(G6PD):c.632A>T (p.Asp211Val)","G6PD","D181V, D211V","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD MALAGA","Pathogenic(Last reviewed: Sep 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000037203","X",153762655,"X",154534440,37203,25421,"rs5030872","NC_000023.11:154534439:T:A"
"NM_001363.5(DKC1):c.961C>G (p.Leu321Val)","DKC1","L321V","Dyskeratosis congenita, X-linked","Pathogenic(Last reviewed: May 10, 2012)","no assertion criteria provided","VCV000038958","X",153999079,"X",154770804,38958,47561,"rs2728726","NC_000023.11:154770803:C:G"
"NM_000132.3(F8):c.5558C>T (p.Ala1853Val)","F8","A1853V","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Dec 1, 1993)","no assertion criteria provided","VCV000010284","X",154133114,"X",154904839,10284,25323,"rs28933677","NC_000023.11:154904838:G:A"
"NM_000132.3(F8):c.5593G>A (p.Asp1865Asn)","F8","D1865N","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010286","X",154132793,"X",154904518,10286,25325,"rs28933678","NC_000023.11:154904517:C:T"
"NM_000132.3(F8):c.5593G>T (p.Asp1865Tyr)","F8","D1865Y","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010287","X",154132793,"X",154904518,10287,25326,"rs28933678","NC_000023.11:154904517:C:A"
"NM_000132.3(F8):c.5618C>G (p.Pro1873Arg)","F8","P1873R","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010289","X",154132768,"X",154904493,10289,25328,"rs28933680","NC_000023.11:154904492:G:C"
"NM_000132.3(F8):c.5822A>G (p.Asn1941Ser)","F8","N1941S","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Apr 9, 2020)","criteria provided, single submitter","VCV000010294","X",154132357,"X",154904082,10294,25333,"rs28933682","NC_000023.11:154904081:T:C"
"NM_000132.3(F8):c.5879G>T (p.Arg1960Leu)","F8","R1960L","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1992)","no assertion criteria provided","VCV000010295","X",154132300,"X",154904025,10295,25334,"rs28937294","NC_000023.11:154904024:C:A"
"NM_000032.5(ALAS2):c.569A>T (p.Asp190Val)","ALAS2","D190V, D177V, D153V","Anemia, hereditary sideroblastic 1, pyridoxine refractory","Pathogenic(Last reviewed: Jul 15, 1997)","no assertion criteria provided","VCV000010474","X",55047554,"X",55021121,10474,25513,"rs28935484","NC_000023.11:55021120:T:A"
"NM_006915.3(RP2):c.353G>A (p.Arg118His)","RP2","R118H","Retinitis pigmentosa 2|Retinal dystrophy|not provided","Pathogenic(Last reviewed: Oct 15, 2019)","criteria provided, multiple submitters, no conflicts","VCV000010546","X",46713161,"X",46853726,10546,25585,"rs28933687","NC_000023.11:46853725:G:A"
"NM_006915.3(RP2):c.353G>T (p.Arg118Leu)","RP2","R118L","Retinitis pigmentosa 2","Pathogenic(Last reviewed: Aug 1, 2001)","no assertion criteria provided","VCV000010549","X",46713161,"X",46853726,10549,25588,"rs28933687","NC_000023.11:46853725:G:T"
"NM_000266.4(NDP):c.370C>T (p.Leu124Phe)","NDP|NDP-AS1","L124F","Familial exudative vitreoretinopathy, X-linked","Pathogenic(Last reviewed: Oct 1, 1993)","no assertion criteria provided","VCV000010684","X",43809077,"X",43949831,10684,25723,"rs28933684","NC_000023.11:43949830:G:A"
"NM_000266.4(NDP):c.1A>G (p.Met1Val)","NDP|NDP-AS1","M1V","Atrophia bulborum hereditaria","Pathogenic(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000010687","X",43817891,"X",43958645,10687,25726,"rs28933685","NC_000023.11:43958644:T:C"
"NM_000169.2(GLA):c.806T>C (p.Val269Ala)","GLA|RPL36A-HNRNPH2","V269A","Fabry disease","Pathogenic(Last reviewed: Jul 1, 1993)","no assertion criteria provided","VCV000010731","X",100653551,"X",101398563,10731,25770,"rs28935488","NC_000023.11:101398562:A:G"
"NM_000132.3(F8):c.1174T>C (p.Ser392Pro)","F8","S392P","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Apr 1, 1994)","no assertion criteria provided","VCV000010206","X",154194798,"X",154966523,10206,25245,"rs28933669","NC_000023.11:154966522:A:G"
"NM_000354.5(SERPINA7):c.347T>A (p.Ile116Asn)","SERPINA7","I96N, I116N","Thyroxine-binding globulin deficiency, partial","Pathogenic(Last reviewed: Mar 1, 1990)","no assertion criteria provided","VCV000009790","X",105280703,"X",106036712,9790,24829,"rs28933689","NC_000023.11:106036711:A:T"
"NM_000044.6(AR):c.2567G>A (p.Arg856His)","AR","R856H, R324H","Partial androgen insensitivity syndrome|Androgen resistance syndrome|Kennedy disease|Androgen resistance syndrome","Pathogenic(Last reviewed: Aug 8, 2019)","criteria provided, single submitter","VCV000009823","X",66942786,"X",67722944,9823,24862,"rs9332971","NC_000023.11:67722943:G:A"
"NM_000132.3(F8):c.5879G>A (p.Arg1960Gln)","F8","R1960Q","Hereditary factor VIII deficiency disease|not provided","Pathogenic(Last reviewed: Dec 6, 2017)","criteria provided, single submitter","VCV000010110","X",154132300,"X",154904025,10110,25149,"rs28937294","NC_000023.11:154904024:C:T"
"NM_000132.3(F8):c.1172G>A (p.Arg391His)","F8","R391H","Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|FACTOR VIII (OKAYAMA)","Pathogenic(Last reviewed: Apr 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000010111","X",154194800,"X",154966525,10111,25150,"rs28935499","NC_000023.11:154966524:C:T"
"NM_000132.3(F8):c.5096A>T (p.Tyr1699Phe)","F8","Y1699F","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Dec 31, 2020)","criteria provided, multiple submitters, no conflicts","VCV000010115","X",154156969,"X",154928694,10115,25154,"rs28935203","NC_000023.11:154928693:T:A"
"NM_000132.3(F8):c.1175C>A (p.Ser392Ter)","F8","S392*","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Apr 1, 1993)","no assertion criteria provided","VCV000010204","X",154194797,"X",154966522,10204,25243,"rs28933668","NC_000023.11:154966521:G:T"
"NM_000132.3(F8):c.1175C>T (p.Ser392Leu)","F8","S392L","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Apr 1, 1993)","no assertion criteria provided","VCV000010205","X",154194797,"X",154966522,10205,25244,"rs28933668","NC_000023.11:154966521:G:A"
"NM_000132.3(F8):c.1214T>G (p.Ile405Ser)","F8","I405S","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Dec 1, 1993)","no assertion criteria provided","VCV000010208","X",154194758,"X",154966483,10208,25247,"rs28933670","NC_000023.11:154966482:A:C"
"NM_000132.3(F8):c.1293G>T (p.Leu431Phe)","F8","L431F","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Oct 1, 1991)","no assertion criteria provided","VCV000010210","X",154194395,"X",154966120,10210,25249,"rs28933672","NC_000023.11:154966119:C:A"
"NM_000132.3(F8):c.1730C>T (p.Ser577Phe)","F8","S577F","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Feb 1, 1993)","no assertion criteria provided","VCV000010229","X",154185254,"X",154956979,10229,25268,"rs28937282","NC_000023.11:154956978:G:A"
"NM_000132.3(F8):c.5323T>G (p.Leu1775Val)","F8","L1775V","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010271","X",154134745,"X",154906470,10271,25310,"rs28937287","NC_000023.11:154906469:A:C"
"NM_004429.4(EFNB1):c.472A>G (p.Met158Val)","EFNB1","M158V","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 8, 2004)","no assertion criteria provided","VCV000011711","X",68059572,"X",68839729,11711,26750,"rs28936071","NC_000023.11:68839728:A:G"
"NM_001109878.2(TBX22):c.790A>T (p.Asn264Tyr)","TBX22","N264Y, N144Y","Cleft palate with ankyloglossia","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000011336","X",79282359,"X",80026860,11336,26375,"rs28935177","NC_000023.11:80026859:A:T"
"NM_014009.3(FOXP3):c.1189C>T (p.Arg397Trp)","FOXP3","R397W, R362W","Insulin-dependent diabetes mellitus secretory diarrhea syndrome|Hydrops fetalis","Pathogenic(Last reviewed: Mar 2, 2020)","criteria provided, single submitter","VCV000011407","X",49107902,"X",49251441,11407,26446,"rs28935477","NC_000023.11:49251440:G:A"
"NM_001037811.2(HSD17B10):c.388C>T (p.Arg130Cys)","HSD17B10","R130C","not provided|HSD10 disease","Pathogenic(Last reviewed: Jun 27, 2019)","criteria provided, multiple submitters, no conflicts","VCV000011442","X",53459034,"X",53432086,11442,26481,"rs28935475","NC_000023.11:53432085:G:A"
"NM_001037811.2(HSD17B10):c.364C>G (p.Leu122Val)","HSD17B10","L122V","HSD10 disease","Pathogenic(Last reviewed: May 1, 2003)","no assertion criteria provided","VCV000011443","X",53459058,"X",53432110,11443,26482,"rs28935476","NC_000023.11:53432109:G:C"
"NM_000047.2(ARSL):c.1732C>T (p.Pro578Ser)","ARSL","P578S, P524S, P603S, P587S","X-linked chondrodysplasia punctata 1","Pathogenic(Last reviewed: Nov 3, 2011)","no assertion criteria provided","VCV000011528","X",2852911,"X",2934870,11528,26567,"rs28935474","NC_000023.11:2934869:G:A"
"NM_004085.4(TIMM8A):c.238C>T (p.Arg80Ter)","TIMM8A","R80*","Deafness dystonia syndrome","Pathogenic(Last reviewed: Jun 1, 2001)","no assertion criteria provided","VCV000011324","X",100601543,"X",101346555,11324,26363,"rs1054894","NC_000023.11:101346554:G:A"
"NM_004429.4(EFNB1):c.474G>T (p.Met158Ile)","EFNB1","M158I","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 8, 2004)","no assertion criteria provided","VCV000011712","X",68059574,"X",68839731,11712,26751,"rs28935170","NC_000023.11:68839730:G:T"
"NM_001110556.2(FLNA):c.245A>T (p.Glu82Val)","FLNA","E82V","Periventricular nodular heterotopia 1","Pathogenic(Last reviewed: Mar 26, 2002)","no assertion criteria provided","VCV000011754","X",153599369,"X",154371001,11754,26793,"rs28935169","NC_000023.11:154371000:T:A"
"NM_001110556.2(FLNA):c.620C>T (p.Pro207Leu)","FLNA","P207L","not specified|Oto-palato-digital syndrome, type I|Cleft palate|Conductive hearing impairment|Short stature","Pathogenic(Last reviewed: Nov 20, 2018)","criteria provided, multiple submitters, no conflicts","VCV000011755","X",153596212,"X",154367844,11755,26794,"rs28935469","NC_000023.11:154367843:G:A"
"NM_001110792.2(MECP2):c.500T>C (p.Phe167Ser)","MECP2","F155S, F167S, F62S","Rett syndrome","Pathogenic(Last reviewed: Apr 10, 2002)","no assertion criteria provided","VCV000011810","X",153296815,"X",154031364,11810,26849,"rs28934905","NC_000023.11:154031363:A:G"
"NM_001110792.2(MECP2):c.509C>T (p.Thr170Met)","MECP2","T158M, T170M, T65M","History of neurodevelopmental disorder|Angelman syndrome|Inborn genetic diseases|Severe neonatal-onset encephalopathy with microcephaly|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|Rett syndrome|Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|not provided|not specified|Autism, susceptibility to, X-linked 3","Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011811","X",153296806,"X",154031355,11811,26850,"rs28934906","NC_000023.11:154031354:G:A"
"NM_000169.2(GLA):c.797A>T (p.Asp266Val)","GLA|RPL36A-HNRNPH2","D266V","not provided|Fabry disease","Pathogenic(Last reviewed: Jan 12, 2021)","criteria provided, multiple submitters, no conflicts","VCV000010735","X",100653777,"X",101398789,10735,25774,"rs28935487","NC_000023.11:101398788:T:A"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+3022G>A","GLA|RPL36A-HNRNPH2","S297F","Fabry disease","Pathogenic(Last reviewed: Dec 1, 1993)","no assertion criteria provided","VCV000010737","X",100653467,"X",101398479,10737,25776,"rs28935489","NC_000023.11:101398478:G:A"
"NM_000169.2(GLA):c.815A>G (p.Asn272Ser)","GLA|RPL36A-HNRNPH2","N272S","Fabry disease","Pathogenic(Last reviewed: Jul 1, 2019)","criteria provided, single submitter","VCV000010774","X",100653542,"X",101398554,10774,25813,"rs28935495","NC_000023.11:101398553:T:C"
"NM_004463.3(FGD1):c.935C>T (p.Pro312Leu)","FGD1","P312L","not provided|Aarskog syndrome|Syndromic X-linked mental retardation 16|Intellectual disability|History of neurodevelopmental disorder","Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)","criteria provided, conflicting interpretations","VCV000010828","X",54496615,"X",54470182,10828,25867,"rs28935498","NC_000023.11:54470181:G:A"
"NM_000354.5(SERPINA7):c.909G>T (p.Leu303Phe)","SERPINA7","L283F, L303F","Thyroxine-binding globulin, variant P","Pathogenic(Last reviewed: Mar 1, 1992)","no assertion criteria provided","VCV000009785","X",105278361,"X",106034370,9785,24824,"rs1804495","NC_000023.11:106034369:C:A"
"NM_000475.5(NR0B1):c.1319A>T (p.Asn440Ile)","NR0B1","N440I","Congenital adrenal hypoplasia, X-linked","Pathogenic(Last reviewed: Jul 1, 2000)","no assertion criteria provided","VCV000010957","X",30322790,"X",30304673,10957,25996,"rs28935481","NC_000023.11:30304672:T:A"
"NM_001145252.3(CFP):c.893G>T (p.Gly298Val)","CFP","G298V","Properdin deficiency, X-linked","Pathogenic(Last reviewed: Jul 1, 2000)","no assertion criteria provided","VCV000011183","X",47486219,"X",47626820,11183,26222,"rs28935480","NC_000023.11:47626819:C:A"
"NM_000033.4(ABCD1):c.1850G>A (p.Arg617His)","ABCD1","R617H","not provided|none provided|Adrenoleukodystrophy","Pathogenic(Last reviewed: Oct 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011312","X",153008510,"X",153743056,11312,26351,"rs11146842","NC_000023.11:153743055:G:A"
"NM_000033.4(ABCD1):c.1849C>T (p.Arg617Cys)","ABCD1","R617C","Adrenoleukodystrophy|none provided|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2021)","criteria provided, multiple submitters, no conflicts","VCV000011313","X",153008509,"X",153743055,11313,26352,"rs4010613","NC_000023.11:153743054:C:T"
"NM_021083.4(XK):c.880T>C (p.Cys294Arg)","XK","C294R","McLeod neuroacanthocytosis syndrome","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000009768","X",37587260,"X",37728007,9768,24807,"rs28933690","NC_000023.11:37728006:T:C"
"NM_000044.6(AR):c.2528T>C (p.Ile843Thr)","AR","I843T, I311T","Kennedy disease|Androgen resistance syndrome","Pathogenic(Last reviewed: Nov 30, 2018)","criteria provided, single submitter","VCV000658124","X",66942747,"X",67722905,658124,650153,"rs9332970","NC_000023.11:67722904:T:C"
"NM_033380.3(COL4A5):c.1948+894C>G","COL4A5","","Alport syndrome 1, X-linked recessive","Pathogenic(Last reviewed: Apr 13, 2018)","no assertion criteria provided","VCV000587241","X",107842994,"X",108599764,587241,578145,"rs5973838","NC_000023.11:108599763:C:G"
"NM_000531.6(OTC):c.809A>G (p.Gln270Arg)","OTC","Q270R","Ornithine carbamoyltransferase deficiency|not specified|History of neurodevelopmental disorder","Benign/Likely benign(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000129867","X",38268220,"X",38408967,129867,135313,"rs1800328","NC_000023.11:38408966:A:G"
"NM_001110792.2(MECP2):c.500T>G (p.Phe167Cys)","MECP2","F155C, F167C, F62C","Rett syndrome|not provided","Uncertain significance","no assertion criteria provided","VCV000143581","X",153296815,"X",154031364,143581,153313,"rs28934905","NC_000023.11:154031363:A:C"
"NM_000531.6(OTC):c.809A>C (p.Gln270Pro)","OTC","Q270P","not provided","Pathogenic","no assertion criteria provided","VCV000097336","X",38268220,"X",38408967,97336,103228,"rs1800328","NC_000023.11:38408966:A:C"
"NM_000330.3(RS1):c.330T>A (p.Cys110Ter)","RS1|CDKL5","C110*","not provided","Pathogenic(Last reviewed: Aug 15, 2019)","criteria provided, single submitter","VCV000098939","X",18662742,"X",18644622,98939,104829,"rs1801161","NC_000023.11:18644621:A:T"
"NM_000330.3(RS1):c.330T>C (p.Cys110=)","RS1|CDKL5","","not provided|not specified","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000098940","X",18662742,"X",18644622,98940,104830,"rs1801161","NC_000023.11:18644621:A:G"
"NM_000402.4(G6PD):c.466A>G (p.Asn156Asp)","G6PD","N126D, N156D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD A+|Glucose 6 phosphate dehydrogenase deficiency|Inborn genetic diseases|not provided|Bone mineral density quantitative trait locus 18|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Glucose 6 phosphate dehydrogenase deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Susceptibility to malaria|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Apr 8, 2021)","criteria provided, conflicting interpretations","VCV000100055","X",153763492,"X",154535277,100055,25399,"rs1050829","NC_000023.11:154535276:T:C"
"NM_000402.4(G6PD):c.653C>T (p.Ser218Phe)","G6PD","S188F, S218F","none provided|Hemolytic anemia, G6PD deficient (favism)|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD SASSARI|G6PD CAGLIARI|Glucose 6 phosphate dehydrogenase deficiency|G6PD MEDITERRANEAN|Inborn genetic diseases|not provided|G6PD deficient hemolytic anemia|Angioedema induced by ACE inhibitors, susceptibility to|Susceptibility to malaria|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Susceptibility to malaria","Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)","criteria provided, conflicting interpretations","VCV000100057","X",153762634,"X",154534419,100057,25407,"rs5030868","NC_000023.11:154534418:G:A"
"NM_000044.6(AR):c.2567G>T (p.Arg856Leu)","AR","R856L, R324L","not provided","Pathogenic(Last reviewed: Aug 13, 2015)","criteria provided, single submitter","VCV000279688","X",66942786,"X",67722944,279688,265060,"rs9332971","NC_000023.11:67722943:G:T"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+3106A>T","GLA|RPL36A-HNRNPH2","V269E","not provided","Uncertain significance(Last reviewed: Jun 30, 2015)","criteria provided, single submitter","VCV000281865","X",100653551,"X",101398563,281865,266102,"rs28935488","NC_000023.11:101398562:A:T"
"NM_001271696.3(ABCB7):c.868G>A (p.Gly290Ser)","ABCB7","G291S, G290S, G250S, G251S, G264S","not provided","Likely pathogenic(Last reviewed: Dec 16, 2014)","criteria provided, single submitter","VCV000213988","X",74293779,"X",75073944,213988,212048,"rs1133577","NC_000023.11:75073943:C:T"
"NM_000169.2(GLA):c.806T>G (p.Val269Gly)","GLA|RPL36A-HNRNPH2","V269G","Migalastat response|Fabry disease","Pathogenic, drug response(Last reviewed: Jan 1, 2014)","no assertion criteria provided","VCV000217399","X",100653551,"X",101398563,217399,214027,"rs28935488","NC_000023.11:101398562:A:C"
"NM_001323289.2(CDKL5):c.2494C>T (p.Gln832Ter)","CDKL5","Q832*","Early infantile epileptic encephalopathy 2","Pathogenic(Last reviewed: Mar 13, 2014)","no assertion criteria provided","VCV000189573","X",18643365,"X",18625245,189573,187625,"rs17857094","NC_000023.11:18625244:C:T"
"NM_000169.3(GLA):c.797A>C (p.Asp266Ala)","GLA|RPL36A-HNRNPH2","D266A","not specified","Uncertain significance(Last reviewed: Mar 11, 2015)","criteria provided, single submitter","VCV000228701","X",100653777,"X",101398789,228701,231408,"rs28935487","NC_000023.11:101398788:T:G"
"NM_000169.2(GLA):c.890C>G (p.Ser297Cys)","GLA|RPL36A-HNRNPH2","S297C","not provided","Uncertain significance(Last reviewed: Jun 24, 2016)","criteria provided, single submitter","VCV000222442","X",100653467,"X",101398479,222442,223878,"rs28935489","NC_000023.11:101398478:G:C"
"NM_005373.2(MPL):c.823C>A (p.Pro275Thr)","MPL","P275T","Congenital amegakaryocytic thrombocytopenia","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000014161","1",43805767,"1",43340096,14161,29200,"rs28928908","NC_000001.11:43340095:C:A"
"NM_170707.4(LMNA):c.664C>T (p.His222Tyr)","LMNA","H222Y, H141Y, H110Y","Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|not provided","Pathogenic(Last reviewed: Jan 17, 2013)","no assertion criteria provided","VCV000014492","1",156104620,"1",156134829,14492,29531,"rs28928901","NC_000001.11:156134828:C:T"
"NM_170707.4(LMNA):c.254T>G (p.Leu85Arg)","LMNA","L85R","not provided|Dilated cardiomyopathy 1A","Pathogenic(Last reviewed: Dec 2, 1999)","no assertion criteria provided","VCV000014480","1",156084963,"1",156115172,14480,29519,"rs28933090","NC_000001.11:156115171:T:G"
"NM_170707.4(LMNA):c.585C>G (p.Asn195Lys)","LMNA","N195K, N114K, N83K","Charcot-Marie-Tooth disease, type 2|Primary dilated cardiomyopathy|not provided|Dilated cardiomyopathy 1A","Pathogenic(Last reviewed: Jul 9, 2019)","criteria provided, multiple submitters, no conflicts","VCV000014483","1",156104265,"1",156134474,14483,29522,"rs28933091","NC_000001.11:156134473:C:G"
"NM_170707.4(LMNA):c.608A>G (p.Glu203Gly)","LMNA","E203G, E122G, E91G","Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided","Pathogenic(Last reviewed: Aug 21, 2015)","criteria provided, single submitter","VCV000014484","1",156104288,"1",156134497,14484,29523,"rs28933092","NC_000001.11:156134496:A:G"
"NM_170707.4(LMNA):c.481G>A (p.Glu161Lys)","LMNA","E161K, E80K, E49K","Cardiomyopathy|Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided","Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2020)","criteria provided, multiple submitters, no conflicts","VCV000014504","1",156100532,"1",156130741,14504,29543,"rs28933093","NC_000001.11:156130740:G:A"
"NM_170707.4(LMNA):c.169G>C (p.Ala57Pro)","LMNA","A57P","not provided|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome","Pathogenic(Last reviewed: Feb 15, 2009)","no assertion criteria provided","VCV000014506","1",156084878,"1",156115087,14506,29545,"rs28928903","NC_000001.11:156115086:G:C"
"NM_001007792.1(NTRK1):c.1730G>T (p.Gly577Val)","NTRK1","G607V, G577V, G613V","not specified|not provided|Hereditary insensitivity to pain with anhidrosis|Familial medullary thyroid carcinoma","Benign/Likely benign(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000012308","1",156848946,"1",156879154,12308,27347,"rs6339","NC_000001.11:156879153:G:T"
"NM_000702.4(ATP1A2):c.2291T>C (p.Leu764Pro)","ATP1A2","L764P","Familial hemiplegic migraine|Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Apr 22, 2021)","no assertion criteria provided","VCV000012917","1",160105635,"1",160135845,12917,27956,"rs28933398","NC_000001.11:160135844:T:C"
"NM_000702.4(ATP1A2):c.2659T>C (p.Trp887Arg)","ATP1A2","W887R","Familial hemiplegic migraine|Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Apr 22, 2021)","no assertion criteria provided","VCV000012918","1",160106455,"1",160136665,12918,27957,"rs28933399","NC_000001.11:160136664:T:C"
"NM_000488.3(SERPINC1):c.166C>T (p.Arg56Cys)","SERPINC1","R56C, R8C","Antithrombin III deficiency|not provided","Likely pathogenic(Last reviewed: Oct 7, 2016)","criteria provided, single submitter","VCV000018022","1",173883933,"1",173914795,18022,33061,"rs28929469","NC_000001.11:173914794:G:A"
"NM_002036.3(ACKR1):c.-67T>C","ACKR1","","White blood cell count quantitative trait locus 1|Plasmodium vivax, resistance to|DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE","Pathogenic, association, protective(Last reviewed: Dec 11, 2017)","no assertion criteria provided","VCV000018395","1",159174683,"1",159204893,18395,33434,"rs2814778","NC_000001.11:159204892:T:C"
"NM_007375.3(TARDBP):c.892G>A (p.Gly298Ser)","TARDBP","","not provided|Amyotrophic lateral sclerosis type 10","Pathogenic(Last reviewed: Jun 22, 2018)","criteria provided, single submitter","VCV000005232","1",11082358,"1",11022301,5232,20271,"rs4884357","NC_000001.11:11022300:G:A"
"NM_000157.4(GBA):c.1342G>C (p.Asp448His)","GBA|LOC106627981","D448H, D361H, D399H","Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease, perinatal lethal|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Parkinson disease, late-onset|Gaucher disease type II|Lewy body dementia|not provided|Gaucher disease|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type III","Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004293","1",155205518,"1",155235727,4293,19332,"rs1064651","NC_000001.11:155235726:C:G"
"NM_000130.4(F5):c.1601G>A (p.Arg534Gln)","F5","","not specified|Thrombophilia due to factor V Leiden|Factor V deficiency|Ischemic stroke, susceptibility to|Budd-Chiari syndrome, susceptibility to|Pregnancy loss, recurrent, susceptibility to, 1|Thrombophilia due to factor V Leiden|Factor V deficiency","Pathogenic, risk factor(Last reviewed: Feb 22, 2021)","criteria provided, multiple submitters, no conflicts","VCV000000642","1",169519049,"1",169549811,642,15681,"rs6025","NC_000001.11:169549810:C:T"
"NM_001160301.1(DPYD):c.85T>C (p.Cys29Arg)","DPYD","C29R","not provided|Dihydropyrimidine dehydrogenase deficiency","Benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000000435","1",98348885,"1",97883329,435,15474,"rs1801265","NC_000001.11:97883328:A:G"
"NM_001122764.3(PPOX):c.1046A>C (p.Asp349Ala)","PPOX","D349A, D187A, D213A, D316A","Variegate porphyria, homozygous","Pathogenic(Last reviewed: Nov 1, 1998)","no assertion criteria provided","VCV000008698","1",161140257,"1",161170467,8698,23737,"rs28936676","NC_000001.11:161170466:A:C"
"NM_005263.5(GFI1):c.1145A>G (p.Asn382Ser)","GFI1","N382S","not provided|Severe congenital neutropenia 2, autosomal dominant","Pathogenic(Last reviewed: Mar 1, 2018)","criteria provided, single submitter","VCV000008739","1",92941710,"1",92476153,8739,23778,"rs28936381","NC_000001.11:92476152:T:C"
"NM_000447.3(PSEN2):c.715A>G (p.Met239Val)","PSEN2","M239V","not provided|Alzheimer disease, type 4","Pathogenic(Last reviewed: Aug 31, 1995)","no assertion criteria provided","VCV000008846","1",227076678,"1",226888977,8846,23885,"rs28936379","NC_000001.11:226888976:A:G"
"NM_001205293.3(CACNA1E):c.2104G>A (p.Ala702Thr)","CACNA1E","A702T","not provided|Developmental and epileptic encephalopathy, 69|Inborn genetic diseases","Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000521483","1",181693635,"1",181724499,521483,511197,"rs12131800","NC_000001.11:181724498:G:A"
"NM_000143.3(FH):c.1021G>A (p.Asp341Asn)","FH","D341N","Fumarase deficiency","Likely pathogenic(Last reviewed: Jul 13, 2017)","criteria provided, single submitter","VCV000405923","1",241667429,"1",241504129,405923,391128,"rs11545655","NC_000001.11:241504128:C:T"
"NM_000143.3(FH):c.679C>T (p.Gln227Ter)","FH","Q227*","Fumarase deficiency","Pathogenic(Last reviewed: Oct 21, 2016)","criteria provided, single submitter","VCV000405913","1",241671962,"1",241508662,405913,391174,"rs11545658","NC_000001.11:241508661:G:A"
"NM_002016.1(FLG):c.3551C>A (p.Ser1184Ter)","FLG","S1184*","not provided","Pathogenic(Last reviewed: Jul 15, 2015)","criteria provided, single submitter","VCV000419209","1",152283811,"1",152311335,419209,404917,"rs3120649","NC_000001.11:152311334:G:T"
"NM_001205293.3(CACNA1E):c.2104G>C (p.Ala702Pro)","CACNA1E","A702P","not provided","Likely pathogenic(Last reviewed: Apr 20, 2016)","criteria provided, single submitter","VCV000427007","1",181693635,"1",181724499,427007,414747,"rs12131800","NC_000001.11:181724498:G:C"
"NM_003126.4(SPTA1):c.2353C>T (p.Arg785Ter)","SPTA1","R785*","Hemolytic anemia","Likely pathogenic","no assertion criteria provided","VCV000812891","1",158632603,"1",158662813,812891,800979,"rs2022057","NC_000001.11:158662812:G:A"
"NM_007375.3(TARDBP):c.892G>T (p.Gly298Cys)","TARDBP","G298C","not provided","Uncertain significance(Last reviewed: Aug 3, 2018)","criteria provided, single submitter","VCV000586812","1",11082358,"1",11022301,586812,576388,"rs4884357","NC_000001.11:11022300:G:T"
"NM_000701.8(ATP1A1):c.311T>G (p.Leu104Arg)","ATP1A1","L104R, L73R","Aldosterone-producing adrenal cortex adenoma","Pathogenic(Last reviewed: Feb 17, 2013)","no assertion criteria provided","VCV000162466","1",116930037,"1",116387415,162466,172140,"rs11540945","NC_000001.11:116387414:T:G"
"NM_000157.4(GBA):c.475C>T (p.Arg159Trp)","GBA|LOC106627981","R159W, R110W, R72W","Gaucher disease|not provided","Pathogenic(Last reviewed: Dec 3, 2019)","criteria provided, multiple submitters, no conflicts","VCV000065570","1",155208421,"1",155238630,65570,76478,"rs439898","NC_000001.11:155238629:G:A"
"NM_170707.4(LMNA):c.585C>A (p.Asn195Lys)","LMNA","N195K, N114K, N83K","not provided","not provided","no assertion provided","VCV000066913","1",156104265,"1",156134474,66913,77810,"rs28933091","NC_000001.11:156134473:C:A"
"NM_170707.4(LMNA):c.608A>T (p.Glu203Val)","LMNA","E203V, E91V, E122V","not provided","not provided","no assertion provided","VCV000066915","1",156104288,"1",156134497,66915,77812,"rs28933092","NC_000001.11:156134496:A:T"
"NM_000350.3(ABCA4):c.5603A>T (p.Asn1868Ile)","ABCA4","N1868I","Age-related macular degeneration 2|Stargardt disease 1|Macular degeneration|Stargardt Disease, Recessive|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|ABCA4-Related Disorders|Cone-rod dystrophy 3|Stargardt disease|not provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jan 30, 2021)","criteria provided, conflicting interpretations","VCV000099390","1",94476467,"1",94010911,99390,105279,"rs1801466","NC_000001.11:94010910:T:A"
"NM_000350.3(ABCA4):c.5693G>A (p.Arg1898His)","ABCA4","R1898H","Age-related macular degeneration 2|Inborn genetic diseases|Retinal dystrophy|ABCA4-Related Disorders|not provided|Stargardt disease|Stargardt disease 1|Retinitis pigmentosa","Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2021)","criteria provided, conflicting interpretations","VCV000099398","1",94476377,"1",94010821,99398,105287,"rs1800552","NC_000001.11:94010820:C:T"
"NM_000110.4(DPYD):c.85= (p.Cys29=)","DPYD","","not provided|Dihydropyrimidine dehydrogenase deficiency","Benign(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000100123","1",98348885,"1",97883329,100123,106000,"rs1801265","NC_000001.11:97883328:A:A"
"NM_000157.4(GBA):c.681T>G (p.Asn227Lys)","GBA|LOC106627981","N227K, N140K, N178K","Gaucher disease type II|Gaucher disease type I|Gaucher disease type 3C|Gaucher disease type III|not provided|Gaucher disease","Pathogenic(Last reviewed: May 26, 2017)","criteria provided, multiple submitters, no conflicts","VCV000093458","1",155208005,"1",155238214,93458,99363,"rs381418","NC_000001.11:155238213:A:C"
"NM_000157.4(GBA):c.721G>A (p.Gly241Arg)","GBA|LOC106627981","G241R, G154R, G192R","Gaucher disease|not provided|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease type I","Pathogenic(Last reviewed: Oct 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093459","1",155207965,"1",155238174,93459,99364,"rs409652","NC_000001.11:155238173:C:T"
"NM_170707.4(LMNA):c.254T>A (p.Leu85His)","LMNA","L85H","Charcot-Marie-Tooth disease, type 2","Uncertain significance(Last reviewed: Dec 16, 2015)","criteria provided, single submitter","VCV000242004","1",156084963,"1",156115172,242004,238146,"rs28933090","NC_000001.11:156115171:T:A"
"NM_000570.4(FCGR3B):c.194A>G (p.Asn65Ser)","FCGR3B","N65S, N48S, N64S","not provided","Benign(Last reviewed: Dec 26, 2017)","criteria provided, single submitter","VCV000242685","1",161599693,"1",161629903,242685,45587,"rs448740","NC_000001.11:161629902:T:C"
"NM_003126.4(SPTA1):c.2353C>A (p.Arg785=)","SPTA1","","not provided|Elliptocytosis 2|Spherocytosis type 3|Hereditary pyropoikilocytosis|none provided","Benign/Likely benign(Last reviewed: Aug 31, 2020)","criteria provided, multiple submitters, no conflicts","VCV000293017","1",158632603,"1",158662813,293017,277717,"rs2022057","NC_000001.11:158662812:G:T"
"NM_000143.3(FH):c.437G>A (p.Gly146Glu)","FH","G146E","not provided|Hereditary cancer-predisposing syndrome|Fumarase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2019)","criteria provided, conflicting interpretations","VCV000186519","1",241675385,"1",241512085,186519,181636,"rs11545654","NC_000001.11:241512084:C:T"
"NM_000130.5(F5):c.1601= (p.Arg534=)","F5","","Factor V deficiency|not provided|hormonal contraceptives for systemic use response - Toxicity/ADR","drug response(Last reviewed: Nov 28, 2017)","reviewed by expert panel","VCV000226007","1",169519049,"1",169549811,226007,227743,"rs6025","NC_000001.11:169549810:C:C"
"NM_001354.5(AKR1C2):c.666T>G (p.His222Gln)","AKR1C2","H222Q, H196Q","46,XY sex reversal 8","Pathogenic(Last reviewed: Aug 12, 2011)","no assertion criteria provided","VCV000030067","10",5037962,"10",4995770,30067,39022,"rs13222","NC_000010.11:4995769:A:C"
"NM_001008212.2(OPTN):c.293T>A (p.Met98Lys)","OPTN|LOC108903148","M98K","Primary open angle glaucoma|Glaucoma, normal tension, susceptibility to|not specified|Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12|none provided|Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, e","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000007099","10",13152400,"10",13110400,7099,22138,"rs11258194","NC_000010.11:13110399:T:A"
"CYP2C19*4A/*30","CYP2C19","R73C","Voriconazole response|Sertraline response|Citalopram response|Escitalopram response","drug response","practice guideline","VCV000634307","10",96534863,"10",94775106,634307,622283,"rs145328984","NC_000010.11:94775105:C:T"
"CYP2C19*4A/*11","CYP2C19","R150H","Citalopram response|Voriconazole response|Sertraline response|Escitalopram response","drug response","practice guideline","VCV000634361","10",96535264,"10",94775507,634361,622288,"rs58973490","NC_000010.11:94775506:G:A"
"NM_001354.5(AKR1C2):c.666T>C (p.His222=)","AKR1C2","","CIC-DUX Sarcoma","Pathogenic","no assertion criteria provided","VCV000805966","10",5037962,"10",4995770,805966,794307,"rs13222","NC_000010.11:4995769:A:G"
"CYP2C19*4A/*25","CYP2C19","F448L","Voriconazole response|Citalopram response|Escitalopram response|Sertraline response","drug response","practice guideline","VCV000633984","10",96612542,"10",94852785,633984,622296,"rs118203759","NC_000010.11:94852784:C:G"
"CYP2C19*4A/*31","CYP2C19","H78Y","Escitalopram response|Sertraline response|Voriconazole response|Citalopram response","drug response","practice guideline","VCV000634161","10",96534878,"10",94775121,634161,622284,"rs1564660997","NC_000010.11:94775120:C:T"
"CYP2C19*4A/*18","CYP2C19","R329H","Sertraline response|Escitalopram response|Citalopram response|Voriconazole response","drug response","practice guideline","VCV000633912","10",96602618,"10",94842861,633912,622291,"rs138142612","NC_000010.11:94842860:G:A"
"CYP2C19*4A/*16","CYP2C19","R442C","Voriconazole response|Escitalopram response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000633982","10",96612522,"10",94852765,633982,622295,"rs192154563","NC_000010.11:94852764:C:T"
"NM_000124.4(ERCC6):c.3637A>G (p.Arg1213Gly)","ERCC6","R1213G","not provided|Macular degeneration|Cockayne syndrome|COFS syndrome|not specified","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000129017","10",50678369,"10",49470323,129017,134463,"rs2228527","NC_000010.11:49470322:T:C"
"NM_000124.4(ERCC6):c.2599-26A>G","ERCC6","","not provided|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B","Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2020)","criteria provided, conflicting interpretations","VCV000190162","10",50681659,"10",49473613,190162,187997,"rs4253196","NC_000010.11:49473612:T:C"
"NM_001360.3(DHCR7):c.452G>A (p.Trp151Ter)","DHCR7","W151*","not provided|2-3 toe syndactyly|Congenital microcephaly|Small for gestational age|Elevated 7-dehydrocholesterol|Smith-Lemli-Opitz syndrome","Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021273","11",71152447,"11",71441401,21273,34125,"rs11555217","NC_000011.10:71441400:C:T"
"NM_199161.5(SAA1):c.209C>T (p.Ala70Val)","SAA1","A70V","Serum amyloid a variant|not provided","Likely benign(Last reviewed: Sep 30, 2018)","criteria provided, single submitter","VCV000018108","11",18290859,"11",18269312,18108,33147,"rs1136743","NC_000011.10:18269311:C:T"
"NM_000482.4(APOA4):c.1140G>T (p.Gln380His)","APOA4","Q360H, Q380H","APOLIPOPROTEIN A-IV POLYMORPHISM, APOA4*1/APOA4*2","Pathogenic(Last reviewed: May 1, 1992)","no assertion criteria provided","VCV000017905","11",116691634,"11",116820918,17905,32944,"rs5110","NC_000011.10:116820917:C:A"
"NM_000039.2(APOA1):c.148G>C (p.Gly50Arg)","APOA1|APOA1-AS","G26R, G50R","Familial amyloid polyneuropathy, Iowa type","Pathogenic(Last reviewed: Oct 1, 1990)","no assertion criteria provided","VCV000017917","11",116707769,"11",116837053,17917,32956,"rs28931574","NC_000011.10:116837052:C:G"
"NM_000039.2(APOA1):c.341T>C (p.Leu114Pro)","APOA1|APOA1-AS","L90P, L114P, L5P","Amyloidosis, cardiac and cutaneous","Pathogenic(Last reviewed: Jan 1, 1999)","no assertion criteria provided","VCV000017931","11",116706987,"11",116836271,17931,32970,"rs28931575","NC_000011.10:116836270:A:G"
"NM_000051.3(ATM):c.3118A>G (p.Met1040Val)","ATM","M1040V","not specified|none provided|B-cell non-Hodgkin lymphoma|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000003027","11",108143299,"11",108272572,3027,18066,"rs3092857","NC_000011.10:108272571:A:G"
"NM_000525.3(KCNJ11):c.440T>C (p.Leu147Pro)","KCNJ11","L147P, L60P","Hyperinsulinemic hypoglycemia, familial, 2","Pathogenic(Last reviewed: Mar 16, 2015)","criteria provided, single submitter","VCV000008665","11",17409199,"11",17387652,8665,23704,"rs28936678","NC_000011.10:17387651:A:G"
"NM_001876.4(CPT1A):c.2126G>A (p.Gly709Glu)","CPT1A","G709E","Carnitine palmitoyltransferase 1A deficiency","Pathogenic(Last reviewed: Mar 7, 2013)","no assertion criteria provided","VCV000009069","11",68527709,"11",68760241,9069,24108,"rs28936374","NC_000011.10:68760240:C:T"
"NM_000051.3(ATM):c.2193C>A (p.Tyr731Ter)","ATM","Y731*","Ataxia-telangiectasia syndrome","Pathogenic(Last reviewed: Aug 21, 2020)","criteria provided, single submitter","VCV000453407","11",108127010,"11",108256283,453407,461330,"rs2229019","NC_000011.10:108256282:C:A"
"NM_001197104.1(KMT2A):c.4576-1G>C","KMT2A","","not provided","Pathogenic(Last reviewed: Feb 16, 2018)","criteria provided, single submitter","VCV000504298","11",118360843,"11",118490128,504298,495702,"rs563239","NC_000011.10:118490127:G:C"
"NM_001098671.2(RASGRP2):c.239+2T>G","RASGRP2","","Abnormal platelet aggregation","Likely pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000627041","11",64508909,"11",64741437,627041,615730,"rs2959650","NC_000011.10:64741436:A:C"
"NM_000051.3(ATM):c.2193C>T (p.Tyr731=)","ATM","","not provided|not specified|Ataxia-telangiectasia syndrome|Malignant tumor of breast|none provided|Hereditary cancer-predisposing syndrome","Benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000140761","11",108127010,"11",108256283,140761,150475,"rs2229019","NC_000011.10:108256282:C:T"
"NM_004183.4(BEST1):c.900G>C (p.Glu300Asp)","BEST1","E300D, E194D, E240D, R368T","Retinal dystrophy|not provided","Pathogenic(Last reviewed: Oct 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000099770","11",61727002,"11",61959530,99770,105659,"rs1805144","NC_000011.10:61959529:G:C"
"NM_000518.5(HBB):c.*132+101G>C","HBB|LOC107133510|LOC110006319","","not provided|not specified|beta Thalassemia","Benign(Last reviewed: Nov 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000256341","11",5246595,"11",5225365,256341,254202,"rs12788013","NC_000011.10:5225364:C:G"
"NM_000217.3(KCNA1):c.724G>C (p.Ala242Pro)","KCNA1","A242P","not provided|Myokymia 1","Pathogenic(Last reviewed: Oct 14, 2016)","criteria provided, single submitter","VCV000013489","12",5021268,"12",4912102,13489,28528,"rs28933381","NC_000012.12:4912101:G:C"
"NM_000217.3(KCNA1):c.677C>G (p.Thr226Arg)","KCNA1","T226R","Episodic ataxia type 1","Pathogenic(Last reviewed: Aug 16, 2012)","no assertion criteria provided","VCV000013492","12",5021221,"12",4912055,13492,28531,"rs28933383","NC_000012.12:4912054:C:G"
"NM_000217.3(KCNA1):c.677C>A (p.Thr226Lys)","KCNA1","T226K","Myokymia 1","Pathogenic(Last reviewed: Apr 1, 2007)","no assertion criteria provided","VCV000013493","12",5021221,"12",4912055,13493,28532,"rs28933383","NC_000012.12:4912054:C:A"
"NM_002273.4(KRT8):c.184G>T (p.Gly62Cys)","KRT8","G62C, G90C","not provided|Cirrhosis, cryptogenic|Cirrhosis, noncryptogenic, susceptibility to","Conflicting interpretations of pathogenicity, risk factor(Last reviewed: May 13, 2003)","no assertion criteria provided","VCV000014630","12",53298582,"12",52904798,14630,29669,"rs11554495","NC_000012.12:52904797:C:A"
"NM_000217.3(KCNA1):c.677C>T (p.Thr226Met)","KCNA1","T226M","Episodic ataxia type 1","Pathogenic(Last reviewed: Aug 16, 2012)","no assertion criteria provided","VCV000021127","12",5021221,"12",4912055,21127,33979,"rs28933383","NC_000012.12:4912054:C:T"
"NM_004985.5(KRAS):c.183A>T (p.Gln61His)","KRAS","Q61H","Neoplasm of the large intestine|Acute myeloid leukemia|Hepatocellular carcinoma|Malignant melanoma of skin|Multiple myeloma|Chronic lymphocytic leukemia|Non-small cell lung cancer|Pancreatic adenocarcinoma|Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Neoplasm of the thyroid gland","Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000045117","12",25380275,"12",25227341,45117,54284,"rs17851045","NC_000012.12:25227340:T:A"
"NM_006446.5(SLCO1B1):c.521T>C (p.Val174Ala)","SLCO1B1","V174A","Gilbert syndrome|not provided|Rotor syndrome|cerivastatin response - Toxicity/ADR|rosuvastatin response - Other|hmg coa reductase inhibitors response - Toxicity/ADR, Metabolism/PK|simvastatin acid response - Metabolism/PK|simvastatin response - Toxicity/ADR|pravastatin response - Metabolism/PK","drug response(Last reviewed: May 21, 2018)","reviewed by expert panel","VCV000037346","12",21331549,"12",21178615,37346,40587,"rs4149056","NC_000012.12:21178614:T:C"
"NM_170665.4(ATP2A2):c.68G>A (p.Gly23Glu)","ATP2A2","G23E","Keratosis follicularis|not provided","Pathogenic(Last reviewed: Aug 19, 2015)","criteria provided, single submitter","VCV000017789","12",110719662,"12",110281857,17789,32828,"rs28929478","NC_000012.12:110281856:G:A"
"NM_000486.5(AQP2):c.170A>C (p.Gln57Pro)","AQP2","Q57P","not provided|Nephrogenic diabetes insipidus, autosomal","Pathogenic(Last reviewed: Feb 5, 2019)","criteria provided, single submitter","VCV000017842","12",50344783,"12",49951000,17842,32881,"rs28931580","NC_000012.12:49950999:A:C"
"NM_020638.3(FGF23):c.535C>T (p.Arg179Trp)","FGF23","R179W","not provided|Autosomal dominant hypophosphatemic rickets","Likely pathogenic(Last reviewed: Nov 20, 2015)","criteria provided, single submitter","VCV000005026","12",4479730,"12",4370564,5026,20065,"rs28937882","NC_000012.12:4370563:G:A"
"NM_000277.3(PAH):c.1169A>G (p.Glu390Gly)","PAH","E390G","Phenylketonuria|not provided|Hyperphenylalaninemia, non-pku","Pathogenic(Last reviewed: Oct 1, 2018)","reviewed by expert panel","VCV000000625","12",103237454,"12",102843676,625,15664,"rs5030856","NC_000012.12:102843675:T:C"
"NM_000277.3(PAH):c.473G>A (p.Arg158Gln)","PAH","R158Q","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 5, 2018)","reviewed by expert panel","VCV000000587","12",103260410,"12",102866632,587,15626,"rs5030843","NC_000012.12:102866631:C:T"
"NM_000277.3(PAH):c.1066-11G>A","PAH","","Phenylketonuria|not provided","Pathogenic(Last reviewed: Oct 1, 2018)","reviewed by expert panel","VCV000000607","12",103237568,"12",102843790,607,15646,"rs5030855","NC_000012.12:102843789:C:T"
"NM_000277.3(PAH):c.143T>C (p.Leu48Ser)","PAH","L48S","not provided|Phenylketonuria","Pathogenic(Last reviewed: Apr 8, 2019)","reviewed by expert panel","VCV000000608","12",103306594,"12",102912816,608,15647,"rs5030841","NC_000012.12:102912815:A:G"
"NM_000277.3(PAH):c.1222C>T (p.Arg408Trp)","PAH","R408W","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 6, 2018)","reviewed by expert panel","VCV000000577","12",103234271,"12",102840493,577,15616,"rs5030858","NC_000012.12:102840492:G:A"
"NM_002150.3(HPD):c.97= (p.Thr33=)","HPD","","Tyrosinemia type 3|Hawkinsinuria|Hawkinsinuria","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000001577","12",122295335,"12",121857429,1577,16616,"rs1154510","NC_000012.12:121857428:T:T"
"NM_000277.3(PAH):c.1315+1G>A","PAH","","Phenylketonuria|Inborn genetic diseases|not provided","Pathogenic(Last reviewed: Aug 5, 2018)","reviewed by expert panel","VCV000000576","12",103234177,"12",102840399,576,15615,"rs5030861","NC_000012.12:102840398:C:T"
"NM_000020.2(ACVRL1):c.632G>A (p.Gly211Asp)","ACVRL1","G211D","Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2019)","criteria provided, multiple submitters, no conflicts","VCV000008253","12",52308229,"12",51914445,8253,23292,"rs28936687","NC_000012.12:51914444:G:A"
"NM_003482.3(KMT2D):c.4131G>A (p.Gln1377=)","KMT2D","","Kabuki syndrome 1","Likely pathogenic(Last reviewed: Nov 1, 2016)","criteria provided, single submitter","VCV000547418","12",49442442,"12",49048659,547418,537993,"rs764942","NC_000012.12:49048658:C:T"
"NM_000431.4(MVK):c.58C>A (p.His20Asn)","MVK","H20N","Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria","Pathogenic(Last reviewed: Jul 1, 2019)","criteria provided, single submitter","VCV000649235","12",110012685,"12",109574880,649235,640599,"rs11544299","NC_000012.12:109574879:C:A"
"NM_002150.3(HPD):c.97A>G (p.Thr33Ala)","HPD","T33A","Hawkinsinuria|Tyrosinemia type 3|Hawkinsinuria","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000802899","12",122295335,"12",121857429,802899,791201,"rs1154510","NC_000012.12:121857428:T:C"
"NM_031157.4(HNRNPA1):c.995A>G (p.Asn332Ser)","HNRNPA1","N332S, N280S","Relapsing remitting multiple sclerosis","Likely pathogenic","no assertion criteria provided","VCV000135599","12",54677683,"12",54283899,135599,139325,"rs3207617","NC_000012.12:54283898:A:G"
"NM_000277.3(PAH):c.1089del (p.Lys363fs)","PAH","K363fs","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 10, 2018)","reviewed by expert panel","VCV000102518","12",103237534,"12",102843756,102518,108254,"rs5030654","NC_000012.12:102843755:C:"
"NM_000277.3(PAH):c.1315+2T>C","PAH","","not provided|Phenylketonuria","Likely pathogenic(Last reviewed: Dec 9, 2018)","reviewed by expert panel","VCV000102588","12",103234176,"12",102840398,102588,108324,"rs1799970","NC_000012.12:102840397:A:G"
"NM_000277.3(PAH):c.199T>C (p.Ser67Pro)","PAH","S67P","not provided|Phenylketonuria","Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000102625","12",103288666,"12",102894888,102625,108361,"rs5030842","NC_000012.12:102894887:A:G"
"NM_000277.3(PAH):c.473G>C (p.Arg158Pro)","PAH","R158P","not provided|Phenylketonuria","Uncertain significance(Last reviewed: Nov 9, 2019)","reviewed by expert panel","VCV000102694","12",103260410,"12",102866632,102694,108430,"rs5030843","NC_000012.12:102866631:C:G"
"NM_000277.3(PAH):c.581T>C (p.Leu194Pro)","PAH","L194P","Phenylketonuria|not provided","Likely pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000102742","12",103249039,"12",102855261,102742,108478,"rs5030844","NC_000012.12:102855260:A:G"
"NM_004985.5(KRAS):c.183A>C (p.Gln61His)","KRAS","Q61H","Juvenile myelomonocytic leukemia|Acute myeloid leukemia|Non-small cell lung cancer|Neoplasm of the large intestine","Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)","no assertion criteria provided","VCV000177881","12",25380275,"12",25227341,177881,175854,"rs17851045","NC_000012.12:25227340:T:G"
"NM_003482.3(KMT2D):c.4131G>C (p.Gln1377His)","KMT2D","Q1377H","Kabuki syndrome 1","Uncertain significance(Last reviewed: Feb 8, 2013)","criteria provided, single submitter","VCV000158766","12",49442442,"12",49048659,158766,168957,"rs764942","NC_000012.12:49048658:C:G"
"NM_000277.3(PAH):c.898G>T (p.Ala300Ser)","PAH","A300S","not provided|Phenylketonuria|Inborn genetic diseases|Hyperphenylalaninemia, non-pku","Pathogenic(Last reviewed: Aug 10, 2018)","reviewed by expert panel","VCV000092751","12",103245479,"12",102851701,92751,98658,"rs5030853","NC_000012.12:102851700:C:A"
"NM_000277.3(PAH):c.1315+1G>T","PAH","","Phenylketonuria","Likely pathogenic(Last reviewed: May 18, 2020)","reviewed by expert panel","VCV000370074","12",103234177,"12",102840399,370074,358082,"rs5030861","NC_000012.12:102840398:C:A"
"NM_000059.4(BRCA2):c.8851G>A (p.Ala2951Thr)","BRCA2","A2951T","Hereditary breast and ovarian cancer syndrome|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Malignant tumor of breast|none provided|not provided|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|not specified","Benign(Last reviewed: Sep 28, 2016)","reviewed by expert panel","VCV000041570","13",32953550,"13",32379413,41570,50009,"rs11571769","NC_000013.11:32379412:G:A"
"NM_004004.6(GJB2):c.50C>T (p.Ser17Phe)","GJB2","S17F","Keratitis-ichthyosis-deafness syndrome, autosomal dominant","Pathogenic(Last reviewed: May 1, 2002)","no assertion criteria provided","VCV000017022","13",20763671,"13",20189532,17022,32061,"rs28929485","NC_000013.11:20189531:G:A"
"NM_000059.3(BRCA2):c.8851G>T (p.Ala2951Ser)","BRCA2","A2951S","Hereditary cancer-predisposing syndrome|Familial cancer of breast","Uncertain significance(Last reviewed: Apr 13, 2016)","criteria provided, single submitter","VCV000441405","13",32953550,"13",32379413,441405,435087,"rs11571769","NC_000013.11:32379412:G:T"
"NM_000321.2(RB1):c.1390-14A>G","RB1","","Retinoblastoma","Likely pathogenic(Last reviewed: Jan 16, 2017)","criteria provided, single submitter","VCV000410932","13",48954175,"13",48380039,410932,400010,"rs9535023","NC_000013.11:48380038:A:G"
"NM_000321.2(RB1):c.1390-14A>T","RB1","","Retinoblastoma|not specified|none provided|not provided","Benign(Last reviewed: Dec 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000167566","13",48954175,"13",48380039,167566,178002,"rs9535023","NC_000013.11:48380038:A:T"
"NM_004004.6(GJB2):c.50C>G (p.Ser17Cys)","GJB2","S17C","not specified","Uncertain significance(Last reviewed: Jun 30, 2014)","criteria provided, single submitter","VCV000179825","13",20763671,"13",20189532,179825,175767,"rs28929485","NC_000013.11:20189531:G:C"
"NM_000059.3(BRCA2):c.9057A>G (p.Lys3019=)","BRCA2","","Hereditary cancer-predisposing syndrome|not provided|Hereditary breast and ovarian cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2020)","criteria provided, conflicting interpretations","VCV000182258","13",32953990,"13",32379853,182258,180681,"rs1799956","NC_000013.11:32379852:A:G"
"NM_001846.4(COL4A2):c.4987G>A (p.Gly1663Ser)","COL4A2","G1663S","Optic nerve hypoplasia|not provided|Porencephaly 2","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000311195","13",111164386,"13",110512039,311195,327447,"rs12877501","NC_000013.11:110512038:G:A"
"NM_000257.4(MYH7):c.746G>A (p.Arg249Gln)","MYH7","R249Q","not provided|MYH7-related late-onset scapuloperoneal muscular dystrophy|Myopathy, distal, 1|Myopathy, myosin storage, autosomal recessive|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Dilated cardiomyopathy 1S|Congenital myopathy with fiber type disproportion|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype|Cardiomyopathy|Hypertrophic cardiomyopathy","Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000014088","14",23900677,"14",23431468,14088,29127,"rs3218713","NC_000014.9:23431467:C:T"
"NM_006194.3(PAX9):c.83G>C (p.Arg28Pro)","PAX9","R28P","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Feb 1, 2004)","no assertion criteria provided","VCV000013773","14",37132180,"14",36662975,13773,28812,"rs28933971","NC_000014.9:36662974:G:C"
"NM_001127701.1(SERPINA1):c.194T>C (p.Leu65Pro)","SERPINA1","L65P","Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI M(PROCIDA)|not provided|Alpha-1-antitrypsin deficiency","Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017971","14",94849381,"14",94383044,17971,33010,"rs28931569","NC_000014.9:94383043:A:G"
"NM_001127701.1(SERPINA1):c.1096G>A (p.Glu366Lys)","SERPINA1","E366K","Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|FRAXE|Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI Z|PI Z(AUGSBURG)|PI Z(TUN)|Inborn genetic diseases|not provided","Pathogenic, risk factor(Last reviewed: May 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000017967","14",94844947,"14",94378610,17967,33006,"rs28929474","NC_000014.9:94378609:C:T"
"NM_001040108.1(MLH3):c.2221G>T (p.Val741Phe)","AREL1|MLH3","V741F","Endometrial carcinoma|not provided|Hereditary nonpolyposis colorectal cancer type 7","Benign/Likely benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005561","14",75514138,"14",75047435,5561,20600,"rs28756990","NC_000014.9:75047434:C:A"
"NM_006432.4(NPC2):c.199T>C (p.Ser67Pro)","NPC2","S67P","Niemann-Pick disease, type C2","Pathogenic(Last reviewed: Jul 22, 2008)","no assertion criteria provided","VCV000008482","14",74951282,"14",74484579,8482,23521,"rs11694","NC_000014.9:74484578:A:G"
"NM_001079668.3(NKX2-1):c.727C>A (p.Arg243Ser)","NKX2-1|SFTA3","R243S, R213S","Benign hereditary chorea","Pathogenic(Last reviewed: Apr 15, 2002)","no assertion criteria provided","VCV000008973","14",36986962,"14",36517757,8973,24012,"rs28936671","NC_000014.9:36517756:G:T"
"NM_001079668.3(NKX2-1):c.713G>T (p.Trp238Leu)","NKX2-1|SFTA3","W238L, W208L","not provided|Benign hereditary chorea","Pathogenic(Last reviewed: May 25, 2016)","criteria provided, single submitter","VCV000008974","14",36986976,"14",36517771,8974,24013,"rs28936672","NC_000014.9:36517770:C:A"
"NM_000257.4(MYH7):c.2573G>C (p.Arg858Pro)","MYH7","R858P","Hypertrophic cardiomyopathy|Cardiovascular phenotype","Likely pathogenic(Last reviewed: Dec 21, 2018)","criteria provided, multiple submitters, no conflicts","VCV000520277","14",23894084,"14",23424875,520277,510481,"rs2856897","NC_000014.9:23424874:C:G"
"NM_000257.4(MYH7):c.746G>T (p.Arg249Leu)","MYH7","R249L","not provided|Familial hypertrophic cardiomyopathy 1","Likely pathogenic(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000635223","14",23900677,"14",23431468,635223,623074,"rs3218713","NC_000014.9:23431467:C:A"
"NM_000257.4(MYH7):c.2573G>T (p.Arg858Leu)","MYH7","R858L","not provided","Uncertain significance(Last reviewed: Apr 1, 2017)","criteria provided, single submitter","VCV000807095","14",23894084,"14",23424875,807095,797018,"rs2856897","NC_000014.9:23424874:C:A"
"NM_000257.4(MYH7):c.2573G>A (p.Arg858His)","MYH7","R858H","Hypertrophic cardiomyopathy","Likely pathogenic(Last reviewed: Sep 1, 2020)","criteria provided, single submitter","VCV000177696","14",23894084,"14",23424875,177696,175471,"rs2856897","NC_000014.9:23424874:C:T"
"NM_000257.4(MYH7):c.2572C>A (p.Arg858Ser)","MYH7","R858S","not specified","Uncertain significance(Last reviewed: Apr 4, 2014)","criteria provided, single submitter","VCV000164326","14",23894085,"14",23424876,164326,175618,"rs2754158","NC_000014.9:23424875:G:T"
"NM_000257.4(MYH7):c.2572C>T (p.Arg858Cys)","MYH7","R858C","not provided|Congenital myopathy with fiber type disproportion|Familial hypertrophic cardiomyopathy 1|Cardiomyopathy|Myopathy|Hypertrophic cardiomyopathy","Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2021)","criteria provided, multiple submitters, no conflicts","VCV000164324","14",23894085,"14",23424876,164324,175617,"rs2754158","NC_000014.9:23424875:G:A"
"NM_000257.4(MYH7):c.2572C>G (p.Arg858Gly)","MYH7","R858G","not specified|not provided|Hypertrophic cardiomyopathy","Uncertain significance(Last reviewed: Feb 2, 2021)","criteria provided, multiple submitters, no conflicts","VCV000164325","14",23894085,"14",23424876,164325,175472,"rs2754158","NC_000014.9:23424875:G:C"
"NM_000326.5(RLBP1):c.700C>T (p.Arg234Trp)","RLBP1","R234W","Bothnia retinal dystrophy|RLBP1-Related Disorders|none provided|not provided|Retinitis pigmentosa|Retinitis punctata albescens","Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013100","15",89754025,"15",89210794,13100,28139,"rs28933990","NC_000015.10:89210793:G:A"
"NM_000138.5(FBN1):c.184C>T (p.Arg62Cys)","FBN1","R62C","Marfan syndrome|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype|not provided|none provided","Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000042295","15",48905270,"15",48613073,42295,51465,"rs25403","NC_000015.10:48613072:G:A"
"NM_014249.4(NR2E3):c.932G>A (p.Arg311Gln)","NR2E3","R311Q","Retinal dystrophy|not provided|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|Retinitis pigmentosa 37|Goldmann-Favre syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome","Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)","criteria provided, multiple submitters, no conflicts","VCV000005532","15",72105913,"15",71813573,5532,20571,"rs28937873","NC_000015.10:71813572:G:A"
"NM_000138.4(FBN1):c.6331T>C (p.Cys2111Arg)","FBN1","C2111R","Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Isolated thoracic aortic aneurysm","Likely pathogenic(Last reviewed: Sep 1, 2018)","criteria provided, multiple submitters, no conflicts","VCV000549340","15",48729567,"15",48437370,549340,539601,"rs363815","NC_000015.10:48437369:A:G"
"NM_000138.4(FBN1):c.4022A>G (p.Asn1341Ser)","FBN1","N1341S","Marfan syndrome|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2019)","criteria provided, conflicting interpretations","VCV000495603","15",48766790,"15",48474593,495603,487575,"rs140638","NC_000015.10:48474592:T:C"
"NM_002693.2(POLG):c.2481-7C>T","POLG","","Toe walking|none provided|POLG-Related Spectrum Disorders|Progressive sclerosing poliodystrophy|not provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000138747","15",89865091,"15",89321860,138747,142450,"rs2307448","NC_000015.10:89321859:G:A"
"NM_014249.4(NR2E3):c.119-2A>C","NR2E3","","Cone-rod dystrophy|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Goldmann-Favre syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome|Retinitis pigmentosa|NR2E3-Related Disorders|Retinal dystrophy|not provided|not specified|Horizontal nystagmus|Visual impairment|Retinal dystrophy|Abnormality of color vision","Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)","criteria provided, multiple submitters, no conflicts","VCV000191059","15",72103821,"15",71811481,191059,188865,"rs2723341","NC_000015.10:71811480:A:C"
"NM_031885.4(BBS2):c.209A>G (p.Asn70Ser)","BBS2","N70S","Bardet-biedl syndrome 2/6, digenic|Bardet-Biedl syndrome","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000004576","16",56548501,"16",56514589,4576,19615,"rs4784677","NC_000016.10:56514588:C:C"
"NM_001040667.3(HSF4):c.355C>T (p.Arg119Cys)","HSF4","R119C","Cataract 5 multiple types","Pathogenic(Last reviewed: Jul 1, 2002)","no assertion criteria provided","VCV000007093","16",67199744,"16",67165841,7093,22132,"rs28937573","NC_000016.10:67165840:C:T"
"NM_001138.2(AGRP):c.199G>A (p.Ala67Thr)","AGRP|ATP6V0D1-DT","A67T","Obesity, late-onset|Leanness, inherited","Pathogenic, association(Last reviewed: Aug 30, 2019)","no assertion criteria provided","VCV000007329","16",67516945,"16",67483042,7329,22368,"rs5030980","NC_000016.10:67483041:C:T"
"NM_000243.3(MEFV):c.442G>C","MEFV","","Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|none provided|not provided|Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2021)","criteria provided, conflicting interpretations","VCV000002542","16",3304626,"16",3254626,2542,17581,"rs3743930","NC_000016.10:3254625:C:G"
"NM_001089.3(ABCA3):c.4772A>C (p.Gln1591Pro)","ABCA3","Q1591P","Surfactant metabolism dysfunction, pulmonary, 3","Pathogenic(Last reviewed: Mar 25, 2004)","no assertion criteria provided","VCV000008014","16",2328017,"16",2278016,8014,23053,"rs28936691","NC_000016.10:2278015:T:G"
"NM_001126108.2(SLC12A3):c.1196G>T (p.Arg399Leu)","SLC12A3","R399L, R398L","not provided|Familial hypokalemia-hypomagnesemia","Likely pathogenic(Last reviewed: Oct 28, 2020)","criteria provided, multiple submitters, no conflicts","VCV000381528","16",56913000,"16",56879088,381528,375217,"rs13306668","NC_000016.10:56879087:G:T"
"NM_004608.3(TBX6):c.-48-240A>G","TBX6","","","no interpretation for the single variant","no interpretation for the single variant","VCV000427808","16",30102802,"16",30091481,427808,418555,"rs3809624","NC_000016.10:30091480:T:C"
"NM_031885.4(BBS2):c.209= (p.Asn70=)","BBS2","","Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|not provided|not specified","Benign(Last reviewed: Nov 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000285261","16",56548501,"16",56514589,285261,269498,"rs4784677","NC_000016.10:56514588:C:T"
"NM_004448.3(ERBB2):c.2740G>A (p.Glu914Lys)","ERBB2","E914K, E884K, E899K","Glioma susceptibility 1","Pathogenic(Last reviewed: Sep 30, 2004)","no assertion criteria provided","VCV000013878","17",37881974,"17",39725721,13878,28917,"rs28933368","NC_000017.11:39725720:G:A"
"NM_004448.3(ERBB2):c.2326G>A (p.Gly776Ser)","ERBB2","G776S, G746S, G761S","Adenocarcinoma of stomach|Neoplasm of stomach|Neoplasm","Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)","no assertion criteria provided","VCV000013879","17",37880997,"17",39724744,13879,28918,"rs28933369","NC_000017.11:39724743:G:A"
"NM_005557.4(KRT16):c.362T>C (p.Met121Thr)","KRT16","M121T","not provided|Pachyonychia congenita 1","Pathogenic(Last reviewed: Mar 23, 2016)","criteria provided, single submitter","VCV000014608","17",39768579,"17",41612327,14608,29647,"rs28928894","NC_000017.11:41612326:A:G"
"NM_000526.5(KRT14):c.356T>C (p.Met119Thr)","KRT14","M119T","not provided|Epidermolysis bullosa simplex Dowling-Meara type","Pathogenic(Last reviewed: Dec 8, 2020)","criteria provided, single submitter","VCV000014619","17",39742731,"17",41586479,14619,29658,"rs28928893","NC_000017.11:41586478:A:G"
"NM_000422.3(KRT17):c.263T>C (p.Met88Thr)","KRT17","M88T","Pachyonychia congenita 2|not provided","Pathogenic(Last reviewed: Nov 1, 1999)","no assertion criteria provided","VCV000014592","17",39780499,"17",41624247,14592,29631,"rs28928898","NC_000017.11:41624246:A:G"
"NM_000546.6(TP53):c.743G>A (p.Arg248Gln)","TP53","R248Q, R116Q, R209Q, R89Q","Breast neoplasm|Neoplasm|Nasopharyngeal carcinoma|Carcinoma of colon|Li-Fraumeni syndrome 1|Carcinoma of pancreas|Choroid plexus papilloma|Osteosarcoma|Glioma susceptibility 1|Familial cancer of breast|Adrenocortical carcinoma, hereditary|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Pancreatic adenocarcinoma|Multiple myeloma|Li-Fraumeni syndrome|Medulloblastoma|Chronic lymphocytic leukemia|Squamous cell carcinoma of the skin|Brainstem glioma|Transitional cell carcinoma of the bladder|Small cell lung carcinoma|Lung adenocarcinoma|Malignant melanoma of skin|Hepatocellular carcinoma|not provided|Neoplasm of ovary|Acute myeloid leukemia|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Myelodysplastic syndrome|Familial cancer of breast|Malignant Colorectal Neoplasm|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Lip and oral cavity carcinoma|Lymphoma|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Ductal carcinoma in situ|Sarcoma|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|Uterine Carcinosarcoma|Glioblastoma","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000012356","17",7577538,"17",7674220,12356,27395,"rs11540652","NC_000017.11:7674219:C:T"
"NM_000546.5(TP53):c.451C>A (p.Pro151Thr)","TP53","P151T, P112T, P19T","Uterine Carcinosarcoma|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Breast adenocarcinoma|Rhabdomyosarcoma (disease)|Multiple myeloma|Adenoid cystic carcinoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Li-Fraumeni syndrome|Neoplasm of brain|Hepatocellular carcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Malignant melanoma of skin|Hereditary cancer-predisposing syndrome|Breast neoplasm|Transitional cell carcinoma of the bladder|not provided|Lung adenocarcinoma","Likely pathogenic(Last reviewed: Oct 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012369","17",7578479,"17",7675161,12369,27408,"rs28934874","NC_000017.11:7675160:G:T"
"NM_000546.6(TP53):c.451C>T (p.Pro151Ser)","TP53","P151S, P112S, P19S","Breast neoplasm|Pancreatic adenocarcinoma|Li-Fraumeni syndrome|Multiple myeloma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Hepatocellular carcinoma|Neoplasm of ovary|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Breast adenocarcinoma|Uterine Carcinosarcoma|Adenoid cystic carcinoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012370","17",7578479,"17",7675161,12370,27409,"rs28934874","NC_000017.11:7675160:G:A"
"NM_000546.5(TP53):c.770T>A (p.Leu257Gln)","TP53","L257Q, L125Q, L218Q, L98Q","Li-Fraumeni-like syndrome|Neoplasm of ovary|Li-Fraumeni syndrome","Uncertain significance(Last reviewed: Sep 3, 2016)","criteria provided, single submitter","VCV000012372","17",7577511,"17",7674193,12372,27411,"rs28934577","NC_000017.11:7674192:A:T"
"NM_001276697.2(TP53):c.-66G>C","TP53","A138P, A6P, A99P","Li-Fraumeni syndrome|Li-Fraumeni syndrome 1","Likely pathogenic(Last reviewed: Jan 1, 2020)","criteria provided, single submitter","VCV000012376","17",7578518,"17",7675200,12376,27415,"rs28934875","NC_000017.11:7675199:C:G"
"NM_000018.4(ACADVL):c.1322G>A (p.Gly441Asp)","ACADVL","G441D, G365D, G464D, G419D","not provided|Very long chain acyl-CoA dehydrogenase deficiency","Pathogenic(Last reviewed: Sep 16, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021016","17",7127184,"17",7223865,21016,33868,"rs2309689","NC_000017.11:7223864:G:A"
"NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)","BRCA1","C61G, C14G","Breast neoplasm|Hereditary cancer-predisposing syndrome|Breast carcinoma|none provided|not provided|Neoplasm of ovary|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial 1|Familial cancer of breast|Pancreatic cancer 4|Breast and/or ovarian cancer","Pathogenic(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000017661","17",41258504,"17",43106487,17661,32700,"rs28897672","NC_000017.11:43106486:A:C"
"NM_000342.4(SLC4A1):c.2561C>T (p.Pro854Leu)","SLC4A1","P854L","Spherocytosis type 4|not provided|not specified|Autosomal dominant distal renal tubular acidosis|DIEGO BLOOD GROUP ANTIGEN|Hemolytic anemia","Benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000017768","17",42328621,"17",44251253,17768,32807,"rs2285644","NC_000017.11:44251252:G:A"
"NM_001614.5(ACTG1):c.611C>G (p.Ala204Gly)","ACTG1","A204G","Baraitser-Winter Syndrome 2|not provided","Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000452404","17",79478405,"17",81511379,452404,445921,"rs11549225","NC_000017.11:81511378:G:C"
"NM_000546.5(TP53):c.770T>C (p.Leu257Pro)","TP53","L125P, L218P, L257P, L98P","Li-Fraumeni syndrome","Uncertain significance(Last reviewed: Feb 12, 2019)","criteria provided, single submitter","VCV000458562","17",7577511,"17",7674193,458562,467516,"rs28934577","NC_000017.11:7674192:A:G"
"NM_000546.5(TP53):c.993+1G>A","TP53","","not provided|Li-Fraumeni syndrome|Neoplasm of ovary","Pathogenic(Last reviewed: Sep 24, 2020)","criteria provided, single submitter","VCV000528261","17",7576852,"17",7673534,528261,532188,"rs11575997","NC_000017.11:7673533:C:T"
"NM_005557.4(KRT16):c.362T>G (p.Met121Arg)","KRT16","M121R","not provided","Pathogenic(Last reviewed: Dec 31, 2015)","criteria provided, single submitter","VCV000419351","17",39768579,"17",41612327,419351,409923,"rs28928894","NC_000017.11:41612326:A:C"
"NM_001276697.2(TP53):c.-27C>G","TP53","P112A, P151A, P19A","Adenocarcinoma of stomach|Neoplasm of the large intestine|Carcinoma of esophagus|Uterine Carcinosarcoma|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenoid cystic carcinoma|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of brain|Multiple myeloma|Hepatocellular carcinoma|Malignant melanoma of skin|Squamous cell lung carcinoma|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder","Pathogenic(Last reviewed: Jun 16, 2020)","criteria provided, single submitter","VCV000376641","17",7578479,"17",7675161,376641,363520,"rs28934874","NC_000017.11:7675160:G:C"
"NM_000546.6(TP53):c.993+1G>C","TP53","","not provided|Li-Fraumeni syndrome","Pathogenic(Last reviewed: Feb 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000379801","17",7576852,"17",7673534,379801,375717,"rs11575997","NC_000017.11:7673533:C:G"
"NM_000546.5(TP53):c.993G>A (p.Gln331=)","TP53","","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided","Likely pathogenic(Last reviewed: Jul 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000428868","17",7576853,"17",7673535,428868,420639,"rs11575996","NC_000017.11:7673534:C:T"
"NM_000088.4(COL1A1):c.589G>T","COL1A1","G197C","not provided|Osteogenesis imperfecta type I","Pathogenic(Last reviewed: Dec 6, 2019)","criteria provided, single submitter","VCV000425635","17",48275363,"17",50198002,425635,414025,"rs8179178","NC_000017.11:50198001:C:A"
"NM_000546.5(TP53):c.993+1G>T","TP53","","Neoplasm of ovary|Li-Fraumeni syndrome|not provided","Pathogenic(Last reviewed: Dec 23, 2019)","criteria provided, single submitter","VCV000634766","17",7576852,"17",7673534,634766,622662,"rs11575997","NC_000017.11:7673533:C:A"
"NM_000018.4(ACADVL):c.1322G>C (p.Gly441Ala)","ACADVL","G365A, G419A, G464A, G441A","Very long chain acyl-CoA dehydrogenase deficiency","Uncertain significance(Last reviewed: Sep 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000803305","17",7127184,"17",7223865,803305,791824,"rs2309689","NC_000017.11:7223864:G:C"
"NM_000546.5(TP53):c.770T>G (p.Leu257Arg)","TP53","L125R, L218R, L257R, L98R","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2019)","criteria provided, conflicting interpretations","VCV000142134","17",7577511,"17",7674193,142134,151848,"rs28934577","NC_000017.11:7674192:A:C"
"NM_000422.3(KRT17):c.263T>A (p.Met88Lys)","KRT17","M88K","not provided","not provided","no assertion provided","VCV000066182","17",39780499,"17",41624247,66182,77079,"rs28928898","NC_000017.11:41624246:A:T"
"NM_005557.4(KRT16):c.362T>A (p.Met121Lys)","KRT16","M121K","not provided","not provided","no assertion provided","VCV000066604","17",39768579,"17",41612327,66604,77501,"rs28928894","NC_000017.11:41612326:A:T"
"NM_007294.4(BRCA1):c.181T>A (p.Cys61Ser)","BRCA1","C61S, C14S","Breast-ovarian cancer, familial 1","Pathogenic(Last reviewed: Apr 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000054359","17",41258504,"17",43106487,54359,69026,"rs28897672","NC_000017.11:43106486:A:T"
"NM_007294.4(BRCA1):c.181T>C (p.Cys61Arg)","BRCA1","C61R, C14R","Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1|not provided","Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2021)","criteria provided, multiple submitters, no conflicts","VCV000054360","17",41258504,"17",43106487,54360,69027,"rs28897672","NC_000017.11:43106486:A:G"
"NM_000546.5(TP53):c.743G>C (p.Arg248Pro)","TP53","R116P, R209P, R248P, R89P","Small cell lung carcinoma|Multiple myeloma|Medulloblastoma|Hepatocellular carcinoma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Myelodysplastic syndrome|Breast neoplasm|Chronic lymphocytic leukemia|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Li-Fraumeni syndrome|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin|Acute myeloid leukemia","Pathogenic(Last reviewed: Jan 10, 2019)","criteria provided, single submitter","VCV000237954","17",7577538,"17",7674220,237954,242980,"rs11540652","NC_000017.11:7674219:C:G"
"NM_000546.5(TP53):c.743G>T (p.Arg248Leu)","TP53","R116L, R209L, R248L, R89L","Small cell lung carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Medulloblastoma|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Multiple myeloma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Myelodysplastic syndrome|Breast neoplasm|Chronic lymphocytic leukemia|Acute myeloid leukemia|Squamous cell carcinoma of the head and neck|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Lung adenocarcinoma|Neoplasm of brain|Brainstem glioma|Squamous cell carcinoma of the skin|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000230253","17",7577538,"17",7674220,230253,236469,"rs11540652","NC_000017.11:7674219:C:A"
"NM_000371.4(TTR):c.148G>A (p.Val50Met)","TTR","V50M","Charcot-Marie-Tooth disease|not provided|none provided|Cardiomyopathy|Amyloidogenic transthyretin amyloidosis|Amyloidogenic transthyretin amyloidosis|Dystransthyretinemic euthyroidal hyperthyroxinemia|Carpal tunnel syndrome","Pathogenic(Last reviewed: Jun 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000013417","18",29172937,"18",31592974,13417,28456,"rs28933979","NC_000018.10:31592973:G:A"
"NM_000371.3(TTR):c.148G>C (p.Val50Leu)","TTR","V50L","Charcot-Marie-Tooth disease|Amyloidogenic transthyretin amyloidosis","Pathogenic","criteria provided, single submitter","VCV000013440","18",29172937,"18",31592974,13440,28479,"rs28933979","NC_000018.10:31592973:G:C"
"NM_000271.5(NPC1):c.2793C>T (p.Asn931=)","NPC1","","Niemann-Pick disease type C1|not specified|not provided","Benign(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000021136","18",21119777,"18",23539813,21136,33988,"rs1140458","NC_000018.10:23539812:G:A"
"NM_000271.5(NPC1):c.2103C>G (p.Asn701Lys)","NPC1","N701K","not provided","Likely pathogenic(Last reviewed: May 22, 2018)","criteria provided, single submitter","VCV000546521","18",21124335,"18",23544371,546521,536965,"rs7227375","NC_000018.10:23544370:G:C"
"NM_000371.3(TTR):c.116C>A (p.Ala39Asp)","TTR","A39D","Amyloidogenic transthyretin amyloidosis","Pathogenic(Last reviewed: Aug 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000565560","18",29172905,"18",31592942,565560,570116,"rs11541795","NC_000018.10:31592941:C:A"
"NM_000271.5(NPC1):c.2103C>T (p.Asn701=)","NPC1","","Niemann-Pick disease type C1|not provided|not specified","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000194159","18",21124335,"18",23544371,194159,191322,"rs7227375","NC_000018.10:23544370:G:A"
"NM_000540.3(RYR1):c.7304G>A (p.Arg2435His)","RYR1","R2435H","not provided|enflurane response - Toxicity/ADR|succinylcholine response - Toxicity/ADR|sevoflurane response - Toxicity/ADR|methoxyflurane response - Toxicity/ADR|isoflurane response - Toxicity/ADR|halothane response - Toxicity/ADR|RYR1-Related Disorders|Central core myopathy|desflurane response - Toxicity/ADR","drug response","reviewed by expert panel","VCV000012966","19",38990637,"19",38499997,12966,28005,"rs28933396","NC_000019.10:38499996:G:A"
"NM_000041.4(APOE):c.455G>A (p.Arg152Gln)","APOE","R152Q, R178Q","APOE2 VARIANT","Pathogenic(Last reviewed: Feb 21, 2017)","no assertion criteria provided","VCV000017874","19",45412008,"19",44908751,17874,32913,"rs28931578","NC_000019.10:44908750:G:A"
"NM_001285829.1(CEBPA):c.-107A>T","CEBPA","H84L, H119L, H70L","Acute myeloid leukemia","Pathogenic(Last reviewed: Mar 1, 2001)","no assertion criteria provided","VCV000017568","19",33793070,"19",33302164,17568,32607,"rs28931590","NC_000019.10:33302163:T:A"
"NM_000527.4(LDLR):c.1323C>T (p.Ile441=)","LDLR","","Familial hypercholesterolemia 1|Familial hypercholesterolemia|not specified","Benign/Likely benign(Last reviewed: Nov 17, 2020)","criteria provided, multiple submitters, no conflicts","VCV000456650","19",11224090,"19",11113414,456650,468439,"rs5933","NC_000019.10:11113413:C:T"
"NM_000527.4(LDLR):c.1056C>T (p.Cys352=)","LDLR","","not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000413780","19",11221443,"19",11110767,413780,403134,"rs13306515","NC_000019.10:11110766:C:T"
"NM_000540.2(RYR1):c.7304G>T (p.Arg2435Leu)","RYR1","R2435L","RYR1-Related Disorders|not provided","Pathogenic(Last reviewed: Apr 1, 2019)","criteria provided, single submitter","VCV000133196","19",38990637,"19",38499997,133196,136943,"rs28933396","NC_000019.10:38499996:G:T"
"NM_000146.4(FTL):c.163T>C (p.Leu55=)","FTL|GYS1","","sporadic abdominal aortic aneurysm|Hereditary hyperferritinemia with congenital cataracts|Neuroferritinopathy|Neuroferritinopathy|Hereditary hyperferritinemia with congenital cataracts|not specified|Glycogen storage disease 0, muscle|not provided","Benign(Last reviewed: Nov 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000156440","19",49469087,"19",48965830,156440,166213,"rs2230267","NC_000019.10:48965829:T:C"
"NM_000527.5(LDLR):c.917C>G (p.Ser306Ter)","LDLR","S306*, S179*, S138*, S265*","Familial hypercholesterolemia 1","Pathogenic(Last reviewed: Nov 5, 2016)","criteria provided, multiple submitters, no conflicts","VCV000251524","19",11218167,"19",11107491,251524,245857,"rs11547917","NC_000019.10:11107490:C:G"
"NM_000527.5(LDLR):c.939C>A (p.Cys313Ter)","LDLR","C313*, C272*, C186*, C145*","Familial hypercholesterolemia|Familial hypercholesterolemia 1","Pathogenic(Last reviewed: Jun 4, 2019)","criteria provided, multiple submitters, no conflicts","VCV000251539","19",11218189,"19",11107513,251539,245872,"rs13306512","NC_000019.10:11107512:C:A"
"NM_000527.5(LDLR):c.939C>G (p.Cys313Trp)","LDLR","C313W, C145W, C272W, C186W","Familial hypercholesterolemia|Familial hypercholesterolemia 1","Conflicting interpretations of pathogenicity(Last reviewed: Aug 13, 2018)","criteria provided, conflicting interpretations","VCV000251540","19",11218189,"19",11107513,251540,245873,"rs13306512","NC_000019.10:11107512:C:G"
"NM_000527.5(LDLR):c.1056C>A (p.Cys352Ter)","LDLR","C352*, C184*, C225*, C311*","Familial hypercholesterolemia 1","Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)","criteria provided, multiple submitters, no conflicts","VCV000251621","19",11221443,"19",11110767,251621,245944,"rs13306515","NC_000019.10:11110766:C:A"
"NM_000527.5(LDLR):c.1056C>G (p.Cys352Trp)","LDLR","C352W, C184W, C225W, C311W","Familial hypercholesterolemia 1|Familial hypercholesterolemia","Pathogenic/Likely pathogenic(Last reviewed: May 24, 2021)","criteria provided, multiple submitters, no conflicts","VCV000251622","19",11221443,"19",11110767,251622,245945,"rs13306515","NC_000019.10:11110766:C:G"
"NM_000527.5(LDLR):c.1323C>G (p.Ile441Met)","LDLR","I441M, I400M, I273M, I314M","Familial hypercholesterolemia|Familial hypercholesterolemia 1","Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2019)","criteria provided, multiple submitters, no conflicts","VCV000251784","19",11224090,"19",11113414,251784,246098,"rs5933","NC_000019.10:11113413:C:G"
"NM_000527.5(LDLR):c.917C>A (p.Ser306Ter)","LDLR","S306*, S179*, S138*, S265*","Familial hypercholesterolemia 1","Pathogenic(Last reviewed: Mar 25, 2016)","criteria provided, single submitter","VCV000251523","19",11218167,"19",11107491,251523,245856,"rs11547917","NC_000019.10:11107490:C:A"
"NM_000041.4(APOE):c.137T>C (p.Leu46Pro)","APOE","L46P, L72P","Alzheimer disease, type 4|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2021)","criteria provided, conflicting interpretations","VCV000242765","19",45411110,"19",44907853,242765,32909,"rs769452","NC_000019.10:44907852:T:C"
"NM_000527.5(LDLR):c.917C>T (p.Ser306Leu)","LDLR","S306L, S138L, S179L, S265L","Familial hypercholesterolemia 1|Familial hypercholesterolemia|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000226337","19",11218167,"19",11107491,226337,228150,"rs11547917","NC_000019.10:11107490:C:T"
"NM_000523.4(HOXD13):c.964A>C (p.Ile322Leu)","HOXD13","I322L","Brachydactyly type D|Brachydactyly type E1","Pathogenic(Last reviewed: Jan 27, 2006)","no assertion criteria provided","VCV000014869","2",176959390,"2",176094662,14869,29908,"rs28928891","NC_000002.12:176094661:A:C"
"NM_000523.4(HOXD13):c.947C>G (p.Ser316Cys)","HOXD13","S316C","Brachydactyly type D|Brachydactyly type E1","Pathogenic(Last reviewed: Apr 1, 2003)","no assertion criteria provided","VCV000014870","2",176959373,"2",176094645,14870,29909,"rs28928892","NC_000002.12:176094644:C:G"
"NM_001072.4(UGT1A6):c.1195A>G (p.Asn399Asp)","UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3","N400D, N132D, N397D, N399D, N401D","UGT1A1-Related Disorders|Crigler-Najjar syndrome, type II|Gilbert syndrome","Uncertain significance(Last reviewed: Nov 21, 2018)","criteria provided, single submitter","VCV000012286","2",234676979,"2",233768333,12286,27325,"rs28934877","NC_000002.12:233768332:A:G"
"NM_000384.3(APOB):c.10580G>A (p.Arg3527Gln)","APOB","R3527Q","Familial hypercholesterolemia|Familial hypercholesterolemia 2|Hypobetalipoproteinemia, familial, 1|Hypobetalipoproteinemia|Hypobetalipoproteinemia, familial, 1|Familial hypercholesterolemia 1|Familial hypercholesterolemia 2|not provided|Familial hypobetalipoproteinemia|Homozygous familial hypercholesterolemia","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000017890","2",21229160,"2",21006288,17890,32929,"","NC_000002.12:21006287:C:T"
"NM_194248.3(OTOF):c.5473C>G (p.Pro1825Ala)","OTOF","P1825A, P1135A, P1058A","Deafness, autosomal recessive 9","Pathogenic(Last reviewed: Apr 26, 2011)","no assertion criteria provided","VCV000006138","2",26684624,"2",26461756,6138,21177,"rs28937591","NC_000002.12:26461755:G:C"
"NM_000348.4(SRD5A2):c.737G>A (p.Arg246Gln)","SRD5A2","R246Q","3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency","Pathogenic(Last reviewed: Oct 5, 2020)","criteria provided, single submitter","VCV000459645","2",31751294,"2",31526224,459645,451158,"rs9332967","NC_000002.12:31526223:C:T"
"NM_000384.3(APOB):c.10580G>T (p.Arg3527Leu)","APOB","R3527L","Familial hypercholesterolemia 1","Pathogenic","no assertion criteria provided","VCV000440523","2",21229160,"2",21006288,440523,434173,"rs5742904","NC_000002.12:21006287:C:A"
"NM_000251.2(MSH2):c.943-1G>T","MSH2","","Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|not provided","Pathogenic(Last reviewed: Nov 29, 2019)","criteria provided, multiple submitters, no conflicts","VCV000408461","2",47643434,"2",47416295,408461,392853,"rs12476364","NC_000002.12:47416294:G:T"
"NM_000348.4(SRD5A2):c.16C>T (p.Gln6Ter)","SRD5A2","Q6*","3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency|not provided","Pathogenic(Last reviewed: Jul 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000436859","2",31805954,"2",31580885,436859,428054,"rs9332960","NC_000002.12:31580884:G:A"
"NM_001072.4(UGT1A6):c.1195A>C (p.Asn399His)","UGT1A9|UGT1A4|UGT1A1|UGT1A3|UGT1A10|UGT1A8|UGT1A7|UGT1A|UGT1A6|UGT1A5","N400H, N399H, N132H, N397H, N401H","not provided","Uncertain significance(Last reviewed: Sep 15, 2017)","criteria provided, single submitter","VCV000594091","2",234676979,"2",233768333,594091,585154,"rs28934877","NC_000002.12:233768332:A:C"
"NM_004304.5(ALK):c.4472A>G (p.Lys1491Arg)","ALK","K1491R, K423R","Hereditary cancer-predisposing syndrome|not specified|Squamous cell lung carcinoma|Neuroblastoma 3|not provided","Benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133474","2",29416481,"2",29193615,133474,137213,"rs1881420","NC_000002.12:29193614:T:C"
"NM_004304.5(ALK):c.4587C>G (p.Asp1529Glu)","ALK","D1529E, D461E","Hereditary cancer-predisposing syndrome|not provided|Squamous cell lung carcinoma|not specified|Neuroblastoma 3","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133476","2",29416366,"2",29193500,133476,137215,"rs1881421","NC_000002.12:29193499:G:C"
"NM_000251.2(MSH2):c.943-1G>A","MSH2","","Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms","Likely pathogenic(Last reviewed: Jun 21, 2019)","reviewed by expert panel","VCV000091252","2",47643434,"2",47416295,91252,96727,"rs12476364","NC_000002.12:47416294:G:A"
"NM_000251.3(MSH2):c.943-1G>C","MSH2","","Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms","Likely pathogenic(Last reviewed: Jun 21, 2019)","reviewed by expert panel","VCV000091253","2",47643434,"2",47416295,91253,96728,"rs12476364","NC_000002.12:47416294:G:C"
"NM_000182.5(HADHA):c.474C>T (p.Tyr158=)","HADHA","","Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not specified","Benign(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000092596","2",26455127,"2",26232259,92596,98504,"rs11552518","NC_000002.12:26232258:G:A"
"NM_000311.5(PRNP):c.385A>G (p.Met129Val)","PRNP","M129V","Prion disease, susceptibility to|Alzheimer disease, early-onset, susceptibility to|Aphasia, primary progressive, susceptibility to|not specified|Creutzfeldt-Jakob Disease, Familial|Huntington disease-like 1|none provided|Genetic prion disease","Benign/Likely benign(Last reviewed: Nov 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013397","20",4680251,"20",4699605,13397,28436,"rs1799990","NC_000020.11:4699604:A:G"
"NM_000516.6(GNAS):c.601C>T (p.Arg201Cys)","GNAS","R201C, R202C, R844C, R186C, R142C, R187C","Breast neoplasm|Neoplasm of the large intestine|Pancreatic adenocarcinoma|McCune-Albright syndrome|Hepatocellular carcinoma|Cushing syndrome|Malignant melanoma of skin|Lung adenocarcinoma|Squamous cell carcinoma of the head and neck|Neoplasm of uterine cervix|Adenocarcinoma of stomach|Adrenocortical carcinoma|Neoplasm|Sex cord-stromal tumor|Pituitary adenoma 3, multiple types","Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000015933","20",57484420,"20",58909365,15933,30972,"rs11554273","NC_000020.11:58909364:C:T"
"NM_000516.6(GNAS):c.601C>A (p.Arg201Ser)","GNAS","R201S, R202S, R187S, R142S, R186S, R844S","McCune-Albright syndrome|Cushing syndrome|Polyostotic fibrous dysplasia, somatic, mosaic|PITUITARY TUMOR 3, GROWTH HORMONE-SECRETING, SOMATIC","Pathogenic(Last reviewed: Jan 7, 2015)","no assertion criteria provided","VCV000015937","20",57484420,"20",58909365,15937,30976,"rs11554273","NC_000020.11:58909364:C:A"
"NM_000516.6(GNAS):c.601C>G (p.Arg201Gly)","GNAS","R201G, R202G, R844G, R186G, R142G, R187G","McCune-Albright syndrome","Pathogenic(Last reviewed: Jan 7, 2015)","no assertion criteria provided","VCV000015945","20",57484420,"20",58909365,15945,30984,"rs11554273","NC_000020.11:58909364:C:G"
"NM_000557.5(GDF5):c.1322T>C (p.Leu441Pro)","GDF5|GDF5-AS1","L441P","Brachydactyly type A2|Fibular hypoplasia and complex brachydactyly","Pathogenic(Last reviewed: Mar 1, 2006)","no assertion criteria provided","VCV000008381","20",34021891,"20",35434093,8381,23420,"rs28936683","NC_000020.11:35434092:A:G"
"NM_018419.3(SOX18):c.283T>A (p.Trp95Arg)","SOX18|TCEA2","W95R","Hypotrichosis-lymphedema-telangiectasia syndrome","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000008001","20",62680587,"20",64049234,8001,23040,"rs28936693","NC_000020.11:64049233:A:T"
"NM_001347721.2(DYRK1A):c.450C>T (p.Tyr150=)","DYRK1A","","Mental retardation, autosomal dominant 7","Likely benign(Last reviewed: Nov 14, 2019)","criteria provided, single submitter","VCV000753666","21",38853089,"21",37480787,753666,773338,"rs1049773","NC_000021.9:37480786:C:T"
"NM_000100.4(CSTB):c.43G>T (p.Glu15Ter)","CSTB","E15*","not provided","Likely pathogenic(Last reviewed: Aug 1, 2019)","criteria provided, single submitter","VCV000809294","21",45196108,"21",43776227,809294,798031,"rs11553836","NC_000021.9:43776226:C:A"
"NM_001953.5(TYMP):c.131G>A (p.Arg44Gln)","TYMP","R44Q","Mitochondrial DNA depletion syndrome 1 (MNGIE type)","Pathogenic(Last reviewed: Jan 14, 2016)","no assertion criteria provided","VCV000016661","22",50968008,"22",50529579,16661,31700,"rs28931613","NC_000022.11:50529578:C:T"
"NM_007194.4(CHEK2):c.1039G>A (p.Asp347Asn)","CHEK2","D347N, D280N, D390N, D126N","Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000182432","22",29092945,"22",28696957,182432,181104,"rs28909980","NC_000022.11:28696956:C:T"
"NM_000055.2(BCHE):c.293A>G (p.Asp98Gly)","BCHE","D98G","not provided|Postanesthetic apnea|Deficiency of butyrylcholine esterase","Pathogenic/Likely pathogenic(Last reviewed: May 29, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013215","3",165548529,"3",165830741,13215,28254,"rs1799807","NC_000003.12:165830740:T:C"
"NM_001354689.3(RAF1):c.775T>A (p.Ser259Thr)","RAF1","S259T, S145T, S178T, S226T","Noonan syndrome|Rasopathy|not provided","Pathogenic(Last reviewed: Apr 3, 2017)","reviewed by expert panel","VCV000040601","3",12645694,"3",12604195,40601,49071,"rs3730271","NC_000003.12:12604194:A:T"
"NM_000551.4(VHL):c.194C>G (p.Ser65Trp)","VHL","S65W","not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jul 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000043597","3",10183725,"3",10142041,43597,52766,"rs5030826","NC_000003.12:10142040:C:G"
"NM_000335.5(SCN5A):c.1673A>G (p.His558Arg)","SCN5A","H558R","Arrhythmia|not specified|not provided|Brugada syndrome|Congenital long QT syndrome|Cardiovascular phenotype|Brugada syndrome 1|none provided|Paroxysmal familial ventricular fibrillation 1|Sick sinus syndrome 1, autosomal recessive|Progressive familial heart block, type 1A|Dilated cardiomyopathy 1E|Long QT syndrome 3","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000048289","3",38645420,"3",38603929,48289,38447,"rs1805124","NC_000003.12:38603928:T:C"
"NM_001904.4(CTNNB1):c.94G>T (p.Asp32Tyr)","CTNNB1","D32Y, D25Y","Transitional cell carcinoma of the bladder|Craniopharyngioma|Medulloblastoma|Malignant melanoma of skin|Hepatoblastoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Hepatocellular carcinoma|Pilomatrixoma","Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000017581","3",41266097,"3",41224606,17581,32620,"rs28931588","NC_000003.12:41224605:G:T"
"NM_020208.4(SLC6A20):c.596C>T (p.Thr199Met)","SLC6A20","T199M","Hyperglycinuria|Iminoglycinuria, digenic","Benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000004845","3",45814094,"3",45772602,4845,19884,"rs17279437","NC_000003.12:45772601:G:A"
"NM_023067.4(FOXL2):c.251T>G (p.Ile84Ser)","FOXL2","I84S","Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1","Pathogenic(Last reviewed: Feb 1, 2003)","no assertion criteria provided","VCV000004863","3",138665314,"3",138946472,4863,19902,"rs28937884","NC_000003.12:138946471:A:C"
"NC_000003.11:g.123774078T>G","KALRN","","Coronary heart disease 5","Pathogenic(Last reviewed: Apr 1, 2007)","no assertion criteria provided","VCV000005458","3",123774078,"3",124055231,5458,20497,"rs9289231","NC_000003.12:124055230:T:G"
"NM_001370658.1(BTD):c.1270G>C (p.Asp424His)","BTD","D424H","not provided|Global developmental delay|Seizures|Biotinidase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000001900","3",15686693,"3",15645186,1900,16939,"rs13078881","NC_000003.12:15645185:G:C"
"NM_001370658.1(BTD):c.695A>G (p.Asp232Gly)","BTD","D232G","not provided|Biotinidase deficiency","Pathogenic(Last reviewed: Dec 9, 2019)","criteria provided, multiple submitters, no conflicts","VCV000001901","3",15686118,"3",15644611,1901,16940,"rs28934601","NC_000003.12:15644610:A:G"
"NM_000551.4(VHL):c.481C>T (p.Arg161Ter)","VHL|LOC107303340","R161*, R120*","Familial infantile myasthenia|Renal cell carcinoma, papillary, 1|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided","Pathogenic(Last reviewed: Sep 8, 2019)","criteria provided, multiple submitters, no conflicts","VCV000002217","3",10191488,"3",10149804,2217,17256,"rs5030818","NC_000003.12:10149803:C:T"
"NM_000551.4(VHL):c.562C>G (p.Leu188Val)","VHL|LOC107303340","L188V, L147V","not provided|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Pheochromocytoma","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)","criteria provided, conflicting interpretations","VCV000002225","3",10191569,"3",10149885,2225,17264,"rs5030824","NC_000003.12:10149884:C:G"
"NM_000551.4(VHL):c.250G>T (p.Val84Leu)","VHL","V84L","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Mar 2, 2012)","criteria provided, single submitter","VCV000002236","3",10183781,"3",10142097,2236,17275,"rs5030827","NC_000003.12:10142096:G:T"
"NM_033337.2(CAV3):c.277G>A (p.Ala93Thr)","CAV3","A93T","Rippling muscle disease 2, autosomal recessive|Long QT syndrome|Cardiovascular phenotype|not provided|Rippling muscle disease 2","Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2020)","criteria provided, conflicting interpretations","VCV000008285","3",8787374,"3",8745688,8285,23324,"rs28936686","NC_000003.12:8745687:G:A"
"NM_033337.2(CAV3):c.260T>C (p.Leu87Pro)","CAV3","L87P","not provided|Long QT syndrome|Rippling muscle disease 2","Uncertain significance(Last reviewed: Nov 15, 2017)","criteria provided, single submitter","VCV000008284","3",8787357,"3",8745671,8284,23323,"rs28936685","NC_000003.12:8745670:T:C"
"NM_001354689.3(RAF1):c.775T>G (p.Ser259Ala)","RAF1","S259A, S226A, S178A, S145A","not provided|Rasopathy|not specified","Pathogenic(Last reviewed: Jun 25, 2020)","reviewed by expert panel","VCV000504514","3",12645694,"3",12604195,504514,496336,"rs3730271","NC_000003.12:12604194:A:C"
"NM_000551.3(VHL):c.407T>C (p.Phe136Ser)","VHL|LOC107303340","F136S","Von Hippel-Lindau syndrome|not provided","Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2019)","criteria provided, multiple submitters, no conflicts","VCV000496064","3",10188264,"3",10146580,496064,487032,"rs5030833","NC_000003.12:10146579:T:C"
"NM_000551.3(VHL):c.407T>G (p.Phe136Cys)","VHL|LOC107303340","F136C","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)","criteria provided, conflicting interpretations","VCV000496065","3",10188264,"3",10146580,496065,486986,"rs5030833","NC_000003.12:10146579:T:G"
"NM_001904.4(CTNNB1):c.94G>C (p.Asp32His)","CTNNB1","D32H, D25H","Melanoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Malignant melanoma of skin|Hepatocellular carcinoma|Medulloblastoma|Transitional cell carcinoma of the bladder","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376054","3",41266097,"3",41224606,376054,362933,"rs28931588","NC_000003.12:41224605:G:C"
"NM_001904.4(CTNNB1):c.94G>A (p.Asp32Asn)","CTNNB1","D32N, D25N","Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Malignant melanoma of skin|Adenocarcinoma of stomach|Endometrial neoplasm|Esophageal Squamous Cell Carcinoma|Hepatocellular carcinoma|Neoplasm of uterine cervix|Medulloblastoma|Transitional cell carcinoma of the bladder","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376228","3",41266097,"3",41224606,376228,363107,"rs28931588","NC_000003.12:41224605:G:A"
"NM_000551.3(VHL):c.250G>A (p.Val84Met)","VHL","V84M","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2019)","criteria provided, conflicting interpretations","VCV000428813","3",10183781,"3",10142097,428813,420439,"rs5030827","NC_000003.12:10142096:G:A"
"NM_000551.3(VHL):c.344A>G (p.His115Arg)","VHL|LOC107303340","H115R","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Likely pathogenic(Last reviewed: Sep 13, 2018)","criteria provided, single submitter","VCV000664415","3",10188201,"3",10146517,664415,630722,"rs5030812","NC_000003.12:10146516:A:G"
"NM_001063.4(TF):c.1623-63del","TF","","Atransferrinemia","Likely pathogenic(Last reviewed: Nov 14, 2019)","no assertion criteria provided","VCV000694735","3",133489289,"3",133770445,694735,682854,"rs8177291","NC_000003.12:133770444:T:"
"NM_000551.3(VHL):c.481C>G (p.Arg161Gly)","VHL|LOC107303340","R161G, R120G","not provided","Pathogenic(Last reviewed: Nov 3, 2017)","criteria provided, single submitter","VCV000618484","3",10191488,"3",10149804,618484,609491,"rs5030818","NC_000003.12:10149803:C:G"
"NM_000551.3(VHL):c.490C>G (p.Gln164Glu)","VHL|LOC107303340","Q164E, Q123E","Von Hippel-Lindau syndrome","Uncertain significance(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625253","3",10191497,"3",10149813,625253,613585,"rs5030819","NC_000003.12:10149812:C:G"
"NM_000551.3(VHL):c.344A>C (p.His115Pro)","VHL|LOC107303340","H115P","not provided","Likely pathogenic(Last reviewed: Sep 16, 2015)","criteria provided, single submitter","VCV000560744","3",10188201,"3",10146517,560744,551819,"rs5030812","NC_000003.12:10146516:A:C"
"NM_020949.3(SLC7A14):c.988G>A (p.Gly330Arg)","SLC7A14|SLC7A14-AS1","G330R","Retinitis pigmentosa 68|not provided","Benign(Last reviewed: Nov 14, 2020)","criteria provided, single submitter","VCV000126446","3",170201230,"3",170483441,126446,131974,"rs2276717","NC_000003.12:170483440:C:T"
"NM_033337.2(CAV3):c.277G>T (p.Ala93Ser)","CAV3","A93S","Cardiovascular phenotype|Long QT syndrome|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2020)","criteria provided, conflicting interpretations","VCV000180798","3",8787374,"3",8745688,180798,179088,"rs28936686","NC_000003.12:8745687:G:T"
"NM_000335.5(SCN5A):c.1844G>A (p.Gly615Glu)","SCN5A","G615E","Cardiovascular phenotype|Long QT syndrome, drug-associated|Brugada syndrome|Arrhythmia|Long QT syndrome 3|not provided|Congenital long QT syndrome|not specified|Death in early adulthood|Death in infancy","Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2021)","criteria provided, conflicting interpretations","VCV000067691","3",38645249,"3",38603758,67691,78586,"rs12720452","NC_000003.12:38603757:C:T"
"NM_000551.3(VHL):c.194C>T (p.Ser65Leu)","VHL","S65L","Pancreatic cysts|Cerebellar hemangioblastoma|Retinal capillary hemangioma|Spinal hemangioblastoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Pathogenic(Last reviewed: Jun 16, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182975","3",10183725,"3",10142041,182975,180112,"rs5030826","NC_000003.12:10142040:C:T"
"NM_000551.3(VHL):c.394C>T (p.Gln132Ter)","VHL|LOC107303340","Q132*","not provided|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, multiple submitters, no conflicts","VCV000288749","3",10188251,"3",10146567,288749,272986,"rs5030813","NC_000003.12:10146566:C:T"
"NM_001354689.3(RAF1):c.775T>C (p.Ser259Pro)","RAF1","S259P, S145P, S178P, S226P","Rasopathy|Noonan syndrome","Likely pathogenic(Last reviewed: Jan 29, 2018)","criteria provided, multiple submitters, no conflicts","VCV000228288","3",12645694,"3",12604195,228288,229012,"rs3730271","NC_000003.12:12604194:A:G"
"NM_000551.3(VHL):c.250G>C (p.Val84Leu)","VHL","V84L","Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Mar 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000229860","3",10183781,"3",10142097,229860,232861,"rs5030827","NC_000003.12:10142096:G:C"
"NM_000551.3(VHL):c.194C>A (p.Ser65Ter)","VHL","S65*","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Sep 23, 2019)","criteria provided, single submitter","VCV000223161","3",10183725,"3",10142041,223161,224892,"rs5030826","NC_000003.12:10142040:C:A"
"NM_000551.4(VHL):c.464-2A>G","VHL|LOC107303340","","not provided|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Pheochromocytoma|Erythrocytosis, familial, 2|Renal cell carcinoma, nonpapillary|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jun 30, 2021)","criteria provided, multiple submitters, no conflicts","VCV000223222","3",10191469,"3",10149785,223222,224950,"rs5030816","NC_000003.12:10149784:A:G"
"NM_000551.3(VHL):c.490C>T (p.Gln164Ter)","VHL|LOC107303340","Q164*, Q123*","not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Oct 4, 2018)","criteria provided, multiple submitters, no conflicts","VCV000223228","3",10191497,"3",10149813,223228,224958,"rs5030819","NC_000003.12:10149812:C:T"
"NM_002448.3(MSX1):c.251A>T (p.Glu84Val)","MSX1","E84V","Orofacial cleft 5","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000014883","4",4861877,"4",4860150,14883,29922,"rs28928890","NC_000004.12:4860149:A:T"
"NM_000128.3(F11):c.976C>T (p.Arg326Cys)","F11","R326C","Hereditary factor XI deficiency disease","Likely pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000011898","4",187201487,"4",186280333,11898,26937,"rs28934608","NC_000004.12:186280332:C:T"
"NM_000222.3(KIT):c.1621A>C","KIT","M541L, M537L","Partial albinism|Mastocytosis|Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor|not provided|Lip and oral cavity carcinoma|not specified|Chronic myelogenous leukemia, BCR-ABL1 positive","Benign/Likely benign(Last reviewed: Nov 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000041599","4",55593464,"4",54727298,41599,50038,"rs3822214","NC_000004.12:54727297:A:C"
"NM_021870.3(FGG):c.571G>A (p.Gly191Arg)","FGG","G191R","not specified|not provided|Hypofibrinogenemia|Afibrinogenemia, congenital|Fibrinogen Milano XII, digenic","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000016378","4",155530877,"4",154609725,16378,31417,"rs6063","NC_000004.12:154609724:C:T"
"NM_000142.5(FGFR3):c.1172C>A (p.Ala391Glu)","FGFR3","A391E, A393E","not provided|Craniosynostosis syndrome|Inborn genetic diseases|Carcinoma|Crouzon syndrome with acanthosis nigricans","Pathogenic(Last reviewed: Oct 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000016329","4",1806153,"4",1804426,16329,31368,"rs28931615","NC_000004.12:1804425:C:A"
"NM_006005.3(WFS1):c.713-1075C>G","WFS1","","not provided|Diabetes mellitus, noninsulin-dependent, association with|Type 2 diabetes mellitus|Wolfram syndrome 1","Benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000004528","4",6295693,"4",6293966,4528,19567,"rs6446482","NC_000004.12:6293965:C:G"
"NM_000232.4(SGCB):c.452C>G (p.Thr151Arg)","SGCB","T151R","not provided|Autosomal recessive limb-girdle muscular dystrophy type 2E","Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008712","4",52895065,"4",52028899,8712,23751,"rs28936383","NC_000004.12:52028898:G:C"
"NM_022965.3(FGFR3):c.931-398C>T","FGFR3","A391V, A393V","not provided","Uncertain significance(Last reviewed: Aug 1, 2017)","criteria provided, single submitter","VCV000809609","4",1806153,"4",1804426,809609,795565,"rs28931615","NC_000004.12:1804425:C:T"
"NM_000222.3(KIT):c.1621A>T (p.Met541Leu)","KIT","M537L, M541L","Hereditary cancer-predisposing syndrome|Gastrointestinal stromal tumor","Likely benign(Last reviewed: Nov 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000715131","4",55593464,"4",54727298,715131,721001,"rs3822214","NC_000004.12:54727297:A:T"
"NM_001145805.1(IRGM):c.313C>T (p.Leu105=)","IRGM","","Inflammatory bowel disease 19","Pathogenic(Last reviewed: Mar 1, 2011)","no assertion criteria provided","VCV000030716","5",150227998,"5",150848436,30716,39673,"rs10065172","NC_000005.10:150848435:C:T"
"NM_213647.3(FGFR4):c.1162G>A (p.Gly388Arg)","FGFR4","G388R","Cancer progression and tumor cell motility|See cases","Uncertain significance(Last reviewed: Oct 17, 2019)","criteria provided, single submitter","VCV000016326","5",176520243,"5",177093242,16326,31365,"rs351855","NC_000005.10:177093241:G:A"
"NM_000521.3(HEXB):c.185C>T (p.Ser62Leu)","HEXB","","Sandhoff disease, infantile type|Sandhoff disease","Benign(Last reviewed: Dec 8, 2020)","criteria provided, single submitter","VCV000003882","5",73981270,"5",74685445,3882,18921,"rs820878","NC_000005.10:74685444:T:T"
"NM_000521.4(HEXB):c.1082+5G>C","HEXB","","Sandhoff disease, infantile type","Pathogenic(Last reviewed: Jan 1, 1999)","no assertion criteria provided","VCV000003885","5",74011520,"5",74715695,3885,18924,"rs5030731","NC_000005.10:74715694:G:C"
"NM_000414.4(HSD17B4):c.317G>C (p.Arg106Pro)","HSD17B4","R106P, R82P, R131P, R88P","Bifunctional peroxisomal enzyme deficiency","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000007657","5",118811533,"5",119475838,7657,22696,"rs25640","NC_000005.10:119475837:G:C"
"NM_004168.4(SDHA):c.1660C>T (p.Arg554Trp)","SDHA","R554W, R506W","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Mitochondrial complex II deficiency, nuclear type 1|Hereditary cancer-predisposing syndrome|Leigh syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)","criteria provided, conflicting interpretations","VCV000008742","5",251215,"5",251100,8742,23781,"rs9809219","NC_000005.10:251099:C:T"
"NM_005211.3(CSF1R):c.2906A>T (p.Tyr969Phe)","CSF1R","Y969F","Neoplasm|Hematologic neoplasm","Likely pathogenic(Last reviewed: May 13, 2016)","no assertion criteria provided","VCV000376270","5",149433645,"5",150054082,376270,363149,"rs1801271","NC_000005.10:150054081:T:A"
"NM_005211.3(CSF1R):c.2906A>G (p.Tyr969Cys)","CSF1R","Y969C","Neoplasm|Hematologic neoplasm","Likely pathogenic(Last reviewed: May 13, 2016)","no assertion criteria provided","VCV000376271","5",149433645,"5",150054082,376271,363150,"rs1801271","NC_000005.10:150054081:T:C"
"NM_000521.4(HEXB):c.185T>C (p.Leu62Ser)","HEXB","L62S","not specified|Sandhoff disease","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000167173","5",73981270,"5",74685445,167173,177767,"rs820878","NC_000005.10:74685444:T:C"
"NM_000176.3(NR3C1):c.66G>A (p.Glu22=)","NR3C1","","Glucocorticoid resistance, generalized|Glucocorticoid resistance, relative","Benign/Likely benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000155925","5",142780339,"5",143400774,155925,31193,"rs6189","NC_000005.10:143400773:C:T"
"NM_001127671.2(LIFR):c.3288C>A (p.Asn1096Lys)","LIFR","N1096K, N1085K","not provided|Stüve-Wiedemann syndrome|Congenital anomalies of kidney and urinary tract","Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)","criteria provided, conflicting interpretations","VCV000353605","5",38481703,"5",38481601,353605,299774,"rs3729751","NC_000005.10:38481600:G:T"
"NM_000521.4(HEXB):c.1082+5G>A","HEXB","","Sandhoff disease","Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2017)","criteria provided, multiple submitters, no conflicts","VCV000354135","5",74011520,"5",74715695,354135,300240,"rs5030731","NC_000005.10:74715694:G:A"
"NM_000414.4(HSD17B4):c.317G>A (p.Arg106His)","HSD17B4","R106H, R131H, R82H, R88H","not provided|not specified|Perrault syndrome 1|none provided|Bifunctional peroxisomal enzyme deficiency|Perrault syndrome|Bifunctional peroxisomal enzyme deficiency","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000198079","5",118811533,"5",119475838,198079,195240,"rs25640","NC_000005.10:119475837:G:A"
"NM_001127671.2(LIFR):c.3288C>T (p.Asn1096=)","LIFR","","not provided|Stüve-Wiedemann syndrome|not specified","Benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000195484","5",38481703,"5",38481601,195484,192645,"rs3729751","NC_000005.10:38481600:G:A"
"NM_000410.3(HFE):c.845G>A (p.Cys282Tyr)","HFE","C282Y, C176Y, C180Y, C190Y, C194Y, C259Y, C268Y, C102Y","Hereditary cancer-predisposing syndrome|Porphyria variegata, susceptibility to|Hemochromatosis, juvenile, digenic|Alzheimer disease, susceptibility to|Transferrin serum level quantitative trait locus 2|Microvascular complications of diabetes 7|Alzheimer disease|Porphyrinuria|Cutaneous photosensitivity|not provided|Hemochromatosis type 2|Hemochromatosis type 1|Porphyria cutanea tarda, susceptibility to|Abdominal pain|Pain|Peripheral neuropathy|Abnormality of the male genitalia|Abnormal peripheral nervous system morphology|Abnormality of the nervous system|Behavioral abnormality|Bronze diabetes|Hereditary hemochromatosis","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: May 1, 2021)","criteria provided, conflicting interpretations","VCV000000009","6",26093141,"6",26092913,9,15048,"rs1800562","NC_000006.12:26092912:G:A"
"NM_139011.3(HFE):c.77-2168C>G","HFE|HFE-AS1","H63D, H40D","Familial porphyria cutanea tarda|Microvascular complications of diabetes 7|Variegate porphyria|Hemochromatosis type 1|Transferrin serum level quantitative trait locus 2|Alzheimer disease|not provided|not specified|Microvascular complications of diabetes 7|Cystic fibrosis|Hemochromatosis type 1|Bronze diabetes|Hereditary hemochromatosis","Conflicting interpretations of pathogenicity, other(Last reviewed: May 1, 2021)","criteria provided, conflicting interpretations","VCV000000010","6",26091179,"6",26090951,10,15049,"rs1799945","NC_000006.12:26090950:C:G"
"NM_139007.3(HFE):c.77-236T>C","HFE","I105T, I82T","Hemochromatosis type 1|Hereditary hemochromatosis","Uncertain significance(Last reviewed: Oct 20, 2020)","criteria provided, single submitter","VCV000000012","6",26091306,"6",26091078,12,15051,"rs28934596","NC_000006.12:26091077:T:C"
"NM_139007.3(HFE):c.77-273G>C","HFE","G93R, G70R","Hemochromatosis type 1","Pathogenic(Last reviewed: Jun 1, 1999)","no assertion criteria provided","VCV000000013","6",26091269,"6",26091041,13,15052,"rs28934597","NC_000006.12:26091040:G:C"
"NM_000500.9(CYP21A2):c.40G>T (p.Ala14Ser)","CYP21A2|LOC106780800","A14S","Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Uncertain significance","no assertion criteria provided","VCV000998097","6",32006239,"6",32038462,998097,985825,"rs6445","NC_000006.12:32038461:G:T"
"NM_001142800.2(EYS):c.3906C>A (p.His1302Gln)","EYS","H1302Q","","no interpretation for the single variant","no interpretation for the single variant","VCV000560533","6",65301854,"6",64591961,560533,551547,"rs12663916","NC_000006.12:64591960:G:T"
"NM_001142800.2(EYS):c.3906C>T (p.His1302=)","EYS","","not specified|Retinitis pigmentosa 25|not provided|Retinitis pigmentosa","Benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000093606","6",65301854,"6",64591961,93606,99510,"rs12663916","NC_000006.12:64591960:G:A"
"NM_000500.9(CYP21A2):c.719T>A (p.Met240Lys)","CYP21A2|LOC106780800","M240K, M105K, M210K","not provided","Pathogenic(Last reviewed: May 23, 2017)","criteria provided, single submitter","VCV000242688","6",32007593,"6",32039816,242688,40032,"rs6476","NC_000006.12:32039815:T:A"
"NM_000324.2(RHAG):c.808G>A (p.Val270Ile)","RHAG","V270I","Rh-null, regulator type","Benign(Last reviewed: Mar 18, 2016)","criteria provided, multiple submitters, no conflicts","VCV000225454","6",49580247,"6",49612534,225454,28104,"rs16879498","NC_000006.12:49612533:C:T"
"NM_172056.2(KCNH2):c.1778T>G (p.Ile593Arg)","KCNH2","I593R, I253R","Congenital long QT syndrome|not provided|Long QT syndrome 2","Pathogenic(Last reviewed: May 24, 2019)","criteria provided, single submitter","VCV000014423","7",150648703,"7",150951615,14423,29462,"rs28928904","NC_000007.14:150951614:A:C"
"NM_172056.2(KCNH2):c.1468G>A (p.Ala490Thr)","KCNH2","A490T, A150T","not provided|Long QT syndrome|Long QT syndrome, bradycardia-induced|Long QT syndrome 2|Congenital long QT syndrome","Pathogenic(Last reviewed: Sep 21, 2019)","criteria provided, multiple submitters, no conflicts","VCV000014430","7",150649602,"7",150952514,14430,29469,"rs28928905","NC_000007.14:150952513:C:T"
"NM_172056.2(KCNH2):c.2350C>T (p.Arg784Trp)","KCNH2","R784W, R444W","Brugada syndrome|Arrhythmia|Long QT syndrome 2, acquired, susceptibility to|Long QT syndrome 2|Congenital long QT syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2021)","criteria provided, conflicting interpretations","VCV000014433","7",150647304,"7",150950216,14433,29472,"rs12720441","NC_000007.14:150950215:G:A"
"NM_000492.4(CFTR):c.224G>A (p.Arg75Gln)","CFTR","R75Q","Hereditary pancreatitis|Cystic fibrosis|not specified|not provided|Abnormality of the pancreas|CFTR-related disorders|Inborn genetic diseases|Lung disease, non-specific|none provided","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000035839","7",117149147,"7",117509093,35839,44503,"rs1800076","NC_000007.14:117509092:G:A"
"NM_000492.3(CFTR):c.3080T>C (p.Ile1027Thr)","CFTR|LOC111674472","","not provided|Cystic fibrosis|Inborn genetic diseases|none provided|CFTR-related disorders|not specified","Benign/Likely benign(Last reviewed: Dec 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000035860","7",117250664,"7",117610610,35860,44524,"rs1800112","NC_000007.14:117610609:T:C"
"NM_000823.4(GHRHR):c.57+1G>A","GHRHR","","Isolated growth hormone deficiency, type 4","Pathogenic(Last reviewed: Dec 1, 2007)","no assertion criteria provided","VCV000015990","7",31003741,"7",30964126,15990,31029,"rs2302022","NC_000007.14:30964125:G:A"
"NM_001098629.3(IRF5):c.-12+198=","IRF5","","Systemic lupus erythematosus 10|Rheumatoid arthritis","Pathogenic, risk factor(Last reviewed: Mar 15, 2008)","no assertion criteria provided","VCV000003396","7",128578301,"7",128938247,3396,18435,"rs2004640","NC_000007.14:128938246:T:T"
"NM_000492.3(CFTR):c.1519A>T (p.Ile507Phe)","CFTR|CFTR-AS1","I507F","Cystic fibrosis","Likely pathogenic(Last reviewed: Dec 14, 2017)","criteria provided, single submitter","VCV000526022","7",117199644,"7",117559590,526022,522783,"rs1801178","NC_000007.14:117559589:A:T"
"NM_172056.2(KCNH2):c.1468G>C (p.Ala490Pro)","KCNH2","A150P, A490P","Congenital long QT syndrome","not provided","no assertion provided","VCV000067202","7",150649602,"7",150952514,67202,78098,"rs28928905","NC_000007.14:150952513:C:G"
"NM_172056.2(KCNH2):c.1778T>A (p.Ile593Lys)","KCNH2","I253K, I593K","Long QT syndrome|Congenital long QT syndrome","Pathogenic(Last reviewed: Jul 25, 2017)","criteria provided, single submitter","VCV000067269","7",150648703,"7",150951615,67269,78165,"rs28928904","NC_000007.14:150951614:A:T"
"NM_172056.2(KCNH2):c.1778T>C (p.Ile593Thr)","KCNH2","I253T, I593T","Congenital long QT syndrome|not provided","Pathogenic(Last reviewed: Feb 2, 2014)","criteria provided, single submitter","VCV000067270","7",150648703,"7",150951615,67270,78166,"rs28928904","NC_000007.14:150951614:A:G"
"NM_000492.3(CFTR):c.131A>G (p.Asp44Gly)","CFTR","D44G","Cystic fibrosis","Pathogenic(Last reviewed: Mar 26, 2018)","criteria provided, single submitter","VCV000053227","7",117144384,"7",117504330,53227,67895,"rs1800074","NC_000007.14:117504329:A:G"
"NM_000492.3(CFTR):c.224G>T (p.Arg75Leu)","CFTR","R75L","Cystic fibrosis|not specified","Uncertain significance(Last reviewed: Apr 10, 2019)","criteria provided, single submitter","VCV000053461","7",117149147,"7",117509093,53461,68129,"rs1800076","NC_000007.14:117509092:G:T"
"NM_000823.4(GHRHR):c.57+1G>T","GHRHR","","Isolated growth hormone deficiency type IB","Uncertain significance(Last reviewed: Sep 28, 2016)","criteria provided, single submitter","VCV000360028","7",31003741,"7",30964126,360028,310914,"rs2302022","NC_000007.14:30964125:G:T"
"NM_005045.4(RELN):c.5200C>G (p.Leu1734Val)","RELN","L1734V","not specified|Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7|Lissencephaly|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)","criteria provided, conflicting interpretations","VCV000196901","7",103205735,"7",103565288,196901,194062,"rs362800","NC_000007.14:103565287:G:C"
"NM_000238.4(KCNH2):c.1956T>C (p.Tyr652=)","KCNH2","","Cardiovascular phenotype|Long QT syndrome|Arrhythmia|not specified|none provided|not provided|Long QT syndrome 2","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000200230","7",150648198,"7",150951110,200230,197235,"rs1137617","NC_000007.14:150951109:A:G"
"NM_172056.2(KCNH2):c.1956T>A (p.Tyr652Ter)","KCNH2","Y312*, Y652*","not provided","Pathogenic(Last reviewed: Dec 14, 2017)","criteria provided, single submitter","VCV000200402","7",150648198,"7",150951110,200402,197236,"rs1137617","NC_000007.14:150951109:A:T"
"NM_000492.3(CFTR):c.1519A>G (p.Ile507Val)","CFTR-AS1|CFTR","I507V","Cystic fibrosis|not provided","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000188863","7",117199644,"7",117559590,188863,186746,"rs1801178","NC_000007.14:117559589:A:G"
"NM_003235.5(TG):c.5986T>A (p.Cys1996Ser)","TG","C1996S","Iodotyrosyl coupling defect","Pathogenic(Last reviewed: Aug 1, 2006)","no assertion criteria provided","VCV000012694","8",133984049,"8",132971804,12694,27733,"rs2076739","NC_000008.11:132971803:T:A"
"NM_006096.3(NDRG1):c.538-1G>A","NDRG1","","Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4D","Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2003)","no assertion criteria provided","VCV000005121","8",134266839,"8",133254596,5121,20160,"rs11575976","NC_000008.11:133254595:C:T"
"NM_020427.3(SLURP1):c.256G>A (p.Gly86Arg)","SLURP1","G86R","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004602","8",143822617,"8",142741199,4602,19641,"rs28937888","NC_000008.11:142741198:C:T"
"NM_020427.3(SLURP1):c.256G>C (p.Gly86Arg)","SLURP1","G86R","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004603","8",143822617,"8",142741199,4603,19642,"rs28937888","NC_000008.11:142741198:C:G"
"NM_012144.4(DNAI1):c.1003G>T (p.Val335Phe)","DNAI1","V335F, V339F","Kartagener syndrome|Primary ciliary dyskinesia","Uncertain significance(Last reviewed: Dec 1, 2017)","criteria provided, single submitter","VCV000525451","9",34500821,"9",34500823,525451,525082,"rs11793196","NC_000009.12:34500822:G:T"
"NM_005502.4(ABCA1):c.1759C>T (p.Arg587Trp)","ABCA1","R587W","ABCA1-Related Disorders","Pathogenic(Last reviewed: Jan 11, 2019)","criteria provided, single submitter","VCV000632033","9",107593339,"9",104831058,632033,620315,"rs2853574","NC_000009.12:104831057:G:A"
"NM_004629.1(FANCG):c.1538G>A (p.Arg513Gln)","FANCG|VCP","R513Q","not provided|not specified|Fanconi anemia, complementation group G|Amyotrophic Lateral Sclerosis, Dominant|Fanconi anemia|Inclusion Body Myopathy, Dominant","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000134361","9",35075022,"9",35075025,134361,138100,"rs17885240","NC_000009.12:35075024:C:T"
"NM_012144.4(DNAI1):c.1003G>A (p.Val335Ile)","DNAI1","V335I, V339I","not specified|Primary ciliary dyskinesia|Kartagener syndrome","Benign/Likely benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000163164","9",34500821,"9",34500823,163164,175107,"rs11793196","NC_000009.12:34500822:G:A"
"NM_001110792.2(MECP2):c.952C>T (p.Arg318Cys)","MECP2","R306C, R318C, R213C","not provided|Severe neonatal-onset encephalopathy with microcephaly|none provided|Intellectual disability|Rett syndrome|Angelman syndrome","Pathogenic(Last reviewed: Mar 26, 2021)","reviewed by expert panel","VCV000011824","X",153296363,"X",154030912,11824,26863,"rs28935468","NC_000023.11:154030911:G:A"
"NM_000402.4(G6PD):c.1093G>A (p.Ala365Thr)","G6PD","A335T, A365T","Susceptibility to malaria|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD CHATHAM|not provided|Inborn genetic diseases","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000010363","X",153761205,"X",154532990,10363,25402,"rs5030869","NC_000023.11:154532989:C:T"
"NM_000132.3(F8):c.5530C>T (p.Pro1844Ser)","F8","P1844S","Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease","Likely pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000010281","X",154133142,"X",154904867,10281,25320,"rs28933675","NC_000023.11:154904866:G:A"
"NM_000132.3(F8):c.5533A>C (p.Thr1845Pro)","F8","T1845P","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jul 1, 1992)","no assertion criteria provided","VCV000010282","X",154133139,"X",154904864,10282,25321,"rs28933676","NC_000023.11:154904863:T:G"
"NM_000132.3(F8):c.5526G>A (p.Met1842Ile)","F8","M1842I","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Dec 1, 1993)","no assertion criteria provided","VCV000010280","X",154133146,"X",154904871,10280,25319,"rs28933674","NC_000023.11:154904870:C:T"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+6256C>T","GLA|RPL36A-HNRNPH2","A156T","Fabry disease","Pathogenic(Last reviewed: Oct 17, 2016)","no assertion criteria provided","VCV000010727","X",100656701,"X",101401713,10727,25766,"rs28935195","NC_000023.11:101401712:C:T"
"NM_000169.3(GLA):c.644A>G (p.Asn215Ser)","GLA|RPL36A-HNRNPH2","N215S","not provided|Fabry disease|Fabry disease|Hypertrophic cardiomyopathy|Cardiovascular phenotype","Pathogenic(Last reviewed: Oct 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000010730","X",100653930,"X",101398942,10730,25769,"rs28935197","NC_000023.11:101398941:T:C"
"NM_000354.5(SERPINA7):c.571G>A (p.Asp191Asn)","SERPINA7","D171N, D191N","Thyroxine-binding globulin, slow","Pathogenic(Last reviewed: Apr 1, 1990)","no assertion criteria provided","VCV000009786","X",105280479,"X",106036488,9786,24825,"rs1050086","NC_000023.11:106036487:C:T"
"NM_000044.6(AR):c.2522G>A (p.Arg841His)","AR","R309H, R841H","Androgen resistance syndrome|not provided|Androgen resistance syndrome|Kennedy disease|Partial androgen insensitivity syndrome","Pathogenic(Last reviewed: Sep 10, 2019)","criteria provided, multiple submitters, no conflicts","VCV000009829","X",66942741,"X",67722899,9829,24868,"rs9332969","NC_000023.11:67722898:G:A"
"NM_001278116.2(L1CAM):c.630C>A (p.His210Gln)","L1CAM","H210Q, H205Q","MASA syndrome","Pathogenic(Last reviewed: Jul 1, 1994)","no assertion criteria provided","VCV000009988","X",153136309,"X",153870854,9988,25027,"rs28933683","NC_000023.11:153870853:G:T"
"NM_000132.3(F8):c.1331A>G (p.Lys444Arg)","F8","K444R","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Aug 15, 1991)","no assertion criteria provided","VCV000010212","X",154194357,"X",154966082,10212,25251,"rs28937272","NC_000023.11:154966081:T:C"
"NM_000132.3(F8):c.2383A>T (p.Arg795Ter)","F8","R795*","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Dec 1, 1990)","no assertion criteria provided","VCV000010248","X",154159682,"X",154931407,10248,25287,"rs2228152","NC_000023.11:154931406:T:A"
"NM_000132.3(F8):c.3169G>A (p.Glu1057Lys)","F8","E1057K","not specified|Hereditary factor VIII deficiency disease","Conflicting interpretations of pathogenicity(Last reviewed: May 10, 2017)","criteria provided, conflicting interpretations","VCV000010251","X",154158896,"X",154930621,10251,25290,"rs28933673","NC_000023.11:154930620:C:T"
"NM_001287345.1(BTK):c.1038+44A>G","BTK","Y361C, Y395C","X-linked agammaglobulinemia","Pathogenic(Last reviewed: Oct 1, 1994)","no assertion criteria provided","VCV000011346","X",100613318,"X",101358330,11346,26385,"rs28935478","NC_000023.11:101358329:T:C"
"NM_001363.5(DKC1):c.113T>C (p.Ile38Thr)","DKC1","I38T","Hoyeraal-Hreidarsson syndrome|Dyskeratosis congenita, X-linked","Pathogenic(Last reviewed: May 10, 2012)","no assertion criteria provided","VCV000011593","X",153993747,"X",154765472,11593,26632,"rs28936072","NC_000023.11:154765471:T:C"
"NM_004586.3(RPS6KA3):c.2186G>A (p.Arg729Gln)","RPS6KA3","R729Q","Inborn genetic diseases|not provided|Coffin-Lowry syndrome|Intellectual disability","Likely pathogenic(Last reviewed: Apr 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011658","X",20173553,"X",20155435,11658,26697,"rs28935171","NC_000023.11:20155434:C:T"
"NM_004429.4(EFNB1):c.451G>A (p.Gly151Ser)","EFNB1","G151S","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 11, 2019)","no assertion criteria provided","VCV000011709","X",68059551,"X",68839708,11709,26748,"rs28936069","NC_000023.11:68839707:G:A"
"NM_004429.4(EFNB1):c.452G>T (p.Gly151Val)","EFNB1","G151V","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 8, 2004)","no assertion criteria provided","VCV000011710","X",68059552,"X",68839709,11710,26749,"rs28936070","NC_000023.11:68839708:G:T"
"NM_001110792.2(MECP2):c.352C>T (p.Arg118Trp)","MECP2","R106W, R118W, R13W","not provided|Autism, susceptibility to, X-linked 3|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|History of neurodevelopmental disorder|not specified","Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011814","X",153297719,"X",154032268,11814,26853,"rs28934907","NC_000023.11:154032267:G:A"
"NM_000054.6(AVPR2):c.337C>T (p.Arg113Trp)","AVPR2","R113W","Nephrogenic diabetes insipidus, X-linked","Pathogenic(Last reviewed: May 27, 1993)","no assertion criteria provided","VCV000010840","X",153171297,"X",153905843,10840,25879,"rs28935496","NC_000023.11:153905842:C:T"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+2933G>T","GLA|RPL36A-HNRNPH2","Q327K","Fabry disease","Pathogenic(Last reviewed: Jul 1, 1993)","no assertion criteria provided","VCV000010739","X",100653378,"X",101398390,10739,25778,"rs28935491","NC_000023.11:101398389:G:T"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+2929C>G","GLA|RPL36A-HNRNPH2","","not provided|Fabry disease","Pathogenic(Last reviewed: Aug 15, 2012)","criteria provided, single submitter","VCV000010740","X",100653374,"X",101398386,10740,25779,"rs28935492","NC_000023.11:101398385:C:G"
"NM_000381.4(MID1):c.1877T>C (p.Leu626Pro)","MID1","L626P, L588P","Opitz GBBB syndrome, type I","Pathogenic(Last reviewed: Oct 12, 2000)","no assertion criteria provided","VCV000010808","X",10417535,"X",10449495,10808,25847,"rs28934611","NC_000023.11:10449494:A:G"
"NM_004463.3(FGD1):c.1829G>A (p.Arg610Gln)","FGD1","R610Q","not provided|Aarskog syndrome","Pathogenic(Last reviewed: Mar 30, 2016)","criteria provided, single submitter","VCV000010825","X",54482666,"X",54456233,10825,25864,"rs28935497","NC_000023.11:54456232:C:T"
"NM_000533.5(PLP1):c.44C>T (p.Pro15Leu)","PLP1|RAB9B","P15L","Pelizaeus-Merzbacher disease","Pathogenic(Last reviewed: Dec 1, 1989)","no assertion criteria provided","VCV000011075","X",103040550,"X",103785621,11075,26114,"rs11543022","NC_000023.11:103785620:C:T"
"NM_139058.3(ARX):c.98T>C (p.Leu33Pro)","ARX","L33P","Mental retardation, with or without seizures, ARX-related, X-linked","Pathogenic(Last reviewed: Apr 15, 2002)","no assertion criteria provided","VCV000011198","X",25033757,"X",25015640,11198,26237,"rs28936077","NC_000023.11:25015639:A:G"
"NM_139058.3(ARX):c.856G>A (p.Gly286Ser)","ARX","G286S","Mental retardation, with or without seizures, ARX-related, X-linked|Epileptic encephalopathy, early infantile, 1|Mental retardation, with or without seizures, ARX-related, X-linked|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000011199","X",25031256,"X",25013139,11199,26238,"rs28935479","NC_000023.11:25013138:C:T"
"NM_000354.5(SERPINA7):c.631G>A (p.Ala211Thr)","SERPINA7","A191T, A211T","not provided|Thyroxine-binding globulin deficiency|Thyroxine-binding globulin, variant A","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000009784","X",105279368,"X",106035377,9784,24823,"rs2234036","NC_000023.11:106035376:C:T"
"NM_001110792.2(MECP2):c.352C>G (p.Arg118Gly)","MECP2","R106G, R118G, R13G","Rett syndrome","Uncertain significance(Last reviewed: Jan 21, 2008)","no assertion criteria provided","VCV000143533","X",153297719,"X",154032268,143533,153265,"rs28934907","NC_000023.11:154032267:G:C"
"NM_001278116.2(L1CAM):c.630C>T (p.His210=)","L1CAM","","not provided","Uncertain significance(Last reviewed: Jun 6, 2013)","criteria provided, single submitter","VCV000092933","X",153136309,"X",153870854,92933,98840,"rs28933683","NC_000023.11:153870853:G:A"
"NM_000132.3(F8):c.2383A>G (p.Arg795Gly)","F8","R795G","Hereditary factor VIII deficiency disease","Likely benign(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000368122","X",154159682,"X",154931407,368122,339082,"rs2228152","NC_000023.11:154931406:T:C"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+2933G>A","GLA|RPL36A-HNRNPH2","Q327*","not provided","Pathogenic(Last reviewed: Aug 19, 2015)","criteria provided, single submitter","VCV000281030","X",100653378,"X",101398390,281030,265267,"rs28935491","NC_000023.11:101398389:G:A"
